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Sexual reproduction is...the masterpiece of nature.
(Erasmus Darwin, 1791)
We must not conceal from ourselves the fact that the
causal investigation of organisms is one of the most
difficult, if not the most difficult problem which the
human intellect has attempted to solve, and that this
investigation, like every causal science, can never reach
completeness, since every new cause ascertained only
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Abstract
Sexual differentiation and normal development of the testis and male genital tract are
tightly regulated processes dependent upon a cascade of molecular and morphological
events. In the past fifty years the incidence of reproductive problems in males
including hypospadias, cryptorchidism and testicular cancer is reported to have
increased progressively in many developed countries. Several studies have also
presented controversial findings suggesting that the average sperm counts and/or
semen quality have also declined over the same time period. It has been suggested
that all these problems could arise from events occurring during fetal and/or neonatal
life. Male offspring born to mothers who were given diethylstilbestrol (DES), a
potent synthetic oestrogen, as a preventive to miscarriage, were found to have
increased incidence of undescended testes, urogenital abnormalities and semen
abnormalities compared with those from mothers not given DES. Similarities between
these observations and the abnormalities being observed in the general population has
led to hypothesis that one potential cause of the rise in male reproductive problems
might be inappropriate exposure to oestrogens during fetal and/or neonatal life.
The aims of the present studies were to firstly examine the ontogeny of gene
expression during normal development of the fetal rat testis and secondly to
investigate if oestrogenic chemicals could affect this process as a first step towards
elucidating the mechanisms which might account for the observed problems in male
reproductive development.
In the first part of the thesis, temporal and spatial localisation of several different
proteins has been studied using immunocytochemistry. Novel results regarding
localisation of androgen receptor and inhibin subunits are reported which demonstrate
differences in their patterns of expression in fetal and adult Leydig cells. Specifically,
in contrast to their adult counterparts, fetal cells do not express androgen receptor
suggesting that the negative feedback loop of testosterone on its own production,
established in adult testis via the androgen receptor, is not functional in the fetus.
Inhibin a and BB subunits were localised to Leydig cells from days 14.5 and 16.5 of
gestation respectively. In addition, functional differentiation of fetal Leydig cells has
been studied by examining the expression of two steroidogenic enzymes 17a-
hydroxylase/17,20-lyase (P450cl7) and 36-hydroxysteroid dehydrogenase (3B-HSD)
and two orphan nuclear receptors, steroidogenic factor-1 (SF-1) and DAX-1. As
expected 3B-HSD and P450cl7 immunolocalised exclusively to fetal Leydig cells.
Vlll
Data on immunoexpression of DAX-1 has not been reported previously; DAX-1
protein was first detectable in the fetal rat testis on day 15.5 in the interstitial cells,
simultaneously with the onset of testosterone production. Co-localisation of SF-1 and
DAX-1 in the fetal testis demonstrated that both proteins are not exclusively co-
localised in the same cell types, a finding at odds with suggestions that SF-1 regulates
expression of DAX-1. The second part of the thesis describes experiments designed
to elucidate potential mechanisms underlying the influence of oestrogens on the
developing fetal testis. Studies have focused on the expression of the enzyme
P450cl7 and the transcription factor SF-1. A significant decrease in mRNA
expression and enzyme activity of P450cl7 occurred in fetuses of mothers treated
with DES or the environmental oestrogen octylphenol (OP) but this was not mirrored
by an obvious reduction in 36-HSD immunostaining. The reduction in P450cl7
expression was paralleled by a reduction in SF-1 mRNA and protein expression. As
SF-1 is known to act to regulate multiple genes in the pituitary - testicular axis,
including P450 enzymes, a reduction in expression of this factor could have a
significant effect on the development of the testis and genital tract.
In conclusion, the studies described in this thesis have elucidated the cellular site of
expression of several gene products implicated in fetal testicular development and
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The mechanisms by which an individual's sex is determined has been one of the great
questions of embryology since antiquity. Aristotle claimed that the sex of the
offspring was determined by the heat of the male partner during intercourse. The
more heated the passion, the greater was the probability of a male offspring. Aristode
also proposed that women are in fact men whose development is arrested prematurely
due to the coldness of their mother's womb overcoming the heat of male semen.
These theories were accepted by the Christian church and by Galen, remaining
popular until the 16th and 17th century (Gilbert, 1994). The 20th century has seen a
dramatic increase in our understanding of the processes underlying sexual
differentiation, and it has become clear that this process is dependant on genetic
information rather than on environment. Some of the most notable contributions were
made by Professor Alfred Jost who in the 1940's and 50's suggested that in the
mammals the default pathway in sexual determination is the development of the female
phenotype. As a direct result of his experimental studies testosterone was identified as
the key hormone essential for virilization of the male fetus (Jost, 1953). Furthermore,
he also suggested the existence of an as yet undiscovered hormone responsible for
degeneration of the female reproductive tract (the hormone was later isolated and
named the Antimullerian hormone (AMH; Jost, 1953). Another important milestone
in studies on sexual determination was the identification of the testis determining
factor (known as SRY/Sry) on the Y chromosome in the late 1980's (Berta et al.,
1990; Sinclair et al., 1990). However, while the pieces of this complex mosaic are
slowly assembling, many unanswered questions still need to be addressed.
In the past few years several publications have highlighted a trend towards an increase
in male reproductive problems. Several studies from different European countries
have shown a dramatic increase in the incidence of testicular cancer (today the most
common cancer of young men in the Western world), cryptorchidism and
hypospadias (Giwercman, 1995; Toppari et al., 1996). It has also been reported that
the average sperm count in men from the Western world is falling by a rate of
approximately 2% per year (Auger et al., 1995; Carlsen et al., 1992; Giwercman,
1995; Giwercman and Skakkebaek, 1992) although this is not universal (Fisch and
Goluboff, 1996; Suominen and Vierula, 1993; Vierula et al., 1996). All these afore¬
mentioned problems in the male reproductive tract have one interconnecting point -
they are believed to have a common origin in events during fetal testicular
development (Sharpe and Skakkebaek, 1993). Firstly, cryptorchidism and
1
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hypospadias are thought to be the consequence of inadequate virilization of the
reproductive tract by testosterone. Secondly, cells causing the most common form of
human testicular cancer, carcinoma in situ (CIS), are believed to arise from the
uncontrolled growth of fetal germ cells (Giwercman, 1995). Thirdly, the apparent
reduction in male sperm counts may also have its origin during fetal/neonatal life with
smaller testicular size resulting from reduced numbers of Sertoli cells, the numbers of
which are fixed at this stage of development (Sharpe and Skakkebaek, 1993). The
aetiology for all these problems is not known, but some evidence suggests that
exposure to oestrogens or chemicals mimicking the action of oestrogens could be
involved. It has been suggested that changes in the lifestyle, diet and pollution of the
environment may all result in a greater exposure of mankind to oestrogens and that
this has contributed to the increase in male reproductive problems (Sharpe and
Skakkebaek, 1993).
The aim of the experiments summarised in this thesis was to study the processes
underlying normal sexual differentiation and to examine the effects of oestrogenic
chemicals on these processes. Ontogeny studies have focussed on examining the
pattern of expression of several key gene products in the fetal testis including the
androgen receptor, two steroidogenic enzymes cytochrome P450cl7 and 36-HSD, the
inhibin/activin subunits and two nuclear orphan receptors SF-1 and DAX-1. The
assumption was that pinpointing the time of onset and changes in the level(s) of these
proteins would enhance our understanding of the role of these factors in testicular
development and function. Studies on normal (untreated) animals were considered an
essential prerequisite to an understanding of the possible causes of abnormalities in
these processes.
The second part of this thesis describes studies designed to examine the possible
influence of environmental oestrogens on fetal gonadal development and function.
These studies have concentrated on the influence of oestrogens on one of the key
steroidogenic enzymes P450cl7 and on the expression of SF-1, another important
factor regulating the development of the adrenal gland and the reproductive tract.
Results indicate that the expression of both these genes is affected by inappropriate
exposure to oestrogens during fetal life and provide a background from which to
expand our understanding of the influence of oestrogens on male reproductive
development.
In conclusion, this thesis provides new data about the expression of factors
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influencing testicular development during fetal and neonatal life and the results
obtained demonstrate that environmental oestrogenic chemicals may affect the
expression of genes the products of which are essential to normal function of the




Sexual determination and development of the gonads is a tightly regulated process
that requires a precise spatial and temporal interaction of many genes and proteins
(reviewed by Bogan and Page, 1994; Capel, 1995; Ryner and Swain, 1995). In
mammals, the sex of the offspring is determined at the moment of fertilisation by
the sperm carrying either an X or a Y chromosome (Gilbert, 1994). Fertilisation of
the ovum with a sperm containing an X chromosome results in a female phenotype
whereas fertilisation with a sperm carrying a Y chromosome triggers development
of the male phenotype (Gilbert, 1994). Differences in cell number and growth rates
between male and female embryos can be seen very early in development, prior to
differentiation of the gonads (reviewed by Mittwoch, 1993).
Gonadal development starts around midgestation in rodents (Kaufman, 1992) and at
the middle of first trimester in humans (Gustafson and Donahoe, 1994). In
mammals, the presence of a segment of the Y chromosome containing the gene for a
Testis determining factor (TDF) triggers differentiation of the testis and subsequent
development of the male phenotype (Koopman et al., 1991; Sinclair et al., 1990).
Otherwise fetal development follows the default pathway resulting in the
development of the female phenotype (Gilbert, 1994). A simplified diagram of
sexual differentiation is presented in figure 2.1.
The gonads develop at the ventral side of the mesonephros, as a bulge of sexually
undifferentiated mesenchymal tissue called the genital ridge (Gustafson and
Donahoe, 1994; Pelliniemi et al., 1993; Satoh, 1985). Within the male genital ridge,
Sertoli cells differentiate from mesenchymal cells and form testicular cords
surrounding the germ cells (Gustafson and Donahoe, 1994; Kaufman, 1992). Sertoli
cells start to produce Antimiillerian hormone (AMH, section 2.10.1) - the factor
responsible for regression of the Miillerian ducts which would otherwise form
female internal genitalia (reviewed by Lee and Donahoe, 1993). Following Sertoli
cell differentiation, the Leydig cells differentiate from mesenchymal cells and start
to produce testosterone, the androgen responsible for masculinisation of the male
fetus (reviewed by Huhtaniemi and Pelliniemi, 1992 and Saez, 1994).
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Figure 2.1: Development of the male or female phenotype
Identification of the product of the SRY gene (see section 2.5.2) as the TDF was a
major breakthrough in studying the mechanisms of sexual differentiation (Koopman
et al., 1991; Sinclair et al., 1990). This discovery together with the recent isolation
of several other genes with potentially important function(s) in sexual differentiation
and gonadal development, promise a greater understanding of these processes.
2.2 Primary sex determination
Primary sex determination concerns the determination of the sex of the gonads
(Gilbert, 1994). In mammals, sex determination is strictly chromosomal and is not
generally influenced by the environment (Bogan and Page, 1994; Gilbert, 1994;
Ryner and Swain, 1995). Normally the female carries two X chromosomes and
therefore each of her eggs contains a single X chromosome. In contrast, the XY
genotype of the male results in sperm bearing either an X or Y chromosome. The X
containing oocyte will develop ovaries and a female phenotype if it fuses with a X
bearing sperm at the time of fertilisation. Alternatively, a male phenotype develops
if the egg is fertilised by a sperm carrying a Y chromosome (Gilbert, 1994). It is the
presence of the SRY gene of the Y chromosome, which is responsible for testis
determination (Gilbert, 1994; Harley, 1993; Ryner and Swain, 1995). Even if an
individual carries more than one X chromosome a male will develop in the presence
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of a single functional Y chromosome. Similarly, an individual with only a single X
chromosome (no second X or Y chromosome) develops as a female and forms
ovarian tissue although these fail to maintain follicular development (Gilbert, 1994;
Harley, 1993).
2.3 Secondary sexual determination
Secondary sex determination concerns the bodily phenotype outside the gonads
(Gilbert, 1994). A male mammal develops a penis and secondary sexual glands
(prostate, seminal vesicles, bulbouretric glands) together with sex specific size,
vocal cartilage and musculature whilst a female mammal develops a vagina, cervix,
uterus, oviducts and mammary glands. These secondary sexual characteristics are
usually determined by hormones secreted from the gonads (Gilbert, 1994).
However, in the absence of the gonads, a female phenotype results, emphasising the
importance of the hormones produced by the fetal testis in the development of male
secondary sexual characteristics (Bogan and Page, 1994; Gilbert, 1994; Jost, 1953).
It is now widely accepted that all secondary sexual characteristics in eutherian
mammals result from the action of two testicular hormones, AMH and testosterone.
AMH is secreted by Sertoli cells and causes regression of the Miillerian ducts which
would otherwise develop into a uterus, oviduct, cervix and upper portion of vagina
(George and Wilson, 1994; Gilbert, 1994; Lee and Donahoe, 1993). The other
hormone testosterone, secreted by Leydig cells (Huhtaniemi and Pelliniemi, 1992;
Saez, 1994), induces the development of male structures derived from the Wolffian
duct including the epididymis, vas deferens and seminal vesicles. In addition, the
formation of .male rather than female external genitalia requires the conversion of
testosterone into dihydrotestosterone in the target tissue (George and Wilson, 1994).
A simplified diagrammatic representation of development of the testis and male
phenotype is illustrated in figure 2.2.
















Figure 2.2: Development of the testis and male phenotype
2.4 Differences between XX and XY embryos during early
development
The sex of the embryo is determined at the time of fertilisation, however, the gonads
develop at a relatively late stage of organogenesis with the most obvious intersex
differences evident only after puberty. Some differences between the sexes appear
very early during development, at the blastocyst stage (Mittwoch, 1993). Several
studies in mammalian species have shown differences in the size and number of
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Tsunoda et al., 1985; Xu et al., 1992). Tsunoda and co-workers (1985) have
reported that male embryos are more advanced at the blastocyst stage. Similarly,
Seller and Perkins-Cole (1987) found that the number of somites present in a 9 day
old mouse embryo varies between 0 and 12, with most of the embryos with 0-5
somites being female and most of the embryos with 6-12 somites being male. These
results have raised the question as to whether the observed differences in
development of early embryos result from a faster growth rate or an earlier time of
fertilisation. The answer has been provided by studies using cattle embryos
obtained by in-vitro fertilisation. These experiments showed that male cattle
embryos, fertilised at the same time as female embryos, were already more
advanced by the blastocyst stage (Avery et al., 1991; Xu et al., 1992). It has been
suggested that the presence of the second X chromosome in the female embryo may
be responsible for slower growth and development (Burgoyne et al., 1983).
Conversely, it has been postulated that the Y chromosome carries a factor which
accelerates the growth of early male embryos (Burgoyne, 1993; Tsunoda et al.,
1985). However, the importance of these observations is unknown.
2.5 Genetic control of sexual determination
Sexual differentiation and development involve the action of many gene products.
In recent years, several of these important genes have been identified and further
studies are underway which will hopefully result in determining the action of these
genes in sexual determination (Bogan and Page, 1994; Capel, 1995; Ryner and
Swain, 1995). The current model of the involvement of some of these factors in the
sexual determination cascade is illustrated in figure 2.3.

















Figure 2.3: Genetic control of gonadal development
2.5.1 Testis determining factor
A small region on the short arm of the Y chromosome has been shown to contain the
testis determining factor (TDF). This factor is responsible for testis determination,
dominantly inducing the development of the testis and thus consequently the male
phenotype (Bogan and Page, 1994; Goodfellow and Lovell-Badge, 1993).
Extensive analysis and comparison of sex chromosomes of XX males containing
small fragments of Y chromosome and XY females lacking fragments of Y
chromosome finally resulted in identification of a single gene, named SRY (for sex
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determining region on the Y chromosome) in humans and Sry in mice (Berta et al.,
1990; Sinclair et al., 1990). Initial evidence implicating SRY/Sry as the TDF came
from expression studies which showed Sry gene expression in the mouse genital
ridges for a short time period prior to testis differentiation (Koopman et al., 1990).
In addition, the identification of de novo mutations in the SRY gene of some XY
females further corroborated SRY's involvement in sex determination (reviewed by
Goodfellow and Lovell-Badge, 1993). Direct evidence that Sry is indeed the
primary testis determining factor was provided by transgenic mice studies. A 14
kilobases long fragment of DNA containing the Sry gene and its flanking sequences
was introduced into XX mice embryos and in some, but not all embryos, the
fragment induced the formation of the testis and therefore a male phenotype
(Koopman et al., 1991). Furthermore, these transgenic animals developed
apparently normal testis as well as internal and external genitalia, suggesting that
testosterone and AMH were produced during fetal development (Koopman et al.,
1991). From these experimental studies it was thus apparent that Sry alone was
capable of inducing testis development.
2.5.2 Structure and function of SRY/Sry
The SRY/Sry protein contains 204 and 395 amino acids in human and mouse
respectively (Dubin and Ostrer, 1994) and is encoded by a small gene containing
one exon (Behlke et al., 1993). This protein belongs to the high mobility group
(HMG), a family of non-histone nuclear proteins (Grosschedl et al., 1994; Laudet et
al., 1993). Members of this family are classified according to the number of DNA
binding HMG domains they contain with proteins containing either multiple, low
sequence specificity, or single, highly nucleotide specific domains. Common
properties of the HMG domain proteins include interaction with the minor groove of
the DNA helix, binding to irregular DNA structures and the capacity to modulate
DNA by bending (Grosschedl et al., 1994; Laudet et al., 1993). The SRY/Sry
protein contains a single HMG domain and binds DNA in a sequence specific
manner (Harley and Goodfellow, 1994). The HMG box in the SRY/Sry protein
selectively binds the sequence NACAAT, with the highest affinity for AACAAT
(Dubin and Ostrer, 1994; Harley et al., 1992), and is capable of bending DNA up to
85° (Harley and Goodfellow, 1994). The DNA sequence encoding the HMG box
region of the SRY/Sry gene is relatively conserved amongst different species
(Sinclair et al., 1990; Whitfield et al., 1993). However, the remaining gene
sequence shows no inter species homology and in fact differs even between two
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subspecies of the mouse, suggesting rapid evolution of the gene (Tucker and
Lundrigan, 1993; Whitfield et al., 1993). This observation together with the fact
that all mutations in human XY females reside inside the HMG box (Goodfellow
and Lovell-Badge, 1993) probably suggest that the HMG box is the only functional
part of the SRY/Sry protein. Some studies have implied that SRY/Sry may directly
regulate AMH gene expression, as both proteins are synthesised by Sertoli cells and
AMH expression immediately follows that of Sry in the mouse embryo (Haqq et al.,
1993; Koopman et al., 1990; Munsterberg and Lovell-Badge, 1991). However, the
lack of any known transcriptional activation domains in human SRY might be
consistent with an indirect action of SRY/Sry on the regulation of AMH gene
expression. This is further supported by recent studies in vitro demonstrating an
indirect interaction between these two factors (Haqq et al., 1994). It is possible that
SRY/Sry acts solely by inducing changes in chromatin structure or by bending the
DNA and therefore allowing interactions between distal regions of DNA and
regulatory proteins (Bogan and Page, 1994).
In the mouse fetus, functional Sry is thought to be expressed only for a short time at
the start of gonadal differentiation. Sry mRNA expression in the genital ridges is
first detectable by PCR on day 10.5 p.c. and remains present until day 12.5 (Hacker
et al., 1995; Jeske et al., 1995; Koopman et al., 1990). This finding suggests that the
expression of Sry precedes Sertoli cell differentiation which occurs on day 12.5 p.c.
In addition, Sry transcripts have also been identified in mouse blastocysts (Qiu et al.,
1995; Zwingman et al., 1993) and differentiating adult germ cells (Capel et al.,
1993). The transcripts in the blastocyst and adult germ cells appear to be unusual in
that they are circular and it is unclear whether these mRNA transcripts are translated
into functional proteins (Capel et al., 1993; Qiu et al., 1995).
The exact cellular localisation of SRY/Sry mRNA and protein have not yet been
determined, partially due to the very low level of expression of the gene. However,
Sry is presumed to be expressed in the somatic component of the developing gonad,
as gonadal development is possible in the absence of germ cells (McLaren, 1991).
Studies in chimeric XX/XY embryos have endorsed this view and shown that most
but not all Sertoli cells are XY, while Leydig cells have a proportion of XX and XY
cells similar to that observed in other organs. Likewise, in the developing ovary the
granulosa cells are almost exclusively XX while other cells have a ratio of XX and
XY cells similar to that observed in other tissues (Patek et al., 1991). In the testis,
this finding suggests that Sry is autonomously expressed in the pre-Sertoli cells and
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this event probably triggers differentiation of other cell types. Furthermore, the
results of these studies imply that the initial steps in male/female gonadal
differentiation occur in pre-Sertoli or pre-granulosa cells but as some XX Sertoli
cells and XY granulosa cells have been detected in chimeric gonads this
autonomous action must be supplemented by additional non-autonomous factors
(Patek et al., 1991).
2.5.3 SOX9
SOX9 is the human homologue of the mouse gene Sox9, a member of a family of
genes related to SRY at the level of their sequence (Foster et ah, 1994; Wagner et
ah, 1994; Wright et ah, 1995). The Sox gene family (Sry-type HMG box) is
composed of more than 10 members which all share up to 60% homology in their
HMG box domain. Unlike SRY/Sry, SOX9/Sox9 is highly conserved between
species showing 96% overall homology between the human and mouse genes
(Wright et al., 1995), an observation which may be consistent with Sox9 having an
important regulatory function. Sequence analysis and comparison suggest that Sox9
may function as a transcription factor and it is thought to be important in the
development of the skeletal system (Foster et al., 1994; Wagner et al., 1994; Wright
et ah, 1995). In the mouse embryo, its expression predominates in mesenchymal
condensations throughout the embryo before and during the deposition of cartilage
(Wright et ah, 1995). In humans, mutations in the SOX9 gene are associated with
the campomelic dysplasia (CD), a skeletal malformation syndrome (Foster et ah,
1994; Wagner et al., 1994). The most obvious feature of CD is congenital bowing
and angulation of the long bones which is often combined with other skeletal
abnormalities. Moreover, two thirds of XY individuals with CD have a female
phenotype or are intersex (Houston et ah, 1983). At present, it is thought that SOX9
is required early in gonadal development as many cases of CD display only
primitive gonadal histology with ovarian-like stroma, occasional primordial
follicles, but with no recognisable testicular structures (Foster et ah, 1994; Wagner
et al., 1994). Sequence similarities between SRY and SOX9 suggest a possible
evolutionary relationship between these two genes and the potential that SRY/SOX9
interactions may be required for full cell function in pre-Sertoli cells. SOX9
expression may also be required in other cell types such as the mesenchymal cells
which migrate from the mesonephros and which are required for testis formation
(Capel, 1995).
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2.5.4 Steroidogenic Factor-1
Steroidogenic factor-1 (SF-1), also called Ad4BP, is a recently discovered
transcription factor that was initially identified as a regulator of cytochrome P450
enzymes including P450scc, P450cl7, P450arom and P450c21 (Clemens et al.,
1994; Ikeda et al., 1993; Lynch et al., 1993; Morohashi et al., 1992; Morohashi et
al., 1993; Zhang and Mellon, 1996). In addition, an SF-1 binding element is
contained in the promoter regions of several other genes including AMH (Shen et
al., 1994) and the common a-subunit of LH and FSH (Barnhart and Mellon, 1994).
The SF-1 protein is encoded by the gene Ftz-Fl, a mammalian homologue of the
Drosophila Fushi tarazu factor 1 gene (Ikeda et al., 1993; Lala et al., 1992;
Tsukiyama et al., 1992). The gene contains 5 introns, is highly conserved between
mice and Drosophila (Ikeda et al., 1993), and is located on mouse chromosome 2
and human chromosome 9q33 (Taketo et al., 1995). Alternative gene splicing
produces two different mRNA transcripts; one of the translation products is
expressed at early stages of embryogenesis and named the embryonic long terminal
repeat (ELP) (Ikeda et al., 1993; Morohashi et al., 1994), the other splicing variant
encodes the 461 amino acid SF-1 protein. SF-1, a member of the nuclear receptor
superfamily, contains a putative DNA binding domain at the amino terminus
containing two zinc fingers and a putative ligand binding domain at the carboxy
terminus (Honda et al., 1993; Tsukiyama et al., 1992). Its ligand has not yet been
identified but some studies suggest that ligand-DNA interactions are necessary for
transcriptional activity. Shen et al. (1994) cotransfected AMH and SF-1 genes in a
HeLa cell line and failed to produce any transcriptional activation of AMH by SF-1.
In contrast, transfection of primary Sertoli cells resulted in enhanced expression of
the AMH gene. In the same study, the removal of the putative SF-1 ligand domain
by deletion mutations resulted in creation of a constitutively active receptor,
implying that a ligand is necessary for activation of SF-1 and that the requirement of
SF-1 for a specific ligand may depend upon the cell type in which it is expressed.
Additional experiments have shown that recombinant SF-1 protein binds with high
affinity to a region of DNA with the sequence AGGTCA termed the SF-1 response
element (Morohashi et al., 1992).
The construction of a transgenic mouse lacking a functional SF-1 gene has
demonstrated the importance of SF-1 in the development of steroidogenic tissues
and reproductive organs as these SF-1 knock out mice lacked gonads and adrenal
glands (Luo et al., 1994). In addition, they had a disorganised ventromedial nucleus
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in the hypothalamus and did not express either LH or FSH in their anterior pituitary
glands (Ingraham et al., 1994). Newborn mice homozygous for the SF-1 knock out
died as a result of insufficient adrenal-derived steroid hormones but did survive if
given replacement gluco- and mineralocorticoids (Luo et al., 1994). In addition, the
hypothalamus of these mice produced GnRH but it was not transported to the
pituitary and therefore the pituitary gonadotroph cells did not express LH, FSH or
the GnRH receptor unless given GnRH exogenously (Ingraham et al., 1994).
However, the lack of LH and FSH was not the cause of the observed agonadism
since gonadal development (and adrenal development) was arrested prior to the
onset of LH and FSH production. Studies have shown that these mice initially
develop genital ridges within the mesonephric area but gonadal differentiation is
soon halted and the cells undergo apoptosis (Ingraham et al., 1994; Luo et al., 1994).
Immunocytochemical and in situ hybridisation studies have shown that SF-1 is
expressed in the mesonephric area, the ventromedial nucleus of hypothalamus and
some pituitary cells in mouse and rat (Hatano et al., 1994; Ikeda et al., 1994;
Ingraham et al., 1994). Initially, SF-1 is expressed in the genital ridges in both
sexes but after initiation of gonadal differentiation, its continued expression is
confined to the testis (Hatano et al., 1994; Ikeda et al., 1994). Within the testis, SF-
1 mRNA and protein have been detected in both Leydig and Sertoli cells although
expression levels are significantly higher in the Leydig cells (Hatano et al., 1994).
This pattern of expression and the presence of an SF-1 response element in the
promoter regions of the genes for P450scc, P450cl7 and AMH provides evidence
that SF-1 regulates the production of testosterone in Leydig cells and the expression
of AMH in Sertoli cells. However, to substantiate this hypothesis additional in vitro
and in vivo studies are required.
Only limited studies on the regulation of SF-1 gene expression have so far been
presented. An E-box element, the binding site for the proteins with a helix-loop-
helix motif, has been identified in the 5'-upstream region of the SF-1 gene (Nomura
et al., 1995) but to date no specific factors controlling SF-1 gene expression have
been identified. The Wilms' tumour (WT-1) gene product is a potential candidate as
the phenotype of WT-1 knock out mice is similar to that observed in SF-1 knock out
mice. However, the results of recent studies which show SF-1 expression in the
urogenital ridges ofWT-1 knock-out mice diminishes the possibility ofWT-1 being
a regulator of SF-1 (K.L. Parker, personal communication).
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2.5.5 Wilms' Tumour (WT-1)
In humans, mutations of the tumour suppressor gene, WT-1, are associated with
both Wilms' tumours and urogenital malformations (Baird et al., 1992; Bruening et
al., 1992; Pelletier et al., 1991a, 1991b). Wilms' tumour is a childhood kidney
malignancy which arises from abnormally persistent renal stem cells (Matsunaga,
1981) and can be associated with other congenital abnormalities such as those seen
in WAGR syndrome (Wilms' tumour, aniridia, genitourinary anomalies and mental
retardation) (Baird et al., 1992) and Denys-Drash syndrome (severe malformations
including ambiguous genitalia and streak gonads; Bruening et al., 1992; Pelletier et
al., 1991a). Individuals heterozygous for null mutations of the WT-1 gene
experience cryptorchidism and hypospadias, suggesting that these malformations are
results of a gene dosage effect (Kreidberg et al., 1993). WT-1 encodes a protein
with a proline/glutamine rich amino-terminal domain and four (Cys)2-(His)2 zinc
fingers at the carboxy-terminus (Buckler et al., 1991; Call et al., 1990; Morris et al.,
1991). Alternative RNA splicing produces four discrete transcripts but the
functional role(s) of the protein products of these transcripts are unknown (Haber et
al., 1991).
In mice the earliest expression of WT-1 is found in the intermediate mesoderm on
day 9.0 and WT-1 mRNA is subsequently expressed in differentiating mesothelium,
spinal cord and brain as well as derivatives of the urogenital ridge (Armstrong et al.,
1992). WT-1 is expressed in the mesenchymal cells of the urogenital ridge and its
expression continues into the epithelial cells of the differentiating meso- and
metanephros, In the mouse fetal testis, the WT-1 gene is expressed in Sertoli cells
at high levels from day 12.5 onwards (Armstrong et al., 1992; Pelletier et al.,
1991c). Its expression stays maximal until after birth (day 8) when it starts to
decline as the animal matures (Pelletier et al., 1991c). A knock-out mutation
introduced into transgenic mice results in embryonic death in homozygotes.
Examination of these embryos revealed a failure of kidney and gonadal development
(Kreidberg et al., 1993). These abnormalities are thought to arise around day 11 of
gestation as a result of apoptotic cell death of the metanephric blastema and failure
of Wolffian duct development. WT-1 negative embryos also exhibited abnormal
development of the heart and lungs (Kreidberg et al., 1993). Taken together this
evidence suggest that WT-1 might be involved in the mesenchymal to epithelial
transformation that occurs during development of the gonads and kidneys.
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The exact function of the WT-1 gene products are unknown but it has been
suggested that one or more may act as a repressor and not an activator of gene
expression. One potential target for WT-1 is the Pax-2 gene, another transcription
factor involved in urogenital development (Ryan et al., 1995; Torres et al., 1995).
The Pax-2 gene, a member of a multigene transcription factor family (Grass and
Walther, 1992), is expressed during development of the metanephros and
Wolffian/Miillerian ducts, but is not expressed in the gonads (Dressier et al., 1990).
Transgenic mice lacking a functional Pax-2 gene fail to develop kidneys, ureters
and secondary sexual structures, but do contain gonads and, unlike WT-1 knock-out
mice, the mutants survive until birth (Torres et al., 1995). In vitro experiments have
shown that WT-1 can repress expression of the Pax-2 gene (Ryan et al., 1995) and
WT-1 knockout mice do not express Pax-2 (Kreidberg et al., 1993), suggesting that
the gene lies downstream from WT-1 in the urogenital development cascade.
2.5.6 DAX-1
Defects in the DAX-1 gene have been identified as resulting in adrenal hypoplasia
congenita (AHC; Guo et al., 1995; Muscatelli et al., 1994). AHC is a rare genetic
X-linked disorder in which the patients have a disorganised nonfunctional adrenal
cortex and which is often associated with the development of hypogonadotrophic
hypogonadism (Grambach and Styne, 1992). Duplication of the region of the X
chromosome to which DAX-1 has been mapped has been associated with the
development of ovaries and a female phenotype in XY individuals despite the
presence of SRY (Dosage sensitive sex reversal, DSS; Bardoni et al., 1994).
DAX-1 is a 470 amino acid protein which is encoded by a small gene containing a
single intron. Sequence analysis has revealed homology to members of the nuclear
hormone receptor superfamily (Zanaria et al., 1994). However, whilst a putative
ligand binding domain has been identified, the putative DNA binding domain in the
N-terminal portion of the protein is dissimilar to that seen in other members of the
family. This DNA binding domain contains a 65-67 amino acid (glycine/alanine
rich) repeat motif with cysteines located at conserved positions and may be
organised in two zinc finger domains (Guo et al., 1995; Zanaria et al., 1994).
Experiments in vitro have demonstrated the ability of the DAX-1 protein to bind
DNA, however, the function of this factor in vivo is completely unknown (Guo et
al., 1995; Zanaria et al., 1994).
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2.5.7 Other genes involved in sexual differentiation
The available evidence suggests that other genes in addition to those described
above are also involved in the regulatory cascade leading to gonadal differentiation.
This assumption follows from observations that the majority of XY females with
gonadal dysgenesis have an intact SRY gene and that in a minority of XX males no
parts of the Y chromosome could be detected in their genome (Fechner et al., 1993a,
1993b; Pao et al., 1993). Apart from the DAX-1 and SOX9 genes, the autosomal
locus on chromosome 9p has been implicated in sex reversal associated with
chromosomal deletions in XY females (Bennet et al., 1993). However in this cases
it is not known if sex reversal is due to monosomy for dosage sensitive gene(s) or
whether the deletions reveal recessive mutations. In addition, a report by
McElreavy et al. (1992) has shown a deletion of the Y chromosome more than 1.8
kb upstream from the SRY gene in a case of XY female sex reversal suggesting that
additional genes on the Y chromosome are involved in sex determination or
alternatively some important undiscovered regulatory parts of SRY reside in its
upstream region. McElreavy et al. (1993) have suggested the existence of an
additional gene, termed the Z gene, in the sexual differentiation cascade. They
proposed that the Z gene is a negative regulator of male sexual differentiation and is
functional in females. In males, the SRY product represses or otherwise negatively
regulates Z and thereby allows male sex determination while in females, the absence
of SRY allows the Z gene to be expressed and would consequently repress the
expression of genes necessary for development of male phenotype (McElreavey et
al., 1993).
2.6 Histogenesis of the gonads
Uniquely within the embryo, the gonadal rudiment has the potential to differentiate
into either a testis or an ovary, an event dependent on the presence or the absence of
the SRY gene as discussed above.
Gonadal rudiments first appear as a bulge on the ventral side of mesonephros
resulting from the rapid proliferation of coelomic epithelium and the condensation
of adjacent mesenchyme (Gilbert, 1994; Pelliniemi et al., 1993). At day 13.5 of
fetal life in the rat (Satoh, 1985) and day 11.5-12.0 in the mouse (Kaufman, 1992)
the gonadal rudiments appear as a ridge, known as the gonadal ridge, which is
indistinguishable between the two sexes. Half a day later, (day 14.0 in rat, 13.0 in
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mouse), epithelial strands extend into the underlying mesenchyme and give rise to
the primitive sex cords in the gonad of the male fetus (Kaufman, 1992; Mittwoch et
al., 1969). It is only at this stage that the sex of the fetus can be determined
morphologically because at this time the ovary has a homogenous granular
appearance while the testis contains wide, regularly arranged, bands of tissue, the
testicular cords, which are destined to form the seminiferous tubules (Kaufman,
1992; Mittwoch et al., 1969). Within the testicular cords epithelial cells destined to
become Sertoli cells surround the germ cells which have migrated from the wall of
the yolk sac (Chiquoine, 1954; Witschi, 1948). Almost immediately after the
formation of the testicular cords, Sertoli cells start to produce antimullerian
hormone, AMH (also known as Miillerian inhibiting substance, MIS), and continue
to do so throughout fetal life (see 2.10.1; reviewed by Lee and Donahoe, 1993).
During the subsequent days of gestation some of the mesenchymal cells between the
testicular cords differentiate into steroid producing Leydig cells and around day 15.5
in the rat fetus, testosterone can be detected in the fetal testis (reviewed by
Huhtaniemi and Pelliniemi, 1992 and Saez, 1994). On day 16.5, the testis and ovary
are easily distinguished by their shape and size with the testis being a bigger and
fairly ovoid shaped structure while the ovary is smaller with its craniocaudal axis
almost three times as long as it is wide (Kaufman, 1992; Mittwoch et al., 1969).
Functionally the testis develops early in fetal life into a major endocrine organ
(Huhtaniemi, 1994). In marked contrast to the testis ovarian mesenchymal cells are
quiescent until postnatal life when they differentiate into granulosa cells and start to
produce steroids (Byskov, 1986; Gilbert, 1994).
In the human fetus, the urogenital ridge first appears around day 28 of gestation and
remains sexually indifferent until day 42 (Gustafson and Donahoe, 1994). After day
42, testicular cords are formed and Sertoli cells start to produce antimullerian
hormone; Leydig cells develop and start to produce testosterone between days 50 -
55 (Gustafson and Donahoe, 1994; Huhtaniemi and Pelliniemi, 1992; Siiteri and
Wilson, 1974). Comparison of the crucial time points in testicular development in
rat, mouse and human is summarised in the table 2.1.
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rat
appearance of genital ridge 13.0-13.5
mouse human
11.5-12.0 28-42
testicular cords formation 14.0
start of AMH production 14.0







Table 2.1: Ontogeny of crucial points in testicular differentiation in rat, mouse
and human fetus in days post coitum
2.7 Development of the testis
2.7.1 Development of Sertoli cells
Sertoli cells are the first differentiated cells that can be recognised morphologically
in the testis. On day 14.0 in the rat fetus, the newly formed epithelial cells in the
genital ridge surround the germ cells, start to produce antimiillerian hormone
(AMH) and are now called Sertoli cells (Byskov, 1986; Pelliniemi et al., 1993).
During fetal life the principle function of the Sertoli cells is to synthesise and secrete
AMH (2.10.1). Several studies have also shown the presence of aromatase in fetal
Sertoli cells thus enabling the conversion of testosterone to oestrogen (2.10.6) The
significance of this oestrogen synthesis and the possible role of oestrogens in the
fetal testis is unknown (reviewed by Dorrington and Khan, 1993).
Sertoli cells divide only during fetal life and for a limited period shortly after birth
(Sharpe, 1994). In rats, the proliferation of Sertoli cells is complete by day 18
postnatally (Nagy, 1972; Orth, 1982) and a similar timespan applies to replication in
mouse (Kluin et al., 1984) and rabbit (Sun and Gondos, 1981) whereas in the sheep
(De Riviers et al., 1980), the boar (Kosco et al., 1989) and the bull (Berndtson et al.,
1987) replication probably extends until 6 to 10 weeks postnatally. The available
but limited evidence for Cebus monkey (Rey et al., 1993) and for man (Cortes et al.,
1987) suggests that in primates, this period is longer and may continue at a low rate
until puberty. However, the stallion appears to be an exception and some reports
suggest that in this species Sertoli cells retain proliferative activity throughout adult
life with seasonal changes in the total number of Sertoli cells (Johnson et al., 1991;
Johnson and Nguyen, 1986). Once Sertoli cell proliferation ceases (with the
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exception of the horse), it never resumes and cell numbers are fixed for life (Sharpe,
1994). Sertoli cells are the somatic component of seminiferous tubules and studies
in rat suggested that an adult Sertoli cell can only support a finite number of germ
cells (Berndtson and Thompson, 1990; Russell and Peterson, 1984). This
observation means that any change in Sertoli cell number will be accompanied by a
change in the total number of germ cells supported through the process of
spermatogenesis in adult life (Orth et al., 1988). Consequently, the ultimate size of
the adult testis and total potential sperm output are determined during fetal and
neonatal life when Sertoli cells are able to proliferate. Any reduction in the rate of
proliferation at this critical stage or premature maturation will result in a smaller
total number of Sertoli cells and hence smaller testes and a reduced number of germ
cells in adult life (Orth et al., 1988; Sharpe, 1994).
FSH is an important regulator of Sertoli cell function in adult life (Sharpe, 1994)
and fetal Sertoli cells also express the FSH receptor (FSH-R) during the later stages
of development. Studies by Ranniki et al. (1995) have shown expression of full
length FSH-R mRNA in fetal rat Sertoli cells on day 16.5 using RT PCR whilst
using northern blots, they were able to detect FSH-R mRNA only on and after day
18.5., consistent with an increased expression of FSH at this stage of development
(Aubert et al., 1985; Watanabe and Daikoku, 1979). These results are in accordance
with other studies (Warren et al., 1984) that demonstrated autoradiographic
localisation of FSH-R on day 17.5 in fetal rat testis. They found low binding of
FSH in fetal testis until day 19.5 p.c. after which it rose sharply until just before
birth. Taken together it is assumed that FSH most likely acts in the fetal testis of the
rat only during the later stages of gestation. One potential role of FSH in the
perinatal period is in the stimulation of Sertoli cell proliferation. Orth (1984) has
studied the role of FSH in the rat fetus on day 18.5 p.c. by either injecting fetuses
with antisera against FSH or through fetal decapitation. Both treatments produced
dramatic reductions in the percentage of dividing Sertoli cells as measured by
(3H)thymidine uptake. Similarly, the addition of recombinant FSH to day 18.5 fetal
gonads in vitro, increased the number of Sertoli cells undergoing mitosis (Orth,
1984). Studies by Boitani et al. (1995) have demonstrated that FSH can increase
mitotic activity in postnatal rat testis in vitro and that this activity could be further
potentiated in the presence of activin.
Whilst the available data suggest that FSH stimulates proliferation of Sertoli cells
during late fetal and early postnatal development, the mechanism involved in
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cessation of their mitogenic activity is unknown although thyroid hormones have
been implicated. Hypothyroidism during early postnatal life results in testicular
enlargement (Cooke and Meisami, 1991) in adult life and studies by Hess et al.
(1993) have shown that this enlargement is due to an increase in the number of
Sertoli cells and consequently a higher germ cell number. Similarly, T3 inhibits the
proliferation of Sertoli cells during postnatal development both in vitro (Cooke et
al., 1994) and in vivo (Van Haster et al., 1993). Studies by Van Haster et al. (1993)
have shown that in rats injections of T3 during postnatal life cause cessation of
proliferation on day 12 (in normal animals this process continues until day 16). In
addition, T3 also promotes the formation of lumens within the testicular cords and
maturation of Sertoli cells as measured by the expression of inhibin-BB (Cooke et
al., 1994; Van Haster et al., 1993) and clusterin (SGP-2; Cooke et al., 1994). Taken
together these observations suggest that thyroid hormones influence maturation of
Sertoli cells but the mechanism and importance of this remain to be elucidated.
2.7,2 Development of Leydig and other interstitial cells
Leydig cells are important endocrine cells in both the fetal and adult testis. Fetal
Leydig cells can be discriminated from undifferentiated mesenchymal cells on day
15.5 in the rat fetus (Magre and Jost, 1980). Leydig cells differentiate from
interstitial cells. Precursors for Leydig cells increase their cytoplasmic content
through the development of large mitochondria, lipid droplets and smooth
endoplasmic reticulum and become morphologically distinct Leydig cells (Magre
and Jost, 1980; Saez, 1994). Fetal Leydig cells usually appear as clusters of several
cells positioned closely together (Huhtaniemi, 1994). Functional maturation of fetal
Leydig cells proceeds in concert with morphological differentiation with
testosterone production starting on day 15.5 in the fetal rat testis (Feldman and
Bloch, 1978; Picon, 1976; Saez, 1994; Warren et al., 1973). Fetal Leydig cells have
a larger steroidogenic capacity than their adult counterparts (Huhtaniemi et al.,
1982; Tapanainen et al., 1984), a feature which is probably required to maintain the
high levels of testosterone necessary for the masculinisation of the fetus
(Huhtaniemi, 1994). The relative number of Leydig cells in the fetal rat testis
reaches its maximum on day 18.5 when they represent about 9% of testis volume
and decreases thereafter to 7% and 5% on days 20.5 and 21.5 respectively (Roosen-
Runge and Anderson, 1959). After day 18.5, the relative and absolute number of
Leydig cells starts to decline and after birth fetal type Leydig cells are slowly
replaced by adult type Leydig cells (Lording and De Kretser, 1972). In the human
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fetal testis, the number of Leydig cells increases sharply following the formation of
the testis and reaches its peak around 14-15 weeks of gestation at which time they
represent about half of the testicular volume (Saez, 1994). After the 16th week of
gestation, the relative number of Leydig cells gradually decreases until birth (Saez,
1994).
The mechanism underlying the regulation of fetal Leydig cell differentiation is
unknown. In a situation akin to the regulation of Sertoli cells by FSH, it is thought
that LH is important in regulation of fetal Leydig cell function during the later
stages of pregnancy. In the rat, LH receptor mRNA was detected in Leydig cells on
or about day 16.5-17.5 p.c. (Zhang et al., 1994), and studies using ligand binding
have demonstrated the ability of fetal Leydig cells to bind LH on day 16.5 (Warren
et al., 1984). It is possible that LH stimulates the increase in Leydig cell number
and testosterone production that occurs on and after this time. However, LH is
unlikely to have an important function prior to this time as it is not detectable in
fetal circulation or pituitary glands before day 17.5 of gestation (Aubert et al., 1985;
Watanabe and Daikoku, 1979). Activin and inhibin have also been shown to
modulate the function of fetal Leydig cells, with activin inhibiting (Lin et al., 1989),
and inhibin stimulating, steroidogenesis in neonatal Leydig cells (Hsueh et al., 1987)
under certain conditions. AMH may also regulate fetal Leydig cell function as
transgenic mice lacking functional AMH show Leydig cell hyperplasia suggesting
that AMH might be one factor inhibiting proliferation of Leydig cells (Behringer et
al., 1994).
Apart from the Leydig cells, other non-steroidogenic cells are present in the
interstitial compartment of the fetal testis including myoid peritubular cells
surrounding the testicular cords. The function of these cells is not known, however,
some of these interstitial cells are likely to be Leydig cells precursors (Hardy et al.,
1989; Pelliniemi et al., 1993).
2.7.3 Development and migration of germ cells
While the somatic and steroidogenic cells of the gonads develop from mesonephric
mesenchyme, germ cells develop from extraembryonic mesoderm in the wall of the
yolk sac and subsequently migrate into the mesonephric region (Chiquoine, 1954;
Lawson and Hage, 1994; McLaren, 1994; Witschi, 1948). Germ cells migrate along
the allantois, the wall of the hindgut and dorsal mesentery and enter the mesonephric
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region by day 12.5 in the rat or around the sixth week of gestation in humans
(Byskov, 1986). Thereafter they become surrounded by developing Sertoli cells
which appear to be necessary for their survival since germ cells that remain outside
the testicular cords usually degenerate (Byskov, 1986). The tyrosine kinase receptor
c-kit and its ligand have been implicated in ensuring germ cell survival within the
gonad (Manova et al., 1993). C-kit is expressed by germ cells (Manova et al., 1990;
Yoshinaga et al., 1991) and its ligand, known as the Kit ligand (KL) or Steel factor
is expressed by Sertoli cells from day 17.5 of gestation (Rossi et al., 1993). Packer
et al. (1995) have shown that injection of postnatal rats with antisera raised against
c-kit induced a fivefold increase in death (apoptosis) of spermatogonia, suggesting
that this factor is important for the germ cell survival.
In the male rat, after entering the mesonephric region, germ cells actively proliferate
until day 16.5 when they became arrested in the G1 mitotic phase and remain as
prespermatogonia until after birth (Byskov, 1986; Vergouwen et al., 1991). A few
days after birth, mitosis of prespermatogonia resumes, they differentiate into
spermatogonia A and B and at the start of the puberty enter meiosis (Clermont and
Perey, 1957; Vergouwen et al., 1991). At the onset of spermatogenesis, many
dividing germ cells degenerate (Roosen-Runge and Leik, 1968), suggesting that the
mere presence of Sertoli cells is not enough to ensure their survival (Byskov, 1986).
The reason the male germ cells within the testicular cords do not enter meiosis but
arrest in G1 mitotic phase has been ascribed to the protective function of the cord
itself or the presence of a meiosis preventing substance (MPS; Byskov and Saxen,
1976), however, to date no such factor has been isolated (Byskov, 1986).
2.8 Development of internal secondary sexual organs
The undifferentiated fetus contains precursors of male and female secondary sexual
organs. Around the same time as the gonadal ridge is formed, two pairs of ducts are
generated. The mesonephric (Wolffian) duct lies posteromedial to the genital ridge
and is situated laterally to the mesonephros, entering the urogenital sinus caudally.
The paramesonephric, or Miillerian ducts, develop as paired longitudinal
invaginations of coelomic epithelium alongside the genital ridge (George and
Wilson, 1994; Gilbert, 1994; Kaufman, 1992).
The mesonephric kidney together with the paramesonephric duct become non¬
functional soon after the formation of the gonadal ridge and their function is taken
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over by the metanephros which forms the kidney (Gilbert, 1994). In the presence of
testosterone the mesonephros does not regress but develops into the epididymis and
the Wolffian duct develops into the vas deferens and seminal vesicles (George and
Wilson, 1994; Gilbert, 1994). Concurrently, secretion of AMH by Sertoli cells
within the testis causes the regression of Miillerian ducts (George and Wilson, 1994;
Gilbert, 1994; Lee and Donahoe, 1993). In rats, development of the epididymis and
vas deferens starts at the same time as production of testosterone on or around day
15.5 and Miillerian duct regression is usually complete on or around day 18.5.
In humans, the genital ducts (Wolffian and Mullerian) are developed by the 6th
week of gestation. Regression of Mullerian ducts, induced by AMH, starts around
day 51 and is completed by day 64 (Gustafson and Donahoe, 1994).
In the absence of the testes, the Wolffian ducts regress and the Mullerian ducts
develop into the fallopian tubes, uterus and the upper portion of the vagina, with the
urogenital sinus developing into the lower portion of the vagina (George and
Wilson, 1994; Gilbert, 1994).
2.9 Development of the external genital organs
Development of the male external sexual organs is induced by dihydrotestosterone,
a locally-produced hormone converted in target tissues from testosterone by the
action of the enzyme 5a-reductase (George and Wilson, 1994; Siiteri and Wilson,
1974; Wilson and Lasnitzki, 1971). In rats, the external sexual organs are almost
identical in both sexes throughout gestation. These bipotential structures include
urogenital folds on either side of urogenital membrane, the labioscrotal swellings
lateral to the urogenital folds, and the genital tubercle formed cranially by fusion of
the urogenital folds. In the presence of dihydrotestosterone, the rapidly growing
tubercule pulls forward the urogenital folds and eventually forms the elongated
phallus with the tubercle forming the glans penis and the urogenital folds the penile
shaft. These folds later fuse, while the labioscrotal swellings migrate caudally and
fuse in the midline to form the scrotum and its septum. In humans, the external
genitalia are identical until the 6th week of gestation. Around 7-8 weeks of
gestation a similar process to that in rats begins and by the 12th week, the
labioscrotal swellings have fused to form the scrotum and the formation of male
external genitalia is completed (George and Wilson, 1994; Gilbert, 1994; Gustafson
and Donahoe, 1994).
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In the absence of testosterone, no major changes appear in the external genitalia
with the tubercule developing into the clitoris and the urogenital folds and the
labioscrotal swellings into the labia minor and labia major, respectively, forming
female external reproductive organs (George and Wilson, 1994; Gustafson and
Donahoe, 1994).
2.10 Endocrine function of the fetal testis
The fetal testis is endocrinologically distinct to the adult testis (reviewed by
Huhtaniemi, 1994). Unlike the quiescent fetal ovary, the fetal testis secretes
testosterone and AMH. These two hormones play key roles in sexual differentiation
and all morphological differences between male and female mammals (apart from
the gonads) result from the action of these two hormones (Bogan and Page, 1994).
Several other hormones and/or growth factors including oestrogens, inhibin and
activin are also produced by the fetal testis.
2.10.1 AntimuHerian hormone (AMH)
The existence of a testicular factor responsible for regression of the female
reproductive ducts (Miillerian ducts) was first proposed by Professor Alfred Jost in
the 1950's (Jost, 1953). In classical experiments, he transplanted a fetal rabbit testis
into the vicinity of Miillerian ducts in a female fetus, observing regression of the
Miillerian ducts. In contrast, the transplantation of fetal ovaries into a male fetus
had no effect. This experiment implied the existence of a testicular hormone, apart
from testosterone, synthesised during fetal life, a substance now known as
antimiillerian hormone or Miillerian inhibiting substance (AMH/MIS; Josso et al.,
1993). AMH is a member of a large multigene family that includes TGF-Bs,
inhibins, activins, Xenopus Vg-1 and Drosophila decapentaplegia complex
(Massague, 1990). Members of this family are homologous in their C-terminus,
particularly around 7 conserved cysteine residues. Many of these proteins are
produced as dimeric precursors and undergo posttranslational processing, cleavage
and dissociation, to release a disulphide-linked bioactive C-terminal fragment
(Massague, 1990).
The sequence of AMH is strongly conserved across species, particularly within its
C-terminal domain (Lee and Donahoe, 1993). In the rat, the protein consist of 553
amino acids and is encoded by a gene containing five exons (Haqq et al., 1992).
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The bovine, rat and human genes have 65-80% homology within their coding
regions and 70-75% homology in the promoter region (Lee and Donahoe, 1993).
Both the 5' and 3' untranslated regions are relatively short and probably do not exert
any translational control (Lee and Donahoe, 1993). Mature AMH undergoes
glycosylation and dimerisation and is secreted as a 140 kilodalton dimer of identical
disulphide-linked subunits, called holo-AMH (Josso and Picard, 1986; Lee and
Donahoe, 1993). Finally, the dimer structure is cleaved between amino acid
residues Arg427 and Ser428 to produce a biologically active 25 kD C-terminal
protein and a biologically inactive 110 kD N-terminal (Lee and Donahoe, 1993;
Pepinsky et al., 1988).
AMH mRNA and protein can be detected in the developing rat fetal testis on day
14.0 (Lee et al., 1992) and in mouse fetal testis on day 12.5 (Munsterberg and
Lovell-Badge, 1991). Expression remains high throughout fetal development
dropping rapidly a few days after birth, although AMH is still present at low levels
right up until puberty (Kuroda et ah, 1990; Lee et ah, 1992; Munsterberg and
Lovell-Badge, 1991; Voutilainen and Miller, 1987). AMH has also been detected in
the ovary (Munsterberg and Lovell-Badge, 1991; Voutilainen and Miller, 1987)
where it is expressed postnatally and reaches its highest levels at puberty and during
adulthood. The presence of AMH in the adult ovary and in the testis, long after
regression of the Miillerian ducts, is suggestive of additional biological functions
(Lee and Donahoe, 1993; Munsterberg and Lovell-Badge, 1991; Voutilainen and
Miller, 1987). Recent studies indicate that rat AMH has two developmentally
regulated mRNA transcripts that are differentially polyadenylated (Lee et ah, 1992).
A larger, 2.0 kilobase species is abundant by day 14.0, decreases markedly at birth
and is barely detectable postnatally. A smaller, 1.8 kilobase species is detectable at
day 18.5, prominent at day 21.5 and thereafter declines but remains detectable after
birth (Lee et ah, 1992; Lee and Donahoe, 1993). Although the biological
significance of these two transcripts is unknown, differential polyadenylation may
affect stability or translatability of the two mRNAs as has been described in other
systems (Sachs, 1990).
Regulation of AMH expression has been studied extensively. The discovery of Sry
was followed by suggestions that Sry might be the factor that directly induces the
expression of AMH. This theory was supported by the timing of expression of both
genes, with expression of Sry immediately preceding that of AMH (Hacker et al.,
1995; Koopman et ah, 1990), and by the finding that Sry can bind to a DNA
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sequence within the 5' upstream region of the AMH gene (Haqq et ah, 1993).
However, the short window of expression of Sry compared to that of AMH does not
support this hypothesis and recent evidence suggests that any interaction between
SRY and AMH is more likely to be indirect (Haqq et al., 1994; Shen et al., 1994).
A 2 kb region upstream of the AMH mRNA start site appears to be sufficient for
cell specific gonadal expression (Peschon et ah, 1992). Recently, the binding site
for Steroidogenic factor-1 (SF-1) has been shown at a site -180 (AMH RE1) within
this region (Shen et ah, 1994). Further experiments have demonstrated that SF-1
binds to this sequence and that an intact SF-1 binding site is required for AMH
expression. Transfection studies in primary Sertoli cell cultures indicate that
interactions between SF-1 and AMH RE1 are sufficient to promote activation of
AMH. However, this activity was not present in HeLa cell lines transfected with
both genes, suggesting that Sertoli cells contain the additional factors such as an SF-
1 ligand and/or cofactors which are necessary for AMH expression (Shen et ah,
1994). The suggestion that SF-1 regulates AMH expression is further supported by
comparison of temporal, spatial and sex-specific profiles of both SF-1 and AMH
transcripts (Ikeda et ah, 1994; Munsterberg and Lovell-Badge, 1991).
The importance of extratesticular factors in the regulation of AMH gene expression
is not clear. FSH has been shown to negatively regulate the production of AMH at
the transcriptional level (Kuroda et ah, 1990, 1991) while testosterone and LH may
act posttranslationally, enhancing the cleavage of holo AMH into its N- and C-
terminal fragments (Kuroda et ah, 1991). None of these substances are likely to be
involved in the induction and early regulation of AMH expression as they are not
present (or are undetectable) in the fetus when AMH expression is induced.
However, it is possible that FSH is involved in the postnatal decline in AMH
expression within the testis (Kuroda et al., 1990).
2.10.2 Function of AMH
To date the only fully explored function of AMH is the regression of the Miillerian
(paramesonephric) ducts. In organ culture experiments, purified AMH alone was
able to induce regression of rat Miillerian ducts (Lee and Donahoe, 1993).
Similarly, female mice chronically expressing AMH have no oviducts or uteri
(Behringer et ah, 1990), while male transgenic mice lacking a functional AMH gene
develop both male and female reproductive organs (Behringer et ah, 1994). In
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addition in about half of human males with persistent Miillerian duct syndrome
mutations in the AMH gene have been identified (Guerrier et al., 1989; Josso et al.,
1991; Knebelmann et al., 1991). In some cattle twin fetuses, the pathological
condition known as Freemartinism occurs when the AMH from male fetus crosses
the placenta and causes the regression of the Miillerian ducts in the female fetus
(Byskov, 1986; Jostet al., 1972; Lillie, 1916, 1917).
AMH acts on its target cells through a specific receptor, recently cloned and
recognised as a member of serine/threonine kinase receptor II family (Baarends et
al., 1994; Di Clemente et al., 1994). Serine/threonine kinase receptors are divided
into three subtypes based on the observations made on the TGF-6 receptors. They
are called receptors I, II or III according to their relative molecular masses of 55, 80
and 280 kD respectively (Chiefetz et al., 1987). The type III receptor is believed to
be involved in presentation and binding of TGF-B to the other receptor types
(Lopez-Casillas et al., 1993). The TGF-B type I receptor cannot bind TGF-B in the
absence of the type II receptor and association with the type I receptor is essential
for the type II receptor to signal growth inhibition (Wrana et al., 1992). If the same
organisation of receptor types/functions is true for the whole family this would
suggest the existence of an as yet undiscovered AMH type I receptor.
The AMH receptor gene identified consists of 11 exons (Visser et al., 1995),
encodes a 1.9 kilobases long mRNA, the open reading frame of which encodes a
highly conserved 557 amino acid protein in rat (Baarends et al., 1994) which has
569 amino acids in rabbit (Di Clemente et al., 1994). In male and female rat gonads
and adjacent ducts, the receptor is expressed in a tissue specific manner on day 14.5
(Baarends et al., 1994). Expression in the female gonads and associated ducts
remains high throughout fetal life while expression in the male fetus becomes
restricted to the small area around the degenerating Mullerian duct (Baarends et al.,
1994).
Male mice lacking AMH (knock outs) still develop the male reproductive system
and produce functional sperm but are usually infertile because of the presence of
female reproductive organs that interfere with the delivery of sperm (Behringer et
al., 1994). However, the testis of these mice exhibit Leydig cell hyperplasia, and
occasionally Leydig cell neoplasia, suggesting a role for AMH in modulating
Leydig cell development (Behringer et al., 1994). The ovaries of mice chronically
expressing AMH become depleted of germ cells and their gonadal somatic cells
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reorganise into testicular cord like structures (Behringer et al., 1990), a processes
that has also been observed occasionally in female free-martin fetuses. These
observations suggest that AMH may play a role in gonadal differentiation.
Likewise, expression of AMH in the adult ovary and testis (Munsterberg and
Lovell-Badge, 1991; Voutilainen and Miller, 1987) suggests additional roles for this
hormone. Some of the proposed functions of AMH postnatally include regulation of
spermatogenesis and oogenesis, testicular descent, lung maturation and Leydig cell
development (reviewed by Lee and Donahoe, 1993).
2.10.3 Testosterone
Testosterone and dihydrotestosterone are the principle male sexual hormones and
have important functions in both fetal and adult life (George and Wilson, 1994;
Sharpe, 1994). Testosterone and dihydrotestosterone are steroid hormones derived
from cholesterol by the action of several steroidogenic enzymes (Fig. 2.4; reviewed
by Miller, 1988). The majority of steroid hormones are produced in the adrenal
cortex and gonads, however, small amounts are also generated in other tissues such
as the brain and gut. Despite their apparently similar structures, the different steroid
hormones have very different functions. Adrenal glands mostly produce gluco- and
mineralocorticoids, which are important in controlling the metabolism of
carbohydrates, fat, proteins and minerals, regulating fluid transport in the kidney
(and consequently control of blood pressure), and exhibit anti-inflammatory
responses (O'Riordan et al., 1988; Orth et al., 1992).
Most sex steroid hormones are produced in the gonads with the ovary producing
mostly oestrogen and progesterone and the testis mostly testosterone. High
concentrations of testosterone are synthesised in the ovary, but the majority of this
hormone is immediately aromatised into oestrogen (Carr, 1992; O'Riordan et al.,
1988). Some oestrogens and testosterone are also produced in the adrenal gland
(Carr, 1992; Griffin and Wilson, 1992; Orth et al., 1992).
The biosynthesis of testosterone and oestrogens is summarised in Fig. 2.4. Briefly,
once inside steroidogenic cells, cholesterol is transported to the inner mitochondrial
membrane, a process in which the recently discovered StAR protein has been
implicated (Lin et al., 1995). The first step in the process of steroidogenesis is the
conversion of cholesterol to pregnenolone, a reaction catalysed by the enzyme
P450scc (cytochrome P450 side chain cleavage) which is located inside the
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mitochondria. Pregnenolone then diffuses across the mitochondrial membranes and
is further metabolised by enzymes associated with the smooth endoplasmic
reticulum. In the smooth endoplasmic reticulum, pregnenolone is initially converted
to progesterone by 3B-HSD and then further catalysed by the cytochrome P450
enzyme, 17a-hydroxylase/Ci7-20 lyase (P450cl7). P450cl7 is a single protein that
catalyses two distinct reactions; the hydroxylation of progesterone at C17 followed
by the cleavage of the two-carbon side-chain to yield the C19 steroid,
androstenedione - the immediate precursor of testosterone. The final reaction in the
process is the reduction of androstenedione to testosterone by 17B-hydroxysteroid
dehydrogenase (reviewed by Miller, 1988).
In its target tissues, testosterone is usually further transformed by the 5a-reductase
enzyme into 5a-dihydrotestosterone, which has a more potent androgenic activity
than testosterone (O'Riordan et al., 1988).
As summarized in fig. 2.4, two different pathways are possible for conversion of
steroids dependent on whether pregnenolone is converted by 3B-HSD or P450cl7.
If pregnenolone is converted to progesterone by 3B-HSD, the A4 or progesterone
pathway is used and if P450cl7 transforms pregnenolone into 17a-
hydroxypregnenolone, the A5 or dehydroepiandrosterone pathway is used.
Conversion of A5 steroids to those of the A4 pathway by 3B-HSD can also occur.
The choice of pathways is not random. Rats use the A4 pathway predominantly if not
exclusively, whilst pigs, rabbits and dogs use the A^ pathway to varying degrees.
Regulation of the choice of pathway could arise either as the result of the properties
of the enzymes or by their arrangement within the membranes. If, for example, the
C21 side-chain cleveage enzyme has a higher affinity for pregnenolone than for
progesterone, the A5 pathway would prevail (Hall, 1994.







Figure 2.4: Pathways involved in biosynthesis of steroid hormones from
cholesterol. Enzymes involved in each step are marked with the numbers and are as
follows: 1. (P450scc); 2. 3B-HSD; 3. P450cl7 (17a-hydroxylase); 4. P450cl7
(Cn/20-lyase); 5. 17B-hydroxysteroid dehydrogenase; 6. P450aromatase. The A4
pathway, predominant in rat, is marked by arrows in bold.
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2.10.4 Regulation of testosterone production
In fetal and adult life, the principle site of testosterone production are the Leydig
cells within the testis. In the rat fetus, testosterone production in the Leydig cells
starts around day 15.5 (Feldman and Bloch, 1978; Picon, 1976; Warren et al., 1973).
This coincides with expression of P450scc which is first detectable using
immunocytochemistry on day 15.5 (Rouiller et al., 1990). Similarly, studies in the
mouse fetus have shown the presence of P450scc, P450cl7 and 3B-HSD mRNAs on
day 13.5 (Greco and Payne, 1994), equivalent to rat day 15.5. Testosterone levels
are low on day 15.5, rise sharply, reaching a peak on day 18.5, and remain high (or
slightly decline) throughout the rest of fetal life (Feldman and Bloch, 1978; Picon,
1976; Warren et al., 1973). In the human fetus, testosterone production starts
between 7 and 8 weeks p.c. (Siiteri and Wilson, 1974) and reaches a peak between
12 and 14 weeks of gestation followed by a gradual decline (Huhtaniemi and
Pelliniemi, 1992; Tapanainen et al., 1981). Studies by Voutilainen and Miller
(1986) have shown strong expression of P450scc and P450cl7 mRNA's in the
human fetal testis between 13 (earliest examined age) and 20 weeks with a rapid
decline thereafter to only 35 and 19% of peak levels of P450scc and P450cl7,
respectively.
Regulation of testosterone production by fetal Leydig cells is still not fully
understood. Luteinizing hormone (LH), the main regulator of testosterone
biosynthesis by adult Leydig cells, has probably only a minor role during fetal life
and is unlikely to be involved in the mechanism that triggers the onset of
testosterone biosynthesis (Saez, 1994). In the rat fetus, binding of LH to fetal
Leydig cells can be demonstrated for the first time on day 15.5 (Gangnerau et al.,
1982; Warren et al., 1984). The mRNA for the extracellular domain of the LH
receptor could be detected by RT PCR on day 15.5 with much stronger expression
one day later (detectable by northern blot hybridisation) on day 16.5 p.c. (Zhang et
al., 1994). However, there is apparently no detectable LH in the blood or pituitaries
at this age (Aubert et al., 1985; Watanabe and Daikoku, 1979). For some time it
was thought that hCG might be responsible for the activation of testosterone
production, as this glycoprotein hormone binds to the fetal Leydig cells and
stimulates testosterone production both in human and rat fetuses (Saez, 1994). It is
possible that hCG is indeed involved in the onset of testosterone production in
primates however hCG-like protein has not been isolated from the rat and a
placental CG is unlikely to have the same role in rodents (Habert and Picon, 1990;
Chapter 2 Literature Review 33
Wurzel et al., 1983). Two alternative explanations have been proposed in rodents;
firstly that there is a non-gonadotrophic factor in the rat fetus that activates and
maintains the initial period of fetal testicular steroidogenesis or secondly that onset
of fetal testicular steroidogenesis is an autonomous process (Saez, 1994). This
second proposal has been supported by studies showing that isolated genital ridges
acquire the ability to synthesise steroids when cultured in vitro in the absence of
gonadotrophins or any other additional factors (Agelopoulou et al., 1984; Gangnerau
and Picon, 1987). A second piece of evidence supporting this hypothesis has arisen
from an investigation using the hypogonadal (hpg) mouse (Cattanach et al., 1977).
These animals have very low gonadotrophin levels due to a mutation in the GnRH
gene rendering the gene product non-functional. Nevertheless, male hpg mice,
despite their hypoplastic gonads are still normally masculinised, suggesting that
their testis must start and maintain some testosterone production in utero without
significant gonadotrophin stimulation (Cattanach et al., 1977). Recently, SF-1,
discussed in section 2.5.4, appears as a possible candidate for an autonomous factor
acting in the Leydig cells. SF-1 has been shown to regulate expression of the
steroidogenic cytochrome P450 enzymes (Ikeda et al., 1993; Morohashi et al., 1992)
and is expressed at the right temporal and spatial location (Hatano et al., 1994; Ikeda
et al., 1994) to act as a trigger for the onset of steroidogenesis in the fetal testis.
Further studies will be needed to clarify the function of SF-1 at this time and its
possible involvement in onset of testosterone biosynthesis.
The regulation of testosterone production in fetal life once steroidogenesis is
established is also unclear. Studies in vitro and in vivo have shown that fetal Leydig
cells are responsive to LH stimulation (Feldman and Bloch, 1978; Gangnerau et al.,
1982). As in the adult testis, LH appears to stimulate testosterone production in
fetal Leydig cells (Feldman and Bloch, 1978; Gangnerau et al., 1982), however,
differences between adult and fetal Leydig cells have been described. For example,
in the adult testis, chronic exposure to LH (or hCG) results in down-regulation of
LH receptors and in the blockade of the 17,20 lyase activity of the P450cl7 enzyme
finally resulting in lower testosterone production (Payne, 1990; Payne and
Youngblood, 1995). This is not the case in the fetal Leydig cells where LH
stimulates testosterone production continuously (Warren et al., 1987). Despite its
ability to stimulate testosterone production in fetal Leydig cells, the physiological
function of LH in the fetus is still questionable. LH is initially detectable in the
pituitary (Watanabe and Daikoku, 1979) and in the fetal blood around day 17.5
(Aubert et al., 1985). LH levels stay very low (below 0.05|ig; about 10% of adult
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levels) until the day 19.5 (Aubert et al., 1985). However, the highest levels of fetal
testicular steroid production occur on day 18.5 of gestation (Feldman and Bloch,
1978; Picon, 1976; Warren et al., 1973) and this means that the most marked
increase in testosterone production occurs in the presence of very low levels of LH
(Saez, 1994). This data together with the studies from the hpg mouse discussed
above thus suggest the existence of other factors or autonomous mechanisms
involved in the regulation of testosterone production in the fetus.
2,10.5 Action of testosterone
In the adult organism, testosterone and its metabolites have effects on the function
of many different tissues. Testosterone is responsible for development and
maintenance of secondary male sexual characteristics (deep voice, body hair,
muscular body) and is essential for maintenance of fertility (O'Riordan et al., 1988;
Sharpe, 1994). Testosterone is responsible for masculinisation of the male fetus,
including stabilisation of the Wolffian ducts and hence is directly responsible for
development of male secondary sexual organs discussed in sections 2.8 and 2.9. In
the absence of testosterone, the Wolffian ducts regress and the external genital
organs develops as in the female (George and Wilson, 1994). The importance of
testosterone is most clearly shown in androgen insensitivity syndrome, the
development of which is associated with mutations in the androgen receptor gene.
Cases with complete androgen insensitivity syndrome develop female external
genitalia despite the presence of developed testis and high levels of circulating
testosterone (Griffin and Wilson, 1989; Quigley et al., 1995).
Once formed, testosterone is secreted from the Leydig cells into the blood. Most of
the blood born testosterone is bound to sex steroid binding globulin (SHBG; Griffin
and Wilson, 1992). At its site of action, testosterone dissociates from SHBG and
passes through the cell membrane into the cytoplasm. Once in the cytoplasm, it is
commonly transformed into the more potent metabolite 5a-dihydrotestosterone by
the enzyme 5a-reductase (Griffin and Wilson, 1992). In the fetal male, testosterone
and 5a-dihydrotestosterone play different roles during differentiation: testosterone is
responsible for virilization of the Wolffian ducts while differentiation of the
urogenital sinus and the external genitalia depends upon the action of 5a-
dihydrotestosterone (George and Wilson, 1994; Siiteri and Wilson, 1974; Wilson
and Lasnitzki, 1971).
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In target cells, testosterone and 5a-dihydrotestosterone both act via the same specific
nuclear hormone receptor, the androgen receptor (AR; George and Wilson, 1994).
The androgen receptor gene is encoded by 8 exons and is located on the X
chromosome (Lubahn et al., 1988; 1989). Deletion mutagenesis studies have
identified three important domains within its structure: an amino terminal segment
involved in transcriptional activation, a cysteine-rich DNA binding domain and a
carboxy terminal hormone binding domain (Rundlett et al., 1990; van Steensel et al.,
1995). The inactive androgen receptor resides in the cytoplasm bound to heat shock
proteins, which prevent its diffusion into the nucleus. Upon testosterone binding the
heat shock proteins dissociate and the androgen receptor together with its ligand are
transposed into the nucleus where they bind to androgen response element(s) (ARE)
in the promoter regions of androgen regulated genes (Parker, 1991; Rundlett et al.,
1990).
The distribution of androgen receptors in the fetus has been studied by
autoradiography and immunocytochemistry. Several studies (Bentvelsen et al.,
1994; Cooke et al., 1991a; Kalloo et al., 1993) have shown the presence of the
androgen receptor throughout development in the Wolffian ducts and urogenital
sinus of the rat, mouse and human fetuses but there are no reports of androgen
receptor localisation in the fetal testis (see chapter 5).
2.10.6 Oestrogens
The role of oestrogens together with their possible pathological role is further
discussed in section 2.11. The physiological role of oestrogens during normal
testicular development is still a matter of debate. The production of oestrogens by
testis was proposed as early as 1934 from studies of the equine testis (Zondek,
1934). Subsequent studies have shown that Sertoli cells are the site of oestrogen
production (Huggins and Moulder, 1945; Lacy et al., 1968), however, only in horses
do adult Sertoli cells appear to have the capacity to aromatise steroids (Dorrington
and Khan, 1993). In other species, the expression of P450arom and consequently
ability to produce oestrogens is limited to immature Sertoli cells (Dorrington and
Khan, 1993; Rommerts et al., 1978; Verhoeven et al., 1979). This function seems to
be stimulated by FSH in immature rat Sertoli cells (Dorrington and Armstrong,
1975) but the ability of Sertoli cells to aromatise testosterone disappears with
maturation of Sertoli cells around day 20 of life (Dorrington and Khan, 1993). In
addition, oestrogen receptor (ER) have been identified in the fetal testis and
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Wolffian ducts (Greco et al., 1992). However, transgenic mice with a non¬
functional oestrogen receptor gene show no abnormalities in fetal testicular
development but display reduced fertility or even infertility in adult life (Korach,
1994). This finding suggests that oestrogens are not required for normal testicular
development, but it is possible that oestrogen may have a negative effect on sexual
differentiation.
Like the AR, the ER is a member of the nuclear receptor superfamily (Carson-
Jumica et al., 1990). Greco et al. (1992) have studied the presence and distribution
of ER in the fetal mouse testis and associated duct system using frozen tissue and
found strong expression in the gonads just after gonadal differentiation on day 13.5.
The intensity of the staining decreased during the rest of the fetal life and became
very weak at birth. Initially, positive nuclear staining appeared in the mesenchymal,
peritubular and Sertoli cells but thereafter weak immunostaining was confined to the
mesenchymal and Leydig cells (Greco et al., 1992, 1993).
2.10.7 Inhibin and activin
Inhibin and activin are members of the TGF-B growth factor family (Wallach, 1996;
Ying, 1988). In the adult testis, inhibin and activin are mainly produced by Sertoli
cells and are able to modulate FSH expression by the pituitary gland (Schwall et al.,
1989; Vale et al., 1988; Ying, 1988). Inhibin and activin are heterodimers formed
by the possible interaction of three subunits, one a and two similar, but distinct, B
subunits (BA and BB). Inhibin is composed of an a-subunit covalently bound
together with one of the two B subunits (BA and BB). On the other hand, activins are
dimers of the B subunits and are classified as activin A (8A/BA), activin B (BB/BB)
and activin AB (BA/BB) (Vale et al., 1988). The genes encoding all three subunits
have a similar structure, containing one intron. In each case, the primary protein
transcript is a large precursor molecule that undergoes post translational cleavage to
form the individual functional subunits. Formation and structure of different
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The precursor molecule for the a-subunit is 366 amino acids long and possesses a
functional 133 amino acid domain in its carboxy terminus. BA and BB subunits are
116 and 115 amino acids respectively and are produced by proteolytic cleavage of
larger precursor molecules of over 400 amino acids in length (Woodruf et al., 1987;
Ying, 1988).
Apart from their influence on FSH secretion, inhibin and activin have been recently
shown as important regulatory factors in the testis (Chen, 1993; Lin et ah, 1989) and
other tissues (Spencer et ah, 1990). Roberts et ah (1991) have reported mRNA
expression of the BA subunit in embryonic heart, dermal layer of skin, whisker
follicles and developing skeleton, suggesting a wide functional role for activin
during development. Weak expression of BA has also been detected in the fetal
ovary, while the testis remained negative until day 21.5 when mRNA was detected
in the interstitial region. The mRNAs for the BB and a subunits were detected in an
area of rapidly dividing cells surrounding the forebrain ventricle as well as in the
testis and ovaries (Roberts et ah, 1991). Studies by Kaipa and co-workers (1994)
have demonstrated that activin can inhibit testicular cell proliferation during early
testicular development (at day 14.5), but found no effect on cell proliferation at days
15.5 or 18.5. Furthermore, studies by Boitani et ah (1995) have shown that FSH
stimulation of Sertoli cell proliferation in neonatal rat testis is greatly enhanced by
the presence of activin. However, inhibin does not appear to be essential for fetal
development since transgenic mice without a functional a subunit develop normally
although these animals later develop Sertoli cell tumours with nearly 100%
penetrance (Matzuk et ah, 1992). In contrast, transgenic mice lacking functional BA
or both BA and BB subunits showed severe abnormalities and died within 24 h of
birth, suggesting that activins are important for normal fetal development (Matzuk et
al., 1995)
2.11 Influence of oestrogenic chemicals on fetal gonadal
development
As detailed in the previous sections, fetal gonadal differentiation is a precise process
and many different factors may interfere with the normal development of the gonads
and/or the development of secondary sexual structures. In particular the role and
importance of androgens, especially testosterone, in orchestrating normal endocrine
reproductive function of the gonads is well known (section 2.10.3). However, the
role of oestrogens has not been as well defined and the function of this steroid
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hormone in mammalian male and female gonadal development has yet to be fully
elucidated. Experimental studies carried out in reptiles, where the sex of the
offspring is determined by the environmental temperature at the time of egg
incubation, have shown that oestrogens applied on the egg shelf can change the sex
of the offspring (Pieau, 1996). Additional studies have also suggested that
temperature regulation of sex in these species is oestrogen dependent and that the
aromatase enzyme, responsible for formation of oestrogens, is under the influence of
a temperature sensitive promoter (Pieau, 1996).
In mammals, overexposure of the fetus to oestrogens results in abnormal
development of the reproductive system, changes which may compromise fertility in
adult life. For example, studies as early as 1939 showed that administration of high
doses of diethylstilbestrol (DES), a synthetic non steroidal oestrogen, to pregnant
rats had a detrimental effect on development of the offspring (Green et al., 1939).
Experiments carried out by Green and co-workers (1939) demonstrated that
pregnant female rats treated with DES delivered fetuses with exclusively female
external genitalia together with visible nipples and that it was only possible to
distinguish between the sex of the pups by internal examination of their gonads.
Further examination of male fetuses from DES-treated females revealed that
development of their seminal vesicles, epididymis, vas deferens and prostate glands
was retarded. The female fetuses from the same mothers also developed
abnormalities of their reproductive organs with extended uteri and remnants of
Wolffian ducts. In another report, Boylan (1978) treated pregnant rats with much
smaller doses of DES (1.2 - 120|ig/animal). These experimental studies showed that
the effect of DES-treatment of mothers on their female offspring was more
pronounced than on their male pups. The females had abnormalities in their nipple
development as well as premature opening of the vagina. Furthermore, DES
treatment prevented parturition of mature fetuses and occasionally acted as an
abortifacent. Studies by McLachlan and Newbold (1975) using mice have shown
the DES treatment affects male offspring when injected daily (day 9 to 16 of
pregnancy) at doses of lOOjlg/Kg to their mothers. Whilst the external appearance
of new-born mice from treated mothers was comparable to that of controls from
untreated mothers, the fertility of the treated male offspring was impaired.
Examination of these males in adulthood revealed a high incidence of epididymal
cysts, testicular abnormalities and in some cases abnormalities of accessory sexual
organs. In experiments by Nomura and Kanzaki (1977), animals received a single
dose of lOjig/Kg of DES between days 9 and 17 of pregnancy. The new-born
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offspring showed no obvious external abnormalities, however, some females
displayed premature opening of the vagina and an increased incidence of ovarian
cancer. In addition, a proportion of the males had small undescended testes
(examined at 12 months of age). No effects on the epididymis or other accessory
sexual organs were reported. Similarly, the synthetic oestrogen RU 2858
(moxestrol) was reported to cause underdevelopment ofWolffian ducts and prostate
glands, hypospadias and in some animals cryptorchidism when given to pregnant
rats subcutaneously every day between days 15.5 to 19.5 p.c. in doses 0.4, 2, 10 or
50|ig of RU 2858 per rat. The effects were most obvious in the group treated with
highest dose of RU 2858 but were noticeable in all treated groups (Vannier and
Raynaud, 1980). Similar effects of oestradiol were reported in the same study.
The influence of oestrogens, in particular the synthetic oestrogen DES, on the
development of the human fetal reproductive tract was shown following use of this
compound in the 1950's and 1960's. Clinical trials by Smith (1948) suggested that
DES was beneficial in both the treatment of threatened abortions and in the
prevention of abortions in patients who repeatedly miscarried. Between the late
1940's and 1971, when DES was finally banned as a therapeutic substance, an
estimated 2-3 million women were prescribed this drug during pregnancy (Stillman,
1982). Unfortunately, control studies have proved that DES is not beneficial in
treating these clinical conditions (Dieckmann et al., 1953) and in fact has serious
adverse effects on fetal development. New-born babies (from mothers prescribed
DES) exhibited no visible external abnormalities, however, follow-up studies have
shown increased abnormalities in the reproductive tract of both male and female
offspring of DES treated mothers. In the 1974, Herbst et al. (1974) reported the
occurrence of vaginal clear cell adenocarcinoma in seven girls aged from 14 to 22
years. These cases exceeded the total of all previously reported cases in this age
group and an epidemiological study has correlated development of this cancer to
DES exposure in utero. Following on from this initial finding, several other serious
long-term consequences of in utero exposure to DES have been described.
Additional studies (Bibbo et al., 1977) have recorded a higher incidence of irregular
menstrual cycles in offspring of DES treated mothers (compared to a control
population) together with a lower incidence of pregnancies. Other reports have
recorded a higher occurrence of anatomic abnormalities and fertility problems
including an increase in spontaneous abortions, ectopic pregnancy and premature
delivery in females (Stillman, 1982). In adult males exposed in utero to DES,
epididymal cysts, hypotrophic testes and capsular induration were found in 25% of
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examined males compared to an incidence of 6% in the control male population
(Bibbo et al., 1977; Gill et al., 1979; Stillman, 1982). Semen analysis of these men
revealed a two fold decrease in sperm motility and sperm density, although these
numbers were still in the normal range. For example, 26% of DES exposed males
produced ejaculate volumes under 1.5ml and "a severely pathological semen" score
was found in 28% of exposed males. No such cases were observed in the control
group and an association between pathologic semen quality and physical
abnormalities was only observed in the group of exposed males (Bibbo et al., 1977;
Gill et al., 1979; Stillman, 1982). Recently, Wilcox et al. (1995) have carried out a
study to establish if the fertility or sexual function of men exposed in utero to DES
is impaired. Surprisingly, their studies have shown that despite an incidence of
congenital malformations three times higher in the exposed group compared with
the control group, the males from both groups showed no significant differences in
fertility based on their responses to a telephone survey.
The most common reproductive abnormalities occurring after in utero exposure to
oestrogens are summarised in table 2.2.
Incidence of Animals Humans
Testicular maldescent Increase Increase
Hypospadias Increase Increase
Testicular cancer no data Increase
Small testes Increase Increase
Low sperm output Increase Increase
Table 2.2: Developmental abnormalities of the male reproductive system
induced by administration of oestrogens to pregnant animals or humans
2.11.1 Mechanism(s) of oestrogenic action on the developing reproductive
tract
The effect of oestrogens on male reproductive development may be mediated either
directly at the level of the testis or indirectly via the pituitary/hypothalamus.
Oestrogens usually act through interaction with specific oestrogen receptors. In the
rat and mouse testes, oestrogen receptors have been identified in developing Leydig
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cells using immunocytochemistry. Studies by Greco and co-workers (1992) have
shown the presence of oestrogen receptors in mouse Leydig and peritubular cells
and in Wolffian ducts between day 13.5 and 17.5 of fetal development using
immunocytochemistry on frozen tissue sections. Furthermore, in adult rats
exogenous administration of oestrogens results in a lowering of testosterone
production, via the inhibition of an essential steroidogenic enzyme P450cl7 (Kalla
et al., 1980; Nozu et al., 1981b). It is therefore possible that exposure of Leydig
cells to oestrogens or oestrogenic chemicals during fetal development might result
in changes in testosterone production through a similar mechanism and thus
ultimately have profound effects on masculinisation of the male fetus.
In addition, oestrogens are known to exert a negative feedback effect on the
synthesis and secretion of LH and FSH in adult males (Griffin and Wilson, 1992)
and this action is thought to result primarily from a decrease in GnRH release from
the hypothalamus (Griffin and Wilson, 1992; Haisenleder et al., 1994). Oestrogen
receptors have not been detected in the GnRH neurons (Herbison and Theodosis,
1992), but are present in some other neurons in the hypothalamus (Herbison and
Theodosis, 1992; Sar et al., 1990) that could modulate the function of the GnRH
neurons. It is possible to speculate that oestrogens might also influence
gonadotrophin production and secretion during fetal life. However, the potential
consequences of oestrogen mediated GnRH inhibition on the developing fetal
gonads is unknown, although it is possible that a decrease in secretion of LH and
FSH could reduce testosterone production and Sertoli cell proliferation during the
latter stages of gestation. Possible sites of oestrogenic action in the reproductive
axis are presented in figure 2.6.
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Environmental
estrogens
Figure 2.6: Possible sites of action for oestrogens and oestrogenic chemicals on the
reproductive axis during fetal development
2.11.2 Evidence for an increase in the incidence of male reproductive
problems
Over the last 5 years, scientific research has documented an increase in reproductive
problems in men in the Western world. In particular, several independent studies
have shown a sharp rise in the incidence of testicular (germ cell derived) cancer,
currently the most common malignancy of young males (Giwercman, 1995;
Giwercman and Skakkebaek, 1992). One of the most conclusive studies arises from
analysis of the Danish Cancer Registry, which has revealed a 3-4 fold increase in the
incidence of testicular cancer between 1940 and 1980 (Oesterlind, 1986). These
findings have also been confirmed in studies carried out in Scotland (Boyle et al.,
1987), the USA (Brown et ah, 1986) and in Finland (Hakulinen et al., 1986). The
incidence of male congenital malformations such as cryptorchidism and
hypospadias, also appears to be on the increase although less research has been
carried out in this area (Giwercman and Skakkebaek, 1992). Furthermore, changes
are also reported to have occurred in the semen of normal males. It has been
observed that semen quality in men in some but not all developed countries is
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declining with reports of smaller ejaculates, less sperm per ejaculate and less viable
sperm steadily increasing throughout the last five decades (Auger et al., 1995;
Carlsen et al., 1992; Toppari et al., 1996; van Waeleghem et al., 1994). Evidence
suggests that the mean sperm count has halved in the last 50 years, with people born
after the 1960's having smaller ejaculates and less motile sperm than men bom prior
to 1950. These reports remain controversial especially as they may not have
occurred in all countries (Fisch and Goluboff, 1996; Suominen and Vierula, 1993;
Vierula et al., 1996), but increasing experimental evidence has endorsed these
findings suggesting that the described trend is a real observation (Giwercman,
1995). Whilst little is known about the aetiology of these conditions and the factors
contributing to the increase in male reproductive problems, Sharpe and Skakkebaek
(1993) have proposed that oestrogens, or chemicals mimicking oestrogens, may
affect male reproductive function. This hypothesis has been based primarily on the
observations that males exposed in utero to the synthetic oestrogen DES (discussed
above) exhibit similar patterns of reproductive abnormalities to those now
increasing in other populations. Sharpe and Skakkebaek (1993) have reviewed the
possible sources of oestrogenic exposure and have suggested that changes in diet,
increases in body fat and obesity, together with increases in exposure to
environmental pollutants with oestrogenic activity could all contribute to these
changes. The diet of the individuals in many developed countries has radically
changed over the last 50 years with an increase in the consumption of milk and dairy
products. These may contain oestrogens due to intensive farming with milking
occuring during pregnancy. A large increase in use of soya (soya is very rich in
phytooestrogens) could also have contributed to an increased exposure to oestrogens
in every day life. Furthermore, it is likely that we are all exposed to many
oestrogens or chemicals mimicking oestrogen action due to environmental pollution.
It has been speculated that usage of contraceptive pills containing synthetic
oestrogens, the use of anabolic oestrogens in animal farming and widespread use of
chemical agents that exhibit oestrogenic activity by industry may all have
contributed to an increasing exposure to oestrogens (Sharpe and Skakkebaek, 1993).
2.11.3 Chemicals with oestrogenic activity
Analysis of environmental chemicals has resulted in the finding that many pollutants
including DDT (and its metabolites) and PCBs have oestrogenic activities (Bittman
and Cecil, 1970). Although these chemical agents have been banned in Western
countries, their continued use in the third world together with their accumulative and
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slow degradational properties has resulted in significant concentrations in the
environment. Recent studies (Kelce et al., 1995) on the DDT metabolite p,p'-DDE
have shown it can bind to the AR and it is therefore possible that DDE could prevent
the action of endogenous androgens at critical times during fetal development. In
addition to DDT and PCBs, weak oestrogenic activity has also been shown for
several other chemicals, all of which have been previously considered
environmentally safe (Jobling et al., 1995; White et al., 1994). The majority of
these chemicals have a different chemical structure to endogenous oestrogens and at
present it is not therefore possible to assess whether a compound is likely to have
oestrogenic activity based on the knowledge of its chemical structure. In many
instances the oestrogenic activity of these chemicals was discovered accidentally.
For example, the observation that oestrogenic substances were released from
laboratory plastic ware led to the identification of alkylphenols, in particularly
nonylphenol and bisphenol-A as a chemicals with oestrogenic activity (Krishnan et
al., 1993; Soto et al., 1991). In addition, oestrogenic activity has also been shown
for phthalate esters, another group of chemicals that are ubiquitously found in the
environment (Jobling et al., 1995).
Alkylphenol polyethoxylates (APEOs) were introduced in the 1940s and are the
second largest group of nonionic surfactants in commercial production (Naylor et
al., 1992). They are widely used in detergents, paints, herbicides, pesticides and
many other products. The mixture of alkylphenol polyethoxylates is usually used in
a 1:4 ratio (octylphenol:nonylphenol polyethoxylates). Over 300000 tons of APEOs
are produced annually world-wide and it is estimated that about 60% of these end up
in the aquatic environment, mostly via sewage treatment works. In the water
APEOs usually form relatively stable metabolites like alkylphenols, nonylphenol
and octylphenol and these by-products tend to accumulate in sewage sludge and
river sediment (Naylor et al., 1992; White et al., 1994). Studies by White et al.
(1994) have shown oestrogenic activity of nonylphenol and octylphenol in vitro and
in vivo and in addition studies by Sharpe et al. (1995) have shown the effects of
octylphenol exposure in utero and postnatally on the adult testis size in rats. This
will be further discussed in chapter 8.
3. General Materials and Methods
The techniques outlined in this chapter are common to a number of studies in this
thesis. Methods specific to individual experiments are described in the relevant
chapters.
3.1 Chemicals and suppliers
Molecular biology grade chemicals were obtained from Sigma, Poole, Dorset and IBI,
Cambridge. All radiolabeled nucleotides were obtained from Amersham, Little
Chalfont, Bucks or DuPont-NEN, Stevenage, Hertfordshire. Enzymes were
purchased from Boehringer Mannheim, Lewes, Sussex or Promega, Southampton.
Phenol/chloroform was bought from CAMLAB, Cambridge, and was pre-buffered
with Tris, pH 8.0. Autoradiography products were obtained from Eastman Kodak,
Rochester, NY, USA, supplied by IBI.
3.2 Animals and treatments
3.2.1 Animals
Animals used for these studies were Wistar rats bred in the MRC Reproductive
Biology Unit in Edinburgh. Rats were maintained in standard conditions of a 12 h
light: 12 h dark cycle and an ambient temperature of 21°C. Food and water were
available ad libitum. To obtain time mated females, the adult females were placed in
the individual cages with one adult male. They were checked every morning for the
presence of a copulating plug and if present, midday of that day was taken as day 0.5
of pregnancy (assuming that animals mated around midnight). Animals were killed by
asphyxiation with CO2 followed by cervical dislocation.
3.3 RNA extraction and separation
3.3.1 Dissection of tissue
Fetuses at day 17.5 and older were collected from the uterus and placed in warm PBS
prior to dissection. Testes or ovaries were isolated from the fetuses under a dissecting
microscope. Several testes or ovaries from the same litter were pooled together,
transferred into 1 ml of TRI reagent (Sigma) and placed on ice.
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3.3.2 Extraction of RNA from fresh tissue
Tissues were homogenised in TRI reagent (Sigma) in Eppendorf 1.5ml tubes by
passing several times through a fine needle (23-26g) until the solution looked
homogenous. To this homogenate, 0.2ml of chloroform was added and the mixture
mixed thoroughly. The mixture was placed on ice for 15 min and then centrifuged at
10000 rpm for 20 min at 4°C. The upper, aqueous phase containing the RNA, was
removed carefully to a new tube and an equal volume of cold (-20°C) isopropanol was
added together with 2p.l of polyinosinic acid (Pharmacia, Milton Keynes) to act as an
inert carrier (Winslow and Henkart, 1991). The RNA was left to precipitate at -20°C
for at least 1 h, pelleted by centrifugation (13000 rpm for 20 min at 4°C), washed in
0.5ml 75% ethanol, recentrifuged and air dried. The RNA pellet was dissolved in
RNase-free water by warming to 65°C for 10 min and stored at -70°C.
RNA was scanned at 260 and 280nm on a spectrophotometer. The 260:280 ratio for
each sample was calculated to give an estimation of the purity of the RNA. A ratio of
2.0 was taken to be pure. The concentration of the RNA was calculated from the
260nm value where an optical density of 1.0 is equal to 40(ig/ml RNA.
3.3.3 Separation of RNA on denaturing agarose gels
RNA was separated on a 1.5% denaturing agarose gel. The gel was prepared by
melting 2.25g agarose (Boehringer) in 127ml pure water. This was cooled to about
60°C and 15ml of 10 x running buffer (containing 200mM MOPS, lOmM EDTA and
50mM sodium acetate at pH 7.0) plus 8.1ml 37% formaldehyde added. The solution
was mixed gently and poured into a gel tray (15 x 20cm) containing a 15 or 20 well
comb in a fume hood. After setting, the comb was removed and the gel submerged in
1 x running buffer in a Sub-Cell electrophoresis tank (Bio-Rad, Hemel Hempstead,
Hertfordshire).
RNA (5-10jig) in a volume of no greater than 5jil was denatured by adding 15.6|il of
sample buffer and heating at 60°C for 5 min. Sample buffer contained lOOfil 10 x
running buffer, 500|il deionised formamide and 178(il formaldehyde (Sigma). After
heating, 8(il of dye solution containing 7.5% w/v ficoll 400, 0.1% w/v bromophenol
blue and l|il of lmg/ml ethidium bromide was added to each sample. Samples were
loaded into individual wells of the gel and separated by electrophoresis for 16 h at 35V
or for 5 h at 120V.
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3.4 Tissue fixation and processing
3.4.1 Fixation
Fetuses were collected from the uterus (3.3.1.), decapitated and were either directly
placed into Bouin's fixative or were dissected under a dissecting microscope to isolate
the individual gonads which were then placed in the Bouin's. Whole fetuses were
fixed from 4 to 8 h, depending on their size and isolated testes and ovaries were fixed
for 1 to 2 h. After fixation, the tissue was processed immediately or stored in 70%
ethanol.
3.4.2 Processing and sectioning of tissue
Tissue was processed through a graded series of alcohols (70%, 80%, 90%, 95%,
100% and xylene respectively) in an automatic 2LE Processor (Shandon Scientific
Limited, Cheshire) using a standard 17.5 (for isolated gonads) or 24 h (for whole
fetuses) cycle and embedded in paraffin wax.
Glass microscope slides to be used for in situ hybridisation were washed, dried and
baked at 300°C for 8 h. Slides were washed in a 2% solution of 3-aminopropyl
triethoxysilane (TESPA; Sigma) in acetone followed by a wash in acetone (BDH Ltd,
Poole, Dorset), rinsed in filtered distilled water and dried.
Tissues embedded in paraffin wax were sectioned to a thickness of 5|im using a hand
operated Leitz (Wetzlar, Germany) microtome and a D-profile knife. Sections used
for in-situ hybridization studies were floated on RNase-free water, transferred onto the
treated slides and dried at 50°C overnight before use. Sections for use in
immunostaining were sectioned as above but were floated on normal distilled water
and dried onto untreated slides.
3.4.3 Staining of sections with haematoxylin and eosin
To examine the gross morphology of developing fetuses and gonads, sections were
stained using haematoxylin and eosin. Briefly, sections were dewaxed in histoclear
(National Diagnostics, Atlanta, GA, USA) and rehydrated in a decreasing series of
alcohols (100%, 95%, 70% respectively). A water wash was followed by 1-3 min
incubation in haematoxylin, a wash in distilled water and a short incubation in Scott's
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tap water. If the staining with haematoxylin was too intense, it was reduced by
placing the slides for a 5 - 10 sec in 1% acid alcohol. After the development of the
blue colour, sections were placed for 5-20 sec in 1% eosin, washed in water and
quickly dehydrated in an increasing series of alcohols. After clearing in histoclear, the
sections were coverslipped using Pertex mounting medium (CellPath, Hemel
Hempstead, Hertfordshire).
3.5 Immunocytochemistry
3.5.1 Preparation and immunodetection
Paraffin tissue sections were dewaxed for 5 min in xylene followed by rehydration in
decreasing alcohols (100%, 96% and 70% respectively) and washed in the tap water
followed by a 5 min wash in 0.05M Tris-HCl buffer pH 7.4 containing 0.85% NaCl
(TBS). Sections were incubated for 30 min with normal serum from the same animal
species as that in which the secondary antibodies were raised (usually rabbit or
swine), diluted 1:5 in TBS. Sections intended for use with the horseradish peroxidase
detection system were incubated in 1% hydrogen peroxide diluted in TBS for 30 min
to block endogenous peroxidase and washed for 5 min in TBS prior to blocking with
normal serum. After 30 min, the area of the slide around the tissue sections was dried
and normal serum was replaced by 50fil of the primary specific antiserum at an
appropriate dilution (specific dilutions are mentioned in the appropriate chapters).
Sections were covered by gelbond film (Flowgene Instruments Ltd, Sittingbourne,
Kent) and incubated in a humidified chamber at 4°C overnight. Next day the
coverslips were removed and sections washed twice for 5 min in TBS, incubated with
secondary antibodies for 30 min at room temperature (the appropriate secondary
antibodies used are detailed in the individual chapters) and then washed twice for 5
min each in TBS. Avidin-biotin complex, peroxidase-antiperoxidase complex or
alkaline phosphatase-anti-alkaline phosphatase complex (Dako, High Wycombe,
Bucks) were used together with their appropriate substrates to detect bound antibodies
and these are described in corresponding chapters. Development of the colour
precipitate was followed by a wash in distilled water. Sections were usually
counterstained with haematoxylin and dependent on the solubility of colour precipitate
either directly mounted with Aquamount mounting medium (BDH) or dehydrated,
cleared in xylene and mounted with Pertex mounting medium (Cellpath).
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3.5.2 Antigen retrieval
Some proteins were only recognised by specific antisera following pretreatment of
tissue sections. The method employed was that of microwave antigen retrieval (Shi et
al., 1993). Briefly, after an initial wash in TBS and blocking in hydrogen peroxide
(as in 3.5.1), the sections in a plastic rack were placed in a glass dish, covered with
0.01M sodium citrate buffer (pH 6.0), wrapped in cling film and microwaved at full
power for 20 min in a 650W Sanyo microwave oven. If the buffer evaporated,
preheated distilled water was added to maintain the buffer level. After microwaving,
the sections were left undisturbed in sodium citrate for an additional 20 min, followed
by a wash in TBS and incubation with blocking serum before proceeding with
immunocytochemical detection (3.5.1).
3.5.3 Control of antibody specificity
The specificity of the antibodies was checked either by replacing the primary
antibodies with normal serum derived from the same animal species as that in which
the primary antibodies were raised in or by preabsorbing the antibodies with the
antigen against which they were raised. Normal mouse or rabbit serum (Dako) was
used in the same dilution as primary antibodies overnight at 4°C and the next day
sections were processed under standard conditions (3.5.1). If the antigen (normally
the peptide against which the antibodies were raised) was available (stated in
corresponding chapters), the primary antibodies were incubated with 20-fold molar
excess of the antigen overnight at 4°C and used the following day at the same dilution
as for normal immunostaining.
3.6 Reverse transcription polymerase chain reaction (RT
PCR)
3.6.1 Synthesis of oligonucleotide primers
Oligonucleotides (17-24mers) were synthesised using phosphoramadite chemistry on
a Model 381 DNA synthesiser (Applied Biosystems (ABI), Warrington, Cheshire).
Oligonucleotides were recovered into 1ml of pure concentrated ammonia, deprotected
by incubating overnight at 55°C, recovered by two rounds of ethanol precipitation and
resuspended in TE buffer (lOmM Tris, ImM EDTA, pH 8.0). The concentration of
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the oligonucleotides were estimated by spectroscopy at 260nm where an optical
density of 1.0 is equal to a concentration of 20|ig/ml. Preprepared oligonucleotides
were also purchased from Oswel, Edinburgh.
3.6.2 RT PCR Reaction
Reverse transcription was undertaken using 250-500ng of total RNA in 20|il volume
containing lOmM Tris-HCl pH 8.3, 90mM KC1, ImM MnCl2, 200pM each dNTP,
5U Tth polymerase (ABI) and 0.75jiM of the appropriate antisense downstream
primer or random primer (Promega) containing a mixture of different hexanucleotides.
The conditions used with antisense primer were usually 65°C 5 min, 50°C 5 min, 70°C
15 min and with random primers 65°C 5 min, 25°C 10 min, 48°C 10 min and 70°C 15
min and thereafter the samples were placed on ice. The reaction volume was increased
to IOOjj.1 and PCR undertaken in buffer containing 1.5mM MgCl2> 40% glycerol,
lOmM Tris-HCl pH 8.3, 890mM KC1, 6mM EGTA, 0.4% Tween 20 (MnCl2 in the
first reaction solution was chelated by the EGTA) and 0.15(iM of the upstream sense
primer. If random primers were used in reverse transcription, upstream and
downstream primers were both added to the PCR reaction at a concentration of
0.15|iM. PCR conditions were adjusted according to the calculated annealing
temperatures of the primers and the length of the DNA fragment to be amplified.
Amplified product(s) were analysed by electrophoresis on 2% agarose gels run in TBE
using standard methods.
3.6.3 Cloning of amplified cDNAs
If RT PCR reactions were conducted with aim of obtaining a probe for in situ
hybridisation and/or RNase protection assay reactions, the amplified DNA fragments
were subcloned into an appropriate plasmid vector. The vector used on most
occasions was the TA vector, pCRII (InVitrogen, Abington). Amplification of the
DNA was followed by purification of the fragments using spin columns (Clontech,
Palo Alto, CA, USA) which had the ability to exclude contaminating cDNAs and
excess oligonucleotide primers with sizes below lOObp or 400 bp dependent upon the
column bed. Columns were prepared by centrifugation in a swing out rotor at 2100
rpm for 3 min. The PCR reaction mixture was pipetted to the centre of the dried
column which was then recentrifuged at 2100 rpm for 3 min. Purified DNAs were
used directly in ligation reactions.
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Plasmid vector (25ng/|il) and ljil of T4 DNA ligase were mixed with 50ng of purified
PCR fragment and the mixture was incubated overnight on 12°C. Competent E. Coli
cells (InvaF', InVitrogen) were thawed on ice and 2|ll of B-mercaptoethanol and l|il
of ligation mixture were gently mixed with the cells in a 2059 Falcon tube. The
mixture was incubated on ice for 30 min, heatshocked by placing in waterbath at 42°C
for 45 sec and placed again on ice for another 2 min. Thereafter 450|il of SOC
medium prewarmed to 37°C was added to the cells which were incubated for 1 h at
37°C at 200 rpm. Aliquots (200|il and 50fil) were spread using an alcohol flamed
glass rod onto LB agar plates containing 100|ig/ml ampicillin and 25(j.l of X-gal
(40|lg/ml stock). Plates were incubated inverted overnight at 37°C. White bacterial
colonies suggesting they contained recombinant plasmids were restreaked on LB agar
plates. The plates were again incubated inverted overnight at 37°C; thereafter
individual plasmid colonies were picked into broth and propagated as described in 3.7.
The presence of the expected cDNA within the recombinant plasmids was checked by
restriction digestion using Eco RI (when the plasmid used was pCRII) and checking
the size of the released fragment on agarose gels. Additional investigations were
carried out by sequencing (3.10).
3.7 Plasmid preparation and analysis
3.7.1 Growth of bacterial cultures
Most of the plasmid preparations used were kindly prepared by Julie Wilson.
Recombinant plasmids containing cDNA inserts were either obtained from colleagues
or were prepared by ligating PCR products amplified from testicular cDNA pools into
plasmid vectors containing ampr gene. Bacteria transformed with recombinant
plasmids were cultured in Luria Bertani (LB) broth containing 50|lg/ml ampicillin.
Typically 10ml of broth was inoculated with a single bacterial colony from an agar
plate, or from a glycerol stock stored at -20°C, and incubated overnight at 37°C
shaking at 225 rev/min.
3.7.2 Plasmid preparation from bacterial cultures
Plasmid DNA was isolated from 10ml bacterial cultures by the alkaline lysis method
using the 'Magic Minipreps' and 'Wizard minipreps' DNA purification systems from
Promega.
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Briefly, bacterial suspensions were centrifuged at 1600g, the supernatant discarded,
cells resuspended in buffer containing 50mM Tris/HCl, pH 7.5, lOmM EDTA and
lOOjlg/ml RNase and mixed with an equal volume of 0.2M NaOH containing 1%
SDS. The resulting solution containing lysed bacterial cells was neutralised by the
addition of 2.55M potassium acetate. The resulting cloudy solution was centrifuged at
12000g to sediment the majority of bacterial genomic DNA. The supernatant
(approximately 600|il) was removed, mixed with a 1ml suspension of DNA
purification resin and passed down a miniprep column which bound the plasmid
DNA. The column was washed with washing buffer, 50|il TE buffer was added and
then incubated at room temperature for lmin. Bound plasmid DNA was eluted from
the column bed by centrifugation at 12000g for 20 sec and collected into a sterile tube.
3.7.3 Analysis of plasmid DNA quality
Purity of plasmid DNA was determined by analysis on a 0.8% (w/v) agarose
minigels. This was prepared using agarose dissolved in lx TBE buffer. The agarose
was melted and approximately 200|ig/ml ethidium bromide was added for
visualisation of the DNA. The gel was poured into a 7 x 10 cm gel tray containing an
8 well comb and submerged in 1 x TBE buffer in submarine cell (Hoefer, Newcastle).
Plasmid DNA (approximately l|il) was run in a sample solution containing l|il
'orange juice' (contains 0.25% w/v orange G, 15% w/v ficoll and 0.5M EDTA at pH
7.0) and 8|il water. Samples were separated in parallel with pGem DNA markers
(range 36-2,645 bp, Promega) or Hae HI digested 0X174 markers (range 72-1353 bp,
IBI) by electrophoresis at 100 volts for 1-2 h in 1 x TBE, viewed under UV light and
photographed. Pure plasmid DNA appeared as two visible 'bands' of greater than 2kb
(depending on plasmid size); one for the circular DNA and the other representing
supercoiled DNA which migrates more rapidly through the gel due to its compact
form.
3.8 Probe preparation for In situ hybridisation
3.8.1 Template preparation
Plasmid DNA prepared as described (see section 3.7) was linearised in a reaction
containing ljig DNA, reaction buffer (contains 10-50mmol/l Tris-HCl, 5-10mmol/l
MgCl2,50-100mmol/l NaCl and lmmol/1 DTT, DTE or B-mercaptoethanol), 10U
restriction enzyme and pure water to a volume of 30|ll. The enzyme used was
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dependent on the plasmid vector being digested and the orientation of the cDNA
relative to the RNA polymerase sites. The reaction was incubated at 37°C for 1-2 h.
Thereafter, 3(ll of reaction mix was separated on a minigel (0.8% agarose) and
compared to an uncut sample of the same plasmid run in a parallel lane to test
efficiency of digestion. Digested DNA was extracted once with Tris-buffered
phenol/chloroform (lOOjll), centrifuged (13000 rpm, 5 min), the upper layer removed
to a fresh tube and precipitated with l/10th volume 3M sodium acetate pH 5.5 and 2.5
volumes absolute ethanol overnight at -20°C. The mixture was centrifuged at 13,000
x rpm for 20 min to pellet the DNA, the supernatant removed, the pellet washed with
75% ethanol, centrifuged, air dried and resuspended in 10|il pure water.
3.8.2 Preparation of radiolabelled riboprobe
Synthesis of riboprobes was carried out using 1 pig linearised template in a reaction
mix containing lOmM DTT, 20U RNase inhibitor (Promega), ImM each rATP, rCTP
and rGTP, transcription buffer (1 x transcription buffer contains 40mM Tris-HCl, pH
7.9, 6mM MgCl2, 2mM spermidine and lOmM NaCl) and 50|iCi 35S-UTP (400
Ci/mmol; Amersham). The reaction was catalysed by addition of 30U of the
appropriate RNA polymerase (T3, T7 or SP6) and incubated at 37°C for
approximately 1.5 h. The DNA template was removed by digestion with 40U RNase-
free DNase for 15 min at 37°C and the radiolabelled cRNA was purified using RNA
spin columns (IBI). Prior to use, the buffer was drained from columns by
centrifugation for 1 min at 2500 rpm. Thereafter, the RNA labelling reaction mixture
was carefully pipetted into the middle of the compacted column bed and the column
recentrifuged in a swing out rotor for 2 min at 2500 rpm. The activity of 2 x lp.1
aliquot of the liquid eluate of the column was determined by liquid scintillation
spectroscopy. The average activity of the two samples was calculated and the volume
of probe solution necessary to give 1 x 106 cpm was determined.
3.9 Radioactive In situ hybridisation
3.9.1 Pretreatment of tissue sections
Tissues were embedded, processed, sectioned and mounted on coated slides as
detailed in 3.4.2. Sections were cleared in xylene for 5 min and rehydrated in a series
of alcohols with decreasing concentrations (100%, 95% and 70% respectively).
Tissue was placed in 0.2N HC1 for 20 min followed by two 5 min washes in ultrapure
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water. Sections were then incubated in 2|ig/ml proteinase K (Sigma) in buffer
containing 20mM Tris/HCl pH7.4 and 50mM EDTA at 37°C for 20 min followed by
0.2% glycine at 4°C for 10 min. Sections were washed briefly in 0.1M
triethanolamine (TEA) pH 8.0 and acetylated in 0.25% acetic anhydride in 0.1M TEA
pH 8.0 for 10 min. Finally, sections were prehybridised in buffer containing 4 x STE
(1 x STE contains 150mM NaCl, 2,5mM Tris and 0.25mM EDTA), 1 x Denhart's
solution (50 x Denhart's contains 5g BSA, 5g polyvinylpyrolidine and 5g ficoll in
500ml solution), lOmM DTT, 125(lg/ml salmon sperm DNA, 125|lg/ml yeast tRNA
and 50% deionised formamide for 2-4 h at probe Tm-25°C.
3.9.2 Hybridisation of Probe to Tissue
Hybridisation was continued overnight with a probe concentration of 1 x 106 cpm
probe in 40|ll buffer/slide. Hybridisation buffer was prehybridisation buffer with
10% dextran sulphate. The incubation was carried out beneath coverslips prepared
from gel bond film (Flowgen Instruments Ltd.) in a humidified chamber at Tm-25°C
where Tm was calculated individually for each probe according to the equation:
Tm = 79.8 + 58.4 (FCC) + 11-8 (Fqc)2 + 18.5 log(M) - 820/L - 0.35 (%F) - (%M)
where:
Fgc = mole fraction of GC content of probe, usually about 0.45
M = monovalent cation concentration (molarity of salt in hybridisation buffer)
L = length of duplexes formed during hybridisation (probe length)
%F = percentage of formamide in buffer
3.9.3 Post hybridisation washes
After incubation sections were washed in 4 x SSC for 10 min to remove the coverslips
and treated with RNase A (Sigma) at a concentration of 20|ig/ml in 0.5M NaCl, 0.1M
Tris pH 8.0 and ImM EDTA for 30 min at 37°C. Sections were washed in RNase
buffer alone for 30 min at 37°C followed by two washes in 2 x SSC at room
temperature for 5 min and finally in 0.1 x SSC/30% formamide at 40°C for 30 min.
3.9.4 Development of In situ hybridisation
After post hybridisation washes sections were dehydrated through alcohols. Slides
were warmed to 45°C and dipped in NTB2 emulsion (Kodak) at 45°C in the dark.
Emulsion coated slides were stored in a humidified, lightproof box overnight before
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transfer to a polyacetyl black trough lightproof box (Lamb's laboratory supplies,
London) with silica gel, and stored at 4°C for a minimum of 7 days (times of exposure
were dependant on the abundance of the signal and are mentioned in appropriate
chapters).
Silver grains formed by reaction of the hybridised, radiolabeled probe with the
emulsion were developed using Kodak D19 developer as follows. Slides were placed
in developer cooled to 15°C for 4 min, followed by a brief wash in pure water and
grains were fixed by incubation for 10 min in Kodak unifix at room temperature.
Sections were washed in water, stained with haematoxylin, dehydrated and mounted
using Pertex mounting medium (Cellpath).
Slides were analysed under dark field using either BIOMED or LABORLUX 12
microscopes (Leitz) or the Olympus Provis Image analysis system (Olympus Corp.,
London) to visualise the silver grains indicating areas of hybridisation. Bright field
microscopy was used to examine the morphology of the tissue sections.
3.10 Sequencing
Most sequencing reactions were carried out by Joe Gaughan. Automatic sequencing
reactions were carried out using the Taq DyeDeoxy Terminator Cycle Sequencing kit
(Applied Biosystems) and were run on the Applied Biosystems Model 373A DNA
sequencing system.
3.10.1 Sequencing reactions
A reaction premix was prepared containing the equivalent of 4(il 5x TACS buffer
(400mM Tris/HCl, lOmM MgCl2 and lOOmM (NH^SCL pH 9.0), lql dNTP mix
(containing 750(iM dITP and 150(iM each dATP, dTTP and dCTP), l(il each ddATP,
ddTTP, ddCTP and ddGTP terminators and 0.5-lp.l AmpliTaq DNA polymerase for
each sequencing reaction to be performed. For sequencing of PCR products lp.1
DMSO was also added. A total of 11.5 (PCR template) or 9.5|il (plasmid DNA
template) of the reaction premix was added to separate tubes containing 3.2 pmol
primer and 5|il template DNA, the total volume adjusted to 20|il with water and
overlaid with mineral oil.
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Tubes were placed in a Perkin Elmer Cetus (Seer Green) thermal cycler Model 480,
preheated to 96°C and 25 cycles of thermal cycling carried out as follows; rapid
thermal ramp to 96°C, 96°C for 30 sec, rapid thermal ramp to 50°C, 50°C for 15sec,
rapid thermal ramp to 60°C and 60°C for 4 min.
On completion of the sequencing reaction, the samples were extracted twice with water
saturated phenokchloroform and precipitated with 15|il 2M sodium acetate, pH 4.5
and 300|il cold absolute ethanol to remove unincorporated labelled terminators.
Labelled DNA was pelleted by centrifugation, the supernatant discarded and the DNA
washed using 75% ethanol, air dried and resuspended in formamide/EDTA buffer (5|ll
formamide, lji.1 50mM EDTA, pH 8.0) prior to loading onto the gel.
3.10.2 Automatic sequencing gel
A sequencing gel mix containing 50g urea, 15ml 40% acrylamide and water made up
to a final volume of 80ml was prepared. Amberlite resin was added to remove
acrylamide free acid and the mixture was stirred with gentle heating until the urea had
dissolved, the solution was filtered through a 0.2|iM cellulose nitrate filter (Nalgene,
Hereford, UK) and 10ml lOx TBE added. The volume was then made up to lOOmls
with pure distilled water. The gel mix was polymerised using 45|il TEMED and
500|il 10% ammonium persulphate and poured carefully between clean glass plates.
The gel was prerun for 10-15 min at 500 volts. Samples resuspended in loading
buffer (100% Formamide: 50mM EDTA, 5:1) were heated to 95°C for 5 min before
loading onto the gel. The gel was run overnight using the automatic data collection
and analysis programs.
3.11 RNase protection assay
3.11.1 Preparation of radiolabeled riboprobes
Radiolabeled antisense RNAs were prepared as described in section 3.8.2. except that
32P-UTP was used in place of 35S-UTP. As a control, the 18S antisense RNA
(Ambion) was prepared as a specific RNA probe. In order to purify only full length
cRNA, radiolabeled cRNA was mixed with loading dye (6x = 0.25% bromphenol
blue, 0.25% xylene cyanol, 30% glycerol, 50mM EDTA), heated at 95°C for 3 min
and loaded on a 6% denaturing polyacrylamide gel and separated by electrophoresis at
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50W (constant power) for 2 h. The gel was wraped in cling film and exposed briefly
(1-2 min) to autoradiographic film (XAR-5, Kodak), the segment of the gel containing
the full length probe cut out and placed in an Eppendorf tube together with 800|il of
elution buffer (0.5M NH4AC, ImM EDTA, 0.1%SDS and lOpg/ml yeast tRNA). The
tube was placed in a water bath at 37°C overnight. The next day, the tube was
centrifuged for 5 min at 13,000 rpm and the supernatant transferred into a fresh tube.
The eluted probe was precipitated in the presence of 0.3M sodium acetate pH 5.5 and
absolute ethanol for 20 min at -20°C and centrifuged for 20 min (13,000 rpm, 4°C).
The resulting pellet was washed with 75% ethanol, air dried, dissolved in 20fil
ultrapure water and the activity of 2 x l|il aliquots determined by liquid scintillation
spectroscopy. The average activity of the two samples was calculated and the volume
of probe necessary to give 5 x 105 cpm was determined.
3.11.2 RNase protection assay reaction
Total RNA extracted from fetal tissues was mixed with 5 x 105 cpm of radiolabeled
cRNA, dried in a freeze drier, dissolved in 20|il of hybridisation buffer (80%
deionised formamide, 40mM PIPES (pH 6.7), 0.4M NaCl, ImM EDTA), heated to
85°C for 10 min and incubated overnight at 45-50°C. The next day, single stranded
RNA (which had not hybridised to radiolabeled cRNA probe) was digested by adding
10-20|i.g/ml RNase A (Sigma) and 20-100U/ml RNase T1 (Boehringer) into the
mixture which was incubated at 37°C for 45 min. Proteinase K (50|ig per reaction)
and 20|il 10% SDS were added and the tubes were incubated at 37°C for a further 15
min. Each complete reaction mixture was then added to an equal volume of phenol
chloroform (1:1, pH 8.0), mixed thoroughly by vortexing and centrifuged at 13,000
rpm for 5 min. The upper aqueous layers were transferred to fresh tubes, precipitated
in the presence of 0.3M sodium acetate and absolute ethanol for 20 min at -20°C and
centrifuged at 13,000 rpm for 20 min at 4°C. The resultant pellet was washed with
75% ethanol and air dried. RNA was dissolved in 10|il of loading buffer (90%
formamide, lOmM EDTA, 0.1% bromphenol blue, 0.1% xylene cyanol) heated to
95°C for 3 min and loaded on a 6% denaturing polyacrylamide gel. The gel was run
for 2 to 3 h at 50W before drying at 80°C for 2 h and either exposed to
autoradiographic film (Kodak) or a phosphorescent screen for use with the
phosphorimager (Molecular Dynamics).
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3.11.3 Preparation of polyacrylamide gel
A polyacrylamide gel composed of 9% acrylamide (30% stock of acrylamide : bis
acrylamide 19:1) and 1.5 x TBE in 12M urea was prepared on Biorad Sequi-Gen





Acrylamide (30%) 12ml 8ml
10 x TBE 6ml 10ml
Water 20ml 4ml
Urea was melted by heating the mixes in the microwave for 2 min at 30% power prior
to the addition of 100(il each of 10% ammonium persulphate and N,N,N',N'-
tetramethylethylenediamine (TEMED) to the base mixture which was poured into the
casting tray. The bottom of the assembled gel apparatus was placed in the casting tray
and the base mix was allowed to set to seal the bottom of the gel plates.
The 'top' mix was filtered using a 0.45p.M millipore filter connected to a syringe prior
to the addition of ammonium persulphate and TEMED (60|il and 20(il respectively)
after which the gel was poured immediately between the gel plates using a 25ml
pipette. A gel comb containing flat-bottom wells was placed into the liquid gel
between the gel plates at the top of the apparatus and the gel was left to polymerise at
room temperature for approximately lh. The comb was removed from the gel, the
individual wells were washed out with 1 x TBE and the gel was prerun in lxTBE at
1800 volts for 30 min prior to sample loading.
4. Histogenesis of the gonads
4.1 Introduction
The gonads develop from embryonic mesoderm within the abdominal cavity.
Gonadal rudiments first appear as a bulge on the ventral side of the mesonephros due
to a rapid proliferation of coelomic epithelium and the condensation of adjacent
mesenchyme (reviewed by Byskov, 1986; Kaufman, 1992; Pelliniemi et ah, 1993).
This process is first evident on day 13.0-13.5 p.c. in the rat fetus (Jost et al., 1973;
Magre and Jost, 1980; Satoh, 1985) and between the 6th and 7th week of gestation in
the human (Gustafson and Donahoe, 1994). The gonads in both the male and female
fetuses are initially histologically indistinguishable. Half a day later, on day 14.0 in
the rat, epithelial strands extend into the underlying mesenchyme, surround the germ
cells and form primitive sex cords in the gonad of the male fetus (Jost et al., 1973;
Magre and Jost, 1980; Satoh, 1985). The same process is evident around day 42 of
gestation in the human fetus (Gustafson and Donahoe, 1994; Jost et al., 1973). At
this developmental stage it is possible to distinguish between the testis and the ovary
under the light microscope. The ovary has a homogenous granular appearance, while
the testis appears to contain wide regularly arranged bands of tissue known as
testicular cords, which are destined to form the seminiferous tubules after birth
(Gustafson and Donahoe, 1994; Jost et al., 1973; Magre and Jost, 1980; Mittwoch et
al., 1969).
Sertoli cells develop from epithelial precursors, which surround the germ cells
residing in the indifferent gonads (Byskov, 1986; Pelliniemi et al., 1993; Satoh,
1985). The morphological differentiation of Sertoli cells is simultaneously
accompanied by their functional differentiation with AMH production already
detectable in the fetal rat testis on day 14.0 (Lee et al., 1992). The germ cells are the
only cells within the gonads that are not derived from the embryonic mesoderm but
migrate to the gonads from extraembryonic mesoderm in the wall of the yolk sac
(Chiquoine, 1954; Witschi, 1948). After entering the gonads, the germ cells undergo
mitotic arrest in G1 phase and resume proliferation only after birth (Byskov, 1986;
Vergouwen et al., 1991). The first Leydig cells can be distinguished in the fetal rat
testis around day 15.5 (Magre and Jost, 1980; Saez, 1994) and in the human fetus
during the eighth week of gestation (Huhtaniemi and Pelliniemi, 1992; Saez, 1994).
Leydig cells are easily recognisable using the electron microscope due to the presence
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of large mitochondria, lipid droplets and a large amount of smooth endoplasmic
reticulum (Magre and Jost, 1980). However, they are not easily distinguishable from
other interstitial cells under the light microscope without specific immunostaining. In
the next few days as the fetal development proceeds, the testis and the ovary become
easier to distinguish morphologically and the testes grow faster. At day 16.5 in the
rat, testis and ovary each have a distinct gross histological appearance with the testis
appearing as a bigger and fairly ovoid structure while the ovary is smaller and has a
much more elongated shape, with its craniocaudal axis being almost three times as
long as it is wide (Kaufman, 1992; Mittwoch et al., 1969). At this time point, the
testis begin their descent in a caudoventral direction while the ovaries remain in their
original place lateral to the kidneys (Kaufman, 1992).
In addition to the Sertoli, Leydig and germ cells, other types of cells are also present
in the fetal testis (Pelliniemi et al., 1993). The function of these cell types is mostly
unknown but at least some interstitial cells are most likely to be precursors of Leydig
cells (Hardy et al., 1989). Peritubular cells surrounding the testicular cords contribute
to the organisation of the testis by synthesising extracellular matrix components
(Pelliniemi et al., 1993). Some studies have suggested that cells from the
mesonephric area migrate into the testis and experiments by Buehr and co-workers
(Buehr et al., 1993) have shown the importance of this migration for normal testicular
development. In the absence of an influx of cells from the mesonephros, normal
differentiation of the testicular cords did not occur, consistent with a role for
peritubular cells in the organisation of the testis (Buehr et al., 1993).
Phagocytic cells in the fetal testis appear last of all the cell types. In rat, these cells
differentiate around day 19.5 p.c. (Hutson, 1990) and in humans between 16 and 20
weeks (Dechelotte et al., 1989). The most probable precursor for these phagocytic
cells are testicular mesenchymal cells although a hematogenous origin for some
macrophages cannot be ruled out (Pelliniemi et al., 1993).
Immediately after birth, the rat testis still retains the same gross histological
appearance as it did during fetal life. A few days after birth, the prespermatogonia
resume mitosis and on day 4 postnatally, a few type A spermatogonia can be
distinguished (Clermont and Perey, 1957; Vergouwen et al., 1991). In the following
days, the spermatogonia as well as the Sertoli cells actively proliferate and on day 9
the first primary spermatocytes appear within the tubules (Clermont and Perey, 1957).
In the rat on day 15 the first zygotene and pachytene spermatocytes are present in the
Chapter 4 Histogenesis of the gonads 62
tubules (Clermont and Perey, 1957) and around days 16-18 a lumen is formed within
the testicular cords/seminiferous tubules (Russell et al., 1989). While the
spermatogonia continue to divide, the proliferation of Sertoli cells starts to decline and
by day 18 no mitotic figures or uptake of (3H)thymidine can be seen in Sertoli cells
(Nagy, 1972; Orth, 1982; Vergouwen et al., 1991). In the subsequent days of life,
the population of tubules by germ cells continues and by day 26 the first spermatids
appear in some of the tubules with the first fully mature sperm detectable around day
45 (Clermont and Perey, 1957). Fetal-type Leydig cells persist in the rat testis for
several days after birth, noticeable by their distinctive appearance in clusters (Saez,
1994). Between days 10 and 15 postnatally, the number of fetal Leydig cells declines
and for a short period only a few steroidogenic cells can be observed in the testis
(Lording and De Kretser, 1972). However, after day 15, the testis is slowly re-
populated with adult type Leydig cells scattered between the tubules (Lording and De
Kretser, 1972). In humans, the number of Leydig cells increases immediately after
birth and reaches a second peak accompanied by a peak in testosterone production
around 2 months of age (Codesal et al., 1990; Forest et al., 1973; Prince, 1990).
Thereafter as in rat testis, the number of Leydig cells decreases and very few Leydig
cells remain in the testis by the end of the first year of life (Codesal et al., 1990; Nistal
and Paniagua, 1979). Similar to rat, the adult Leydig cells then start to repopulate the
testis and are again numerous during puberty (Nistal and Paniagua, 1979).
The aim of this chapter is to give basic histological information on gonadal
development in the rat as a background to the studies described in the rest of the
thesis.
4.2 Experimental procedures
4.2.1 Collection and processing of tissues
Fetuses were collected, dissected, fixed and processed as described in Chapter 3.
Tissue sections were cut and stained with H&E following the protocol described in
sections 3.4.2 and 3.4.3.
4.2.2 Immunocytochemical staining
For examination of different cell types within the testis, immunocytochemical staining
using different antibodies were used. Antibodies against AMH (donated by Dr.
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Rudolfo Rey and Dr. Nathalie Josso, Montrouge, France) were used to visualise
Sertoli cells, antibodies against 3B-HSD (donated by Professor Ian Mason, University
of Edinburgh, UK) were used as a marker for steroidogenic Leydig cells and
antibodies against proliferating cell nuclear antigen (PCNA, purchased from Dako)
were used as a marker formitotically active (proliferating) cells.
Immunocytochemical stainings were performed as described in chapter 3. Polyclonal
antibodies raised in rabbits against human AMH were used in dilution 1:500; antigen
retrieval was necessary for successful staining (section 3.5.1). Bound antibodies
were detected using swine anti-rabbit biotinylated immunoglobulins (Dako) at a
dilution of 1:500 incubated for 30 min at room temperature. Two washes in TBS
were followed by incubation with ABC-alkaline phosphatase complex (Dako) for 30
min at room temperature. After two further washes in TBS, sections were washed in
Tris-Mg buffer (lOOmM Tris-HCL pH 9.5, lOOmM NaCl, 50mM MgCl2) for 5 min.
Colour reaction product was developed by incubation in a solution containing 337.5
|ig/ml nitro-blue tetrazolium, 175 |ig/ml 5-bromo-4-chloro-3-indolyphosphate and
ImM levamisol in Tris-Mg buffer for 15-30 min. After a wash in distilled water,
sections were counterstained with haematoxylin, dehydrated in alcohols, cleared in
xylene and coverslipped using Pertex mounting medium (Cellpath).
Polyclonal antibodies raised in rabbit against human 36-HSD were used in dilution
1:1000 and incubated on sections overnight at 4°C. The following day, the sections
were washed twice in TBS, incubated with biotinylated swine anti-rabbit
immunoglobulins (Dako) for 30 min at room temperature, washed twice in TBS and
incubated with ABC-horseradish peroxidase complex (Dako) for 30 min at room
temperature. After two washes in TBS, colour reaction product was developed by
incubating sections in a mixture of 0.05% (w/v) 3,3'-diaminobenzidine tetra-
hydrochloride (DAB, Sigma) in 0.05M Tris-HCl, pH 7.4 and 0.01% hydrogen
peroxide. After 5-15 min, sections were washed in water, counterstained with
haematoxylin, dehydrated in graded ethanols, cleared in xylene and coverslipped
using Pertex mounting medium (Cell path).
Proliferating cell nuclear antigen (PCNA) is a marker of dividing cells. It functions as
an auxiliary protein to DNA polymerase delta (Bravo et al., 1987) and is strongly
expressed in the cells during G1 and S phase of the cell cycle and weaker during M
phase (Kurki et al., 1986). Monoclonal antibodies raised in mice against PCNA were
used at a dilution of 1:1000 with biotinylated rabbit-antimouse secondary antibodies
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(1:500) and ABC-horseradish peroxidase complex with DAB as a substrate for
visualisation of bound antibodies as described for anti-3B-HSD antibodies.
The specificity of the specific antibodies was checked by replacing them with normal
serum from the same animal species from which the primary antibodies derived
(section 3.5.2). None of these controls resulted in any signal above background.
Sections were analysed using an Olympus Provis microscope and images captured
onto computer using Nikon N90 camera with a Kodak DC digitalizer.
4.3 Results
4.3.1 General morphological appearance
Rat fetuses of different ages from day 11.5 until birth were fixed, sectioned and
examined. Staining of sections with haematoxylin and eosin showed a well preserved
tissue throughout the fetus which contained the expected tissue structures. There was
no obvious gonadal ridge in the 12.5 p.c. old fetuses but at day 13.5, the gonadal
tissue could first be identified (Fig. 4.1a). On saggital sections, the streak of the
tissue lying ventromedial on the mesonephros was observed. At this age in the rat,
the gonadal ridge is similar in appearance in both male and female and the gonads are
indistinguishable under the microscope. Half a day later (day 14.0), the genital ridge
became more prominent and for the first time, the testis could be distinguished from
the ovary by its "stripy" appearance, resulting from organisation of testicular cords by
Sertoli cells, which become more prominent on day 14.5 (Fig. 4.1b, c). At that age,
the ovaries and testis are still similar in shape and size.
Figure 4.1: The genital ridges (g) in the rat fetus can first be identified on day 13.5
beside the mesonephros (m; panel a), however, at this time the male and female
gonads are histologically indistinguishable. One day later, on day 14.5 (b), testicular
cords formed by the newly developed Sertoli cells can be seen (asterisk) and the testis
can be distinguished from the ovary (c) for the first time. Magnification x300 (a);
x400 (b,c).
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By day 15.5, the testicular cords within the testis were further developed and it was
easy to distinguish the testis from the ovary. The difference in the size and shape of
the gonads started to become obvious on day 15.5 and became more obvious on
subsequent days; the testes were bigger and more ovoid in shape while the ovary
remained elongated with its length being about three times that of its width (day 17.5;
Fig. 4.2). Similarly, the position of the gonads in relation to other organs started to
change on or about day 15.5/16.5. Whilst the ovary remained in its original position
on the lateral side of the kidney, the testes started to descend ventrocaudally. On day
17.5 a change in the histological appearance of the ovary was apparent and small
sexual cords, formed by theca cells surrounding germ cells, could be distinguished
(Fig. 4.2b, arrowheads). However, these "cords" are much smaller and more evenly
distributed throughout the ovary than the seminiferous cords of the testis (Fig. 4.2a,
asterisks). For the remainder of gestation the histological appearance of the gonads
remained similar to that on day 17.5 while the position of the testes within the
abdominal cavity continued to change as they moved more ventrocaudally (Fig. 4.3).
After birth, the cords within the testis gradually increased in size mainly due to a
proliferation of germ cells which began to occupy a greater volume as development of
the first wave of spermatogenesis commences. There was also an obvious reduction
in the volume of the interstitial compartment (Fig. 4.4a) compared with that seen in
fetal life (Fig. 4.2a). Sertoli cells cease to proliferate on day 18 (see section 4.3.4)
and at around that age, a lumen appeared within the seminiferous cords (Fig. 4.4b).
Postnatally, the germ cells that had previously resided in the centre of the testicular
cords moved to their periphery and resumed mitosis (Fig. 4.4a). The
prespermatogonia differentiated into type A spermatogonia and thereafter the different
types of germ cells could be distinguished. The first pachytene spermatocytes were
observed on day 15 (Fig. 4.5a, arrows), the first round spermatids around day 25 and
the first mature elongate spermatids around day 45 (Fig. 4.5b).
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Figure 4.2: On day 17.5, the testis (a) could be easily distinguished from the ovary
by its shape and the presence of prominent testicular cords (asterisks). At around this
time, small sexual cords (triangles) are formed within the ovary (b), however, they are
much smaller than the testicular cords. The shape of both organs is also obviously
different at that age with the ovary having a much more elongated shape compared to
the testis (compare b with a). Magnification x200.
Chapter 4 Histogenesis of the gonads 68
Figure 4.3: From day 15.5 onwards the testes gradually move ventrocaudally and
on day 17.5 the testis (t; panel a), which is bigger than the ovary (o; panel b) lies more
caudally than the ovary which remains in its original position close to the kidney (k)
and adrenal gland (arrow).
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Figure 4.4: By day 7 after birth (a) the germ cells (arrowheads) within the testis
resume mitosis and move to the periphery of the cords. The lumen (L) within the
testicular cords first appears around day 16 (b). Magnification x300.
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Figure 4.5: Postnatally the seminiferous tubules become larger as they are
populated by successive generations of germ cells. The first pachytene spermatocytes
(arrows) appear around day 15 (a), before the lumen is formed within the cords. The
first wave of spermatogenesis is complete by day 45 at which time the first mature
elongate spermatids can be distinguished (c, day 48). Magnification x300.
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4.3.2 Staining with antibodies raised against AMH
Immunocytochemical staining with anti-AMH antibodies resulted in a strong
immunopositive signal within the testicular cords which was confined to the
cytoplasm of Sertoli cells. Positive immunostaining was first detected on day 14.0
(Fig. 4.6a), coincident with formation of testicular cords. The immunopositive
staining remained strong throughout fetal life (Fig. 4.6a, b). Shortly after birth AMH
immunostaining declined in the testis and by postnatal day 10 AMH was no longer
detectable using immunocytochemistry.
4.3.3 Staining with antibodies against 3B-HSD
3B-HSD is an enzyme involved in steroidogenesis. Staining of fetal testis using
antibodies against this enzyme resulted in cytoplasmic staining exclusively in some
interstitial cells. Immunostaining was first apparent on day 14.5 p.c., however, on
that day only a few cells were weakly immunopositive (Fig. 4.7a). One day later
(15.5), the staining became much more prominent (Fig. 4.7b) and stayed strong
throughout the remainder of fetal life (Fig. 4.7c) and for several days after birth (Fig.
4.7d). Within the interstitial compartment, only a subpopulation of interstitial cells
within the fetal testis were immunopositive with anti-3B-HSD antibodies. The role of
this enzyme in steroidogenesis led to the conclusion that these were fetal type Leydig
cells which are the site of testosterone biosynthesis but no conclusion can be drawn
about the identity or function of the immunonegative interstitial cells. The
immunostaining remained strong in clusters of Leydig cells after birth. Around day
10, the fetal type Leydig cells started to disappear and for several days between day 10
and 15, very few immunopositive cells were observed (Fig. 4.8a). After day 15, the
numbers of immunopositive cells once more increased, however, an obvious
difference in the distribution of these cells compared with younger ages was observed;
immunopositive cells before postnatal day 10 were mostly grouped into clusters,
however after day 15 immunopositive cells were scattered between the tubules (Fig.
4.8b).
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Figure 4.6: In the rat morphological and functional maturation of the Sertoli cells is
a simultaneous process and positive immunostaining with antibodies raised against
AMH was already detectable on day 14.0 (a). Immunostaining for AMH remained
strong throughout fetal life (b, day 17.5; c, day 20.5) but started to decline shortly
after birth (d, day 7 postnatally). Magnification x200.
Ciiapter 4 Histogenesis of the gonads 73
Figure 4.7: Formation of Sertoli cells is followed by differentiation of
steroidogenic Leydig cells within the interstitial compartment; few cells expressing 36-
HSD can first be detected in the testis on day 14.5 (a), although at this age the adrenal
gland (Ad) is strongly immunopositive. The numbers of immunopositive cells within
the interstitial compartment of the testis had increased one day later (b, day 15.5) and
thereafter immunopositive clusters of fetal-type Leydig cells could be identified
throughout fetal life (c, day 20.5) and after birth (d, day 7 postnatal). Magnification
x200.
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Figure 4.8: After the first week of life the numbers of 3B-HSD immunopositive
fetal-type Leydig cells reduced progressively (a, day 11) and thereafter were replaced
slowly by adult-type Leydig cells (b, day 16) that were scattered between the tubules.
Magnification x400.
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4.3.4 Staining with antibodies against PCNA
Immunocytochemical staining using antibodies specific for PCNA resulted in strong
nuclear staining in the testis, ovary and surrounding areas throughout fetal life. As
expected, all cells in the fetal testis on day 15.5 strongly expressed PCNA (Fig. 4.9a),
and a similar pattern was observed throughout fetal development with the exception of
some interstitial cells which appeared to be immunonegative (Fig. 4.9b, arrows).
For several days after birth the majority of the cells within the testis were
immunopositive (Fig. 4.9c) with the exception of some interstitial cells which were
immunonegative. Immunostaining of Sertoli cells was reduced from day 15 onwards
and by day 20 no Sertoli cell nuclei with positive immunostaining were detectable
(Fig. 4.9d).
Figure 4.9: Staining with antibodies raised against PCNA revealed that the majority
of cells were dividing at the earlier stages of testicular development (a, day 15.5), and
the situation remained similar throughout fetal development with the exception of
some interstitial cells which appear immunonegative (arrows; b, day 17.5). For
several days after birth the majority of cells in the testis expressed PCNA with the
exception of some interstitial cells (c, day 7 postnatally). However, thereafter the
numbers of Sertoli cells proliferating starts to decline and on day 18 (d) Sertoli cells
(arrowheads) were no longer immunopositive for PCNA. Magnification x400.
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4.4 Discussion
As previously described, the gonadal rudiments are reported to appear in the rat fetus
around day 13.0-13.5 of gestation as a thickening of the tissue on the ventral side of
the mesonephros (Mittwoch et al., 1969; Satoh, 1985). Our results do not differ from
those previously described and we first noticed the presence of an obvious gonadal
ridge in 13.5 day old fetuses. At this age, it is impossible to distinguish the testis
from the ovary following staining with H&E. However, this observation does not
exclude the probability that the ovaries and testis already differ at this age at the
molecular level. Experiments in the mouse have demonstrated that the mRNA for the
testis determining factor, Sry, is present in male genital ridges prior to a time when
they are morphologically distinguishable from those of females (Jeske et ah, 1995;
Koopman et al., 1990). Following the formation of the genital ridge, differentiation
of the testis is swift and within half a day, the formation of the testicular cords
containing Sertoli cells is evident (Kaufman, 1992; Magre and Jost, 1980; Mittwoch et
ah, 1969). Initially the Sertoli cells differentiate by mesenchymal to epithelial cell
transformation, a process the regulation of which is not yet fully understood. Some
studies have suggested that the Wilms' tumour (WT1) gene product could be involved
in this process since in mice lacking a functional WT1 gene testicular cords fail to
develop and the gonadal rudiments subsequently regress (Kreidberg et ah, 1993).
Recently, another gene called SOX9 has been implicated in this process (Foster et al.,
1994; Wagner et ah, 1994; Wright et ah, 1995). Mutations in the SOX9 gene are
responsible for development of a pathological condition called campomelic dysplasia,
which is associated with failure of differentiation of cartilaginous tissue resulting in
severe abnorrnalities in the skeletal system which are usually fatal soon after birth
(Foster et ah, 1994; Wagner et ah, 1994). Notably, campomelic dysplasia is often
associated with 46,XY male to female sex reversal. Development of cartilaginous
tissue requires transformation of mesenchyme suggesting that SOX9 may be essential
for this process. The suggestion that SOX9 may also be involved in mesenchymal
differentiation in the testis is further supported by its pattern of expression in the fetal
gonads. SOX9 is expressed in the gonadal ridge before sexual differentiation (Wright
et ah, 1995); thereafter SOX9 continues to be expressed in the Sertoli cells within the
fetal testis but is switched off in the ovary (R. Lovell-Badge, personal
communication). Whilst its expression in the testis throughout development suggests
that it may have additional functions, it is possible that SOX9 is involved in the
transformation of Sertoli cells from their precursors.
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From day 15.5 onwards, the size of the gonads increases rapidly and the difference
between testis and ovary becomes more obvious. The data described in this chapter
show very similar results to those described previously for mice and rats regarding the
size and morphological appearance of both gonads (Kaufman, 1992; Magre and Jost,
1980; Mittwoch et al., 1969).
AMH is reported to be one of the earliest protein products synthesised by
differentiated Sertoli cells (Lee et al., 1992; Munsterberg and Lovell-Badge, 1991).
Antibodies directed against AMH were used successfully to demonstrate the
development and organisation of Sertoli cells within the testicular cords. Positive
immunostaining was first detected on day 14.0, coinciding with the morphological
differentiation of recognisable testicular cords, confirming that morphological and
functional differentiation of Sertoli cells in the rat proceeds simultaneously.
Immunostaining for AMH in Sertoli cells remained strong throughout fetal life in the
rat, a finding consistent with the important role of AMH in inducing regression of the
Miillerian ducts (Josso and Picard, 1986; Lee and Donahoe, 1993). However, as the
regression of the Miillerian ducts is mostly complete by day 18.5 in the rat fetus,
strong expression of AMH in the testis after that age would suggest additional
functions for this hormone. In male fetuses in the absence of production or function
of AMH the Miillerian ducts persist, as illustrated by the human pathological
condition, Persistent Miillerian Ducts Syndrome (Lee and Donahoe, 1993). Male
patients suffering from this condition develop both male and female internal
reproductive organs due either to lack of bioactive AMH (Knebelmann et al., 1991;
Lee and Donahoe, 1993) or mutations in the AMH receptor preventing regression of
Miillerian ducts during fetal life (Lee and Donahoe, 1993).
Positive immunostaining with 3B-HSD antibodies consistent with development of
functional Leydig cells was first detectable on day 14.5 in male rat fetuses where it
was confined to a very few interstitial cells. This result is surprising since previous
studies have reported the appearance of morphologically typical steroidogenic cells
only on day 15.5 (Magre and Jost, 1980), the first day on which testosterone
production has been detected (Feldman and Bloch, 1978; Picon, 1976; Warren et al.,
1973). However, Bloch (1979) has reported the presence of 3B-HSD enzyme activity
on day 14.5 in the rat testis, suggesting that functional differentiation of the Leydig
cells starts before their morphological differentiation. The importance of this finding
is not known, however, it is possible that Leydig cell precursors slowly acquire
steroidogenic capacity and the expression of some of the enzymes within the cascade
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starts a little earlier than the capacity to synthesise testosterone. This hypothesis is
supported by studies on expression of P450cl7 which was found to be detectable
only from day 15.5 (Chapter 6).
Immediately after birth, the overall appearance of the testis remains unchanged for the
first week of life, however, the testicular cords grow fast resulting in a reduction in
the proportion of the testis occupied by the interstitial compartment. By day 10, the
immature testis appears similar to the adult testis with small interstitial spaces between
the tubules. In accordance with other reports, the lumen in the cords appear on or
around day 16-18 postnatally (Russell et al., 1989) and the data gathered from
animals examined during the course of the present study agrees with this.
Immunostaining using antibodies directed against PCNA resulted in strong uniform,
nuclear staining in the majority of cells in the fetal testis throughout development. This
result was surprising since prespermatogonia are reported to be quiescent during fetal
development following their initial proliferation on or about day 14.5 (Byskov, 1986;
Vergouwen et al., 1991). However, these cells are reported to be arrested in the G1
phase of the cell cycle and as previous studies have demonstrated the expression of
PCNA at this stage (Kurki et al., 1986), it is possible that PCNA is present in the
prespermatogonia arrested in Gl. The only cells in the fetal testis that did not contain
detectable PCNA were some of the interstitial cells. It has been suggested that
functional Leydig cells do not proliferate but are formed by differentiation from
precursors and it is possible that the immunonegative cells are functional, non¬
proliferative Leydig cells.
Immediately after birth, the pattern of immunocytochemical staining using antiserum
directed against PCNA showed a strong positive reaction in most cells within the
testis. However, as development proceeded, the immunostaining of Sertoli cells was
reduced such that by day 18 Sertoli cells were all immunonegative. This finding is in
accordance with other reports, claiming that in the rat and mouse Sertoli cells divide
only during fetal life and for short time after birth, after which they cease to divide and
their numbers remain fixed throughout life (Kluin et al., 1984; Nagy, 1972; Orth,
1982; Sharpe, 1994). While the same appears to be true for most species, horses
appear to be an exception with several reports suggesting that their Sertoli cells retain
proliferative activity throughout life with seasonal changes in cell numbers (Johnson et
al., 1991; Johnson and Nguyen, 1986). The available, but limited evidence, suggests
that in primates (e.g. Cebus monkey and human) Sertoli cell proliferation continues at
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a low rate until puberty (Cortes et al., 1987; Rey et al., 1993) and studies by Schlatt
and Weinbauer (1994) have detected some PCNA immunopositive Sertoli cells in
testis from prepubertal Rhesus monkeys. It is possible that the specialised function(s)
of Sertoli cells in the adult testis which are essential for maintenance of germ cell
development are incompatible with proliferative activity. At about the same time as the
Sertoli cells differentiated and stopped dividing they also stopped expressing AMH.
In the present study immunostaining for AMH was still present on day 7 after birth
although it was already much weaker than during fetal life and by day 10 postnatally it
had completely disappeared.
For the first few days after birth, the Leydig cells appeared similar in distribution and
appearance to those in the fetal testis; the cells were organised in clusters and strongly
expressed steroidogenic enzymes. However, thereafter, in the rat the number of
Leydig cells in the testis starts to decline so that between day 10 and 15 postnatally,
only a few cells were immunopositive for 3B-HSD. After day 15 the numbers of
steroidogenic Leydig cells increased but these cells remained scattered between the
tubules and did not aggregate into clusters, as had typically been seen during fetal life.
These adult-type Leydig cells seem to differ from their fetal counterparts not only in
appearance but also functionally. Whilst fetal Leydig cells do not express androgen
receptor suggesting they are not responsive to the action of testosterone (Chapter 5),
they contain inhibin a and B subunits (Chapter 7) while in the adult the Leydig cells
contain only very low levels of these proteins (Roberts et al., 1989; Shaha et al.,
1989). The morphological and physiological differences between fetal and adult type
Leydig cells, confirmed by the findings in this thesis support studies that suggest adult
Leydig cells are not formed from fetal type Leydig cells but represent a completely
different population of steroidogenic interstitial cells which develop independently
from mesenchymal precursors.
The appearance of the testicular cords starts to change soon after birth; the
prespermatogonia differentiate to spermatogonia, migrate to the periphery of the
tubules and resume cell division whilst Sertoli cells stop dividing (Vergouwen et al.,
1991). As germ cell division and differentiation proceeds, the new types of cells start
to populate the testis (Clermont and Perey, 1957). During this initial wave of
spermatogenesis, many of the developing germ cells within the seminiferous tubule
degenerate (Roosen-Runge and Leik, 1968). It is possible that this is because the
Sertoli cells are still developing and have not yet acquired all the functions necessary
to fully support and nourish the developing germ cells. As germ cells numbers
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increase there is a dramatic increase in testicular size despite the presence of a fixed
number of Sertoli cells.
In conclusion, the data described in this chapter generally agree with previously
published observations and provide useful background information for the following
chapters.
5. Ontogeny of androgen receptor in the fetal
testis and associated ducts
5.1 Introduction
Androgens are essential for masculinisation of the reproductive tract and external
genitalia during development in utero (George and Wilson, 1994). Androgen action
is mediated by a specific intracellular receptor expressed in target tissues which binds
to testosterone and dihydrotestosterone with high affinity (Carson-Jurnica et al.,
1990). The androgen receptor is a member of the nuclear receptor superfamily
(Carson-Jurnica et al., 1990; Rundlett et al., 1990). Deletion mutagenesis has
identified three important domains within its structure, the carboxy terminal domain
responsible for hormone binding, a cysteine rich DNA binding domain and an amino
terminus which contains sequences essential for transcriptional activation (Rundlett
et al., 1990; van Steensel et al., 1995). Upon binding with androgens, the
conformation of the receptor changes and the hormone-receptor complex becomes
able to bind to specific regions of DNA (androgen response elements) resulting in up
or down regulation of the transcription of target genes (Parker, 1991; Rundlett et al.,
1990).
The importance of a functional androgen receptor for development of the male
reproductive tract is clearly illustrated by the condition known as androgen
insensitivity syndrome (AIS; Quigley et al., 1995). Patients suffering from this
disorder develop testes and produce androgens, however mutations in the gene
encoding androgen receptor which make the receptor totally or partially non¬
functional prevent the normal action of androgens on their target tissue. The
consequence of this is the incomplete masculinisation of the fetus and in extreme
cases, when a functional AR is absent, these patients develop female external
genitalia despite the presence of TDF and a developed testis. The phenotype of AIS
patients varies greatly depending upon the nature of the mutation in their AR and
consequently the degree by which the function of the AR is impaired (Quigley et al.,
1995).
The location of the androgen receptor in fetal mouse reproductive organs has been
studied by several groups (Bentvelsen et al., 1995; Cooke et al., 1991a; Kalloo et al.,
1993) who have used autoradiography or immunocytochemistry to document the
ontogeny of AR in reproductive tissues. In the rat fetus Bentvelsen et al. (1995)
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recorded that the first immunoexpression of AR occurred on day 14.5 in the efferent
ductules and epididymis, thereafter in the vas deferens and finally in the seminal
vesicle. The first AR immunopositive cells in the prostate were detected on day 16.5
while mesenchymal cells of the urogenital tubercule expressed AR from day 14.5
onwards (Bentvelsen et al., 1995). Cooke et al. (1991a) have shown similar results in
mice using autoradiography. They found that radiolabeled androgens bound to
mesenchymal cells in the efferent ductules, Wolffian ducts, urogenital sinus,
epididymis, ductus deferens, seminal vesicles, prostate and bulbourethral glands from
day 13.5 of fetal development. However, the binding to epithelial cells was only
detectable in efferent ductules on day 16.5, in epididymis and ductus deferens on day
19.5 and in seminal vesicle, prostate and bulbourethral glands after birth. Similarly,
Kalloo et al. (1993) have reported the expression of androgen receptor in human
external genitalia to be strong in mesenchymal cells at 18-22 weeks of gestation
while epithelial cells did not show positive immunocytochemical staining for
androgen receptor at this time.
In the adult testis, testosterone is an important regulator of testicular function
(reviewed by Sharpe, 1994). Recent reports have documented the presence of
androgen receptors in several cell types within the testis. Immunocytochemical
staining revealed a positive signal in Sertoli, Leydig, peritubular cells and cells lining
arterioles (Bremner et al., 1994). In the rat, staining in the nuclei of Sertoli cells
appears to be stage dependent consistent with the reported role of testosterone in
supporting the process of spermatogenesis (Bremner et al., 1994; Vornberger et al.,
1994).
At the time the study reported in this chapter was undertaken there were no reports
detailing the pattern of expression of androgen receptor in the fetal testis. In view of
the important role of androgens in development of the normal male phenotype and
testicular function in the adult we decided to use immunocytochemistry to determine
the ontogeny of androgen receptor in the rat testis and associated ducts.
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5.2 Experimental procedures
5.2.1 Collection and processing of tissues
Tissues were collected from time mated animals, fixed and processed into paraffin
wax as described in chapter 3 (section 3.4). Tissue sections were cut and processed
as described in section 3.4.2.
5.2.2 Immunocytochemical staining
Immunocytochemical staining was performed essentially as described in chapter 3.
A specific antiserum raised against a peptide containing the first 17 aminoacids of
the human androgen receptor was purchased from Novocastra (Newcastle). Primary
antibodies were used in a dilution of 1:20 overnight at 4°C. Prior to incubation with
primary antibodies, the sections were subjected to antigen retrieval technique (section
3.5.1). The following day, sections were washed twice in TBS, incubated with
biotinylated swine anti-rabbit immunoglobulins (Dako) for 30 min at room
temperature, washed twice with TBS and incubated with ABC alkaline phosphatase
complex (Dako) for 30 min at room temperature. After two washes in TBS, sections
were washed in Tris-Mg buffer (lOOmM Tris-HCL pH 9.5, lOOmM NaCl, 50mM
MgCl2) for 5 min. Colour reaction product was developed by incubation in a
solution containing 337.5jig/ml nitro-blue tetrazolium, 175pg/ml 5-bromo-4-chloro-
3-indolyphosphate and ImM levamisol in Tris-Mg buffer for 30 - 120 min. After
washing in distilled water, sections were counterstained with haematoxylin,
dehydrated in alcohols, cleared in xylene and coverslipped using Pertex mounting
medium (Cellpath).
To detect androgen receptor and the steroidogenic enzyme 36-hydroxysteroid
dehydrogenase (36-HSD) simultaneously in one tissue section, double
immunostaining using antibodies directed against androgen receptor and anti 36-
HSD was performed. Antibodies against human 36-HSD (Lorence et al., 1990),
raised in rabbits, were kindly donated by Professor Ian Mason (University of
Edinburgh, UK). Immunostaining with anti-androgen receptor antibodies (as
described above) was followed by a wash in TBS before blocking with normal swine
serum. Thereafter the sections were reincubated with anti-36-HSD used at a dilution
of 1:1000 in TBS overnight at 4°C. The next day, the sections were washed twice for
5 min each time in TBS, incubated with swine anti rabbit antibodies (Dako) at a
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dilution of 1:60 for 30 min at room temperature, rewashed twice in TBS and
incubated with rabbit peroxidase-antiperoxidase complex (Dako) at a dilution of
1:100 at room temperature for 30 min. After two washes in TBS, colour reaction
was developed by incubating the sections in a mixture of 0.02% 3-amino-9-
ethylcarbazole (Sigma) in 10ml 0.02M sodium acetate buffer (pH 5.2) containing
1.2ml dimethylsulphoxide (DMSO; BDH) and 0.01% hydrogen peroxide. After 5 -
10 min, the sections were washed in double distilled water and coverslipped using
Aquamount (BDH) mounting medium.
The specificity of the antibodies was tested by either replacing the primary antiserum
with the normal serum derived from the same animal as primary antibodies or by
preabsorbing the antibodies with the peptide against which the antibodies were raised
(section 3.5.2).
The sections were analysed using Olympus Provis image analysis system and images
captured onto Macintosh computer using Nikon N90 camera with Kodak DC
digitalizer.
5.3 Results
In the testes and associated structures, there was no signal detected on days 14.5 or
15.5 (earliest examined days) using anti-AR antibodies. On day 16.5 (Fig. 5.1a),
immunopositive staining was present in the nuclei of the mesenchymal cells
surrounding Wolffian ducts and mesonephric tubules, but the staining was clearly
absent from the region around the regressing Mtillerian duct. Weak nuclear staining
was also noticed in the epithelial cells of the Wolffian duct. Half a day later, on day
17.0, the immunostaining in the mesenchymal cells and epithelium of the Wolffian
duct became stronger while the cells around the Mullerian duct remained
immunonegative. At that stage, few immunopositive cells were detected within the
testes (not shown) but were confined to interstitial regions in the vicinity of the
mesonephros. On day 17.5 (Fig. 5.1b), the situation remained similar to that
observed half a day earlier, with strong immunostaining in the nuclei of
mesenchymal cells around Wolffian ducts and mesonephric tubules but none in the
area around the Mullerian duct. Within the testis a few immunopositive cell nuclei
were detected in the interstitial region adjacent to the mesonephros. On day 18.5,
staining in the nuclei of cells adjacent to the ducts became very strong (Fig. 5.1c).
Within the testis, immunopositive cells were now spread throughout the interstitial
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region of the testis. Cells forming a narrow layer around the individual testicular
cords (presumably peritubular myoid cells) contained positive nuclear staining (Fig.
5.1c, arrowheads). For the remainder of gestation and for several days after birth the
pattern of immunostaining observed on day 18.5 p.c. remained unchanged with
strong nuclear immunostaining of mesenchymal cells in developing epididymis
(mesonephric tubules), and interstitial and peritubular cells surrounding testicular
cords within the testes (Fig. 5.2a,b).
Figure 5.1: Androgen receptor immunostaining was first detectable on day 16.5 (a)
in some mesenchymal cells within the mesonephros (asterisk) and in the area around
the Wolffian duct (W). On day 17.5 (b), the staining in the mesonephric cells and
around the Wolffian duct became stronger. Some epithelial cells of the Wolffian
ducts started to show a positive signal but immunostaining was clearly absent from
the area around Miillerian duct (m). For the first time some AR positive cells
appeared within the testis in the interstitial region close to the mesonephros (small
arrows). On day 18.5 (c), the immunostaining in the mesonephros and Wolffian
ducts remained strong while within the testis, the staining was now widespread and
confined to the interstitial cells and peritubular cells (arrowheads) surrounding
testicular cords. Magnification x200.
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Figure 5.2: The pattern of immunostaining on day 20.5 p.c. (a) was similar to that
observed on day 18.5 with positive nuclear staining in interstitial and peritubular
cells. Postnatally on day 5 (b), the interstitial and peritubular cells remain strongly
positive and weak immunostaining appeared in Sertoli cell nuclei (arrowheads) for
the first time. Magnification x400.
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In order to address whether AR immunopositive cells within the interstitial
population of the testis were members of the fetal Leydig cell population double
immunostaining with antibodies directed against AR and 38-HSD was undertaken.
Immunostaining with anti-36-HSD resulted in a strong immunopositive signal in the
cytoplasm of steroidogenically active Leydig cells which make up a proportion of the
total interstitial cell population. AR immunostaining was localised to cell nuclei as
described above. A comparison between the immunopositive cells identified by
these two antisera revealed that the interstitial cells expressing androgen receptor are
not exclusively the same cells that express 36-HSD (fetal Leydig cells) and that only
a few cells express both proteins (Fig. 5.3).
Figure 5.3: On day 19.5, the fetal Leydig cells contained a strong immunopositive
staining using antibodies directed against 3B-HSD (arrowheads), however double
immunostaining clearly shows that different populations of cells express 36-HSD and
AR (arrows). Few cells also expressed both proteins (open arrow). Magnification
x400.
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5.4 Discussion
In the male fetus testosterone synthesis is essential for masculinisation of the
reproductive tract (George and Wilson, 1994). Production of testosterone in the rat
fetal testis starts on day 15.5 p.c. and reaches its peak on day 18.5 (Feldman and
Bloch, 1978; Warren et al., 1973). Androgens, and a functional androgen receptor,
are essential for normal development of male genitalia and a number of studies have
addressed the timing and distribution of androgen receptors in the developing
urogenital system using binding assays (Cooke et al., 1991a) or
immunocytochemistry (Bentvelsen et al., 1995; Kalloo et al., 1993). These studies
and those using in vitro approaches have implicated the cells of the mesenchyme as
the primary targets for androgen action during fetal life. The studies described above
have identified clear and abundant nuclear AR in mesenchymal cells surrounding the
Wolffian duct on and after day 16 of pregnancy. However, AR were not distributed
uniformly throughout the mesenchymal cells within the mesonephric area being
absent from the cells surrounding the Miillerian duct which is destined to regress
under the influence of anti-Miillerian hormone (Lee and Donahoe, 1993) and sparse
in the central region directly adjoining the testis. Some cells within the epithelial
layer of the Wolffian duct, especially in the area which will develop into the
epididymis, contained nuclear AR on day 16.5 and the nuclei of nearly all the
epithelial cells of the ducts were positively stained for AR on and after day 17. The
present results are consistent with the location of AR described in earlier reports
using ligand binding but seem to place expression of AR in the epithelial cells of the
ducts one to two days earlier than might have been expected from reports in the
mouse (Cooke et al., 1991a) reflecting the greater sensitivity of the
immunohistochemical technique and show that expression of AR within the
mesenchymal cells of the mesonephric region is not uniform.
In the adult testis the primary target for androgen action is believed to be the Sertoli
cells within the seminiferous epithelium (reviewed by Sharpe, 1994) although both
peritubular myoid cells and Leydig cells also express AR. In the rat only the Sertoli
cells were found to exhibit stage-dependent expression of nuclear AR (Bremner et
al., 1994) which correlates with the reported stage-dependent effects of testosterone
in this species (Sharpe et al., 1992), but the immunoexpression of AR does not
appear to be stage specific in primates (marmoset and human; Saunders et al., 1996).
In the fetal rat we failed to find convincing immunolocalisation of nuclear AR in the
testis before day 17 p.c., at which time a few cells of the interstitial cell population
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did appear positive. As testicular development progressed the number of cells in the
interstitial cell population with AR nuclear immunostaining increased. Based on
their location within the testis and lack of staining with an antibody against 36-HSD
these AR positive cells are likely to be peritubular and interstitial mesenchymal cells,
both of which have a fibroblastic appearance. In the adult testis peritubular myoid
cells around the tubules have been shown to contain AR (Verhoeven, 1980) and in
other studies conducted in Edinburgh nuclear AR were found in adult peritubular
cells (Bremner et al., 1994). In an interesting series of experiments in vitro, Buehr
and co-workers (1993) found that cells from the mesonephric region migrated into
the testis on or after day 11.5 p.c. in the mouse and contributed to the interstitial cell
population including those in the peritubular layer. In the absence of an influx of
cells from the mesonephros normal differentiation of testis cords did not occur,
consistent with the synthesis of components of the extracellular matrix by peritubular
cells contributing to organisation of the testis. In the context of the current findings it
is interesting to speculate that the cells in the fetal testis containing AR have
developed from the same cell population which express AR in the mesonephros and
which we were able to detect on day 16.5 p.c. Previous studies have suggested that a
peritubular sheath of cells is present at birth but these do not become 'myoid' cells
until puberty when they do so under the influence of testosterone (Bressler and Ross,
1972; Skinner, 1991). These results which demonstrate abundant immunostaining of
AR around the testicular cords would indicate that peritubular cells have the potential
to be responsive to androgens during fetal life and this may have implications for
development of the fetal testis. Peritubular cells from immature rats (postnatal days
15-25) have recently been shown to secrete activin-A (de Winter et al., 1994) and to
respond to androgens with increased expression of an androgen response element
reporter (Ku et al., 1994). Previous studies have shown that at this time they can
secrete a range of growth factors and regulatory agents (reviewed by Skinner, 1991)
the production of some of which may be testosterone dependent. Peritubular cells
may also demonstrate similar functions during fetal life and could influence
development of the fetal testis. Positive staining of AR protein within the cells of the
seminiferous cords was unconvincing prior to birth. Previous reports have
demonstrated an increase in the expression of AR in immature Sertoli cells of the rat
over the period when spermatogenesis is becoming established between days 14 and
28 of postnatal life and establishment of stage-dependent immunostaining of Sertoli
cells in the rat (Bremner et al., 1994; Ku et al., 1994).
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To detect the AR protein in our sections of fixed tissue it was necessary to undertake
antigen retrieval of the samples by microwaving in citrate buffer (Shi et ah, 1993).
In the absence of this pretreatment, which was recommended by the supplier of the
antiserum, no immunostaining was detected. In separate studies using adult rat testes
AR immunostaining in Sertoli cell nuclei at stages IV-VII has been reported both
following antigen retrieval (Bremner et ah, 1994) and in samples embedded in
polyester wax and not subjected to antigen retrieval (Vornberger et ah, 1994). The
immunogen used to raise the antiserum used in this study is located at the extreme N
terminal end of the receptor protein in the region associated with ligand-independent
transcriptional activation (Jenster et al., 1991). Antigen retrieval, due to the high
temperatures used, is believed to cause 'unmasking' of antigenic sites and has been
particularly applicable to proteins with a nuclear location, and can sometimes be
mimicked by treatment of sections with proteolytic enzymes (Shi et al., 1993). ARs
are known to associate with other proteins both before and after ligand binding
(reviewed by Carson-Jurnica et al., 1990) and a recent study has shown retention of
receptor-bound androgen is enhanced by an interaction between the AR N terminal
and steroid binding domains (Zhou et al., 1995). In the present study whether the
detection of AR by the antibody directed against the N terminal epitope is dependent
upon the conformation of the AR protein was not investigated but in a previous study
it was assumed that immunohistochemical localisation of AR reflected the presence
of an active ligand-bound receptor because of the correlation with known sites of
androgen action (Bremner et al., 1994).
In conclusion, some cells within the mesonephric mesenchyme contain AR as early
as day 16 of gestation, consistent with these cells being a primary target of androgen
action, but cells around the Miillerian duct remain receptor negative. In the fetal rat
testis AR detected by immunohistochemistry is confined to cells of the interstitial
population which may have migrated from the mesonephros but is mostly absent
from Leydig cells. In the rat androgen action within the testis during fetal life seems
likely to be confined to the peritubular and interstitial mesenchymal cell population.
6. Functional differentiation of Leydig cells
during fetal and neonatal life
6.1 Introduction
Androgens are essential for normal differentiation and virilization of the male fetus.
Leydig cells in the developing testis are the main source of testosterone during fetal life
(George and Wilson, 1994). Cells containing large mitochondria with tubular cristae,
lipid droplets and smooth endoplasmic reticulum, all characteristics of steroidogenic
cells, have been observed in fetal rat testis on day 15.5 of gestation (Magre and Jost,
1980). This timing coincides with the start of testosterone production, which is first
detectable on day 15.5 and thereafter rises to reach its peak around day 18.5 of
gestation (Feldman and Bloch, 1978; Picon, 1976; Warren et al., 1973). While the
testis is a very active endocrine organ throughout fetal life, steroidogenesis in the
ovary does not start until several days after birth (Juneau et al., 1993).
Conversion of cholesterol to testosterone requires the activity of four steroidogenic
enzymes: cholesterol side chain cleavage (P450scc), 38-hydroxysteroid
dehydrogenase (36-HSD), 17a-hydroxylase/17,20-lyase (P450cl7) and 178-
hydroxysteroid dehydrogenase. Both testosterone and androstendione can be
converted to oestrogen by the enzyme aromatase (P450arom) while testosterone is
often converted to DHT by the enzyme 5a-reductase in its target cells (Miller, 1988).
Several investigators have studied the pattern of production of steroid hormones and
the presence of steroidogenic enzymes in fetal rat testis by measuring different
hormones and their precursors (Bloch, 1979; Feldman and Bloch, 1978; Picon, 1976;
Rouiller et al., 1990; Warren et al., 1973). The presence of P450scc in the fetal rat
testis was demonstrated using immunocytochemistry on day 15.5 p.c. by Rouiller et
al. (1990), but there are no other reports containing immunocytochemical evidence for
the expression of the other steroidogenic enzymes in the fetal rat testis prior to day
18.5 p.c. Greco and Payne (1994) have identified mRNAs for P450scc, 38-HSD,
P450cl7 and P450arom in fetal mouse gonads using reverse transcription plus
polymerase chain reaction (RT PCR). They found evidence of expression of the
genes encoding P450scc, 3B-HSD and P450cl7 in fetal testis from day 13.5 p.c. (the
earliest examined day, equivalent to day 15.5 in rat) while aromatase gene expression
appeared only later in development on day 17.5 p.c. Expression of all three
steroidogenic enzymes remained high in all fetal testis examined. In contrast, the
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developing ovaries did not show expression of steroidogenic enzymes with the
exception of 36-HSD that was detected in about one third of examined samples.
Two recently discovered members of the nuclear hormone receptor superfamily are
thought to have essential roles in development of the gonads and adrenal glands.
Firstly, steroidogenic factor 1 (SF-1; Lala et al., 1992; Morohashi et al., 1992) has
been shown to regulate expression of several cytochrome P450 steroidogenic enzymes
(Ikeda et al., 1993; Morohashi et al., 1992) as well several other genes including
AMH (Shen et al., 1994) and aGSU (Barnhart and Mellon, 1994). A functional SF-1
gene is required for development of gonads, adrenal glands, hypothalamus and
pituitary gonadotrophs (Ingraham et al., 1994; Luo et al., 1994). Secondly, defects in
the DAX-1 gene have been identified as responsible for the pathological condition
adrenal hypoplasia congenita which is often associated with hypogonadotrophic
hypogonadism (Guo et al., 1995; Muscatelli et al., 1994; Zanaria et al., 1994). DAX-
1 lies in a region on the X chromosome (Zanaria et al., 1994), identified as
responsible for XY sex reversal when it is duplicated (dosage sensitive sex reversal,
DSS; Bardoni et al., 1994). The position of DAX-1 in this region suggests that
duplications of DAX-1 could be responsible for DSS, however this data is not yet
conclusive. The function of the DAX-1 gene is as yet unknown but similarities
between SF-1 knock out mice (which lack gonads and adrenals) and patients with
adrenal hypoplasia congenita suggest a possible interaction between these two genes
or their products. While the expression of SF- 1 in the fetal gonads has been explored
(Hatano et al., 1994; Ikeda et al., 1994), little is known about the cellular site and
timing of expression ofDAX-1.
6.2 Experimental procedures
6.2.1 Collection and processing of tissues
Tissues were collected from time mated animals, fixed and processed into paraffin
wax as described in chapter 3 (section 3.4). Tissue sections were cut and processed
as described in section 3.4.2.
6.2.2 Immunocytochemistry
Immunocytochemical staining was essentially performed as described in chapter 3.
Polyclonal rabbit antiserum directed against recombinant human P450cl7 (Imai et al.,
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1993), used at a 1:1000 dilution was a gift from Professor Michael Waterman
(Vanderbilt University, Nashville, Tennessee), polyclonal rabbit anti-human 36-HSD
(Lorence et al., 1990) antiserum (used at a dilution of 1:1000) was a gift from
Professor Ian Mason (University of Edinburgh, UK) and polyclonal rabbit antiserum
raised against bovine SF-1 (Morohashi et al., 1993) was donated by Dr. Ken
Morohashi (Kyushu University, Japan) and used at a dilution of 1:200. Polyclonal
rabbit antibodies against human DAX-1 were purchased from Santa Cruz
Biotechnology (San Diego, CA, USA) and used at 1:100 dilution. All diluted primary
antisera were incubated on tissue sections at 4°C overnight. Staining with anti-
P450cl7, anti-SF-1 and anti-DAX-1 antibodies required antigen retrieval prior to
immunostaining to detect a positive signal (section 3.5.1). The incubation with
primary antibodies was followed by two washes in TBS and incubation with
biotinylated swine anti-rabbit immunoglobulins (Dako, 1:500) for 30 min at room
temperature. Sections were washed again twice in TBS, incubated for 30 min at room
temperature with ABC-horseradish peroxidase complex (Dako) and washed twice in
TBS. Colour reaction product was developed by incubation in a mixture of 0.05%
(w/v) 3,3-diaminobenzidine tetrahydrochloride (DAB, Sigma) in 0.05M Tris-HCl,
pH 7.4 and 0.01% hydrogen peroxide. The development of the colour reaction was
monitored under the microscope and after 5-15 minutes, the slides were placed in
distilled water to stop the reaction. Slides were counterstained in haematoxylin,
dehydrated in graded alcohols, cleared in xylene and coverslipped using Pertex
mounting medium (Cellpath).
The specificity of the antibodies was checked by replacing the primary antibodies with
the normal serum from the same species that the primary antibodies were raised in.
Specificity of the DAX-1 antiserum was also checked by preabsorbing the antibodies
with the peptide. In none of the controls was a positive signal detected.
In some cases, double immunostaining was performed as follows: staining with anti-
SF-1 antibodies was performed as above and development of a colour reaction was
followed by a wash in distilled water and a wash in TBS. Sections were then blocked
with normal swine serum diluted 1:5 in TBS for 30 min at room temperature prior to
incubation with anti-3B-HSD or anti-DAX-1 antibodies overnight at 4°C. The
following day sections were washed twice in TBS, incubated for 30 min at room
temperature with swine anti-rabbit antibodies (Dako) used at a dilution 1:60, washed
twice in TBS and incubated for 30 min at room temperature with rabbit alkaline
phosphatase-anti alkaline phosphatase complex diluted 1:100 (Dako). After two
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washes in TBS, colour reaction product was developed by incubating the sections in
l|ig/ml solution of Fast blue (Sigma) in Fast blue buffer (0.1M TRIS pH 8.2, 2%
dimethylformamide, 0.02% naphtol). Slides were washed in distilled water,
counterstained with haematoxylin and embedded using aquamount (BDH) mounting
medium.
6.3 Results
6.3.1 Detection of 3R-HSD in the fetal gonads
Staining of fetal testes with antibodies against 38-HSD resulted in a strong
immunocytochemical positive signal in the cytoplasm ofmany of the interstitial cells
between testicular cords (fetal Leydig cells). No positive staining has been detected on
day 14.0 p.c., the earliest stage at which it was possible to morphologically
distinguish the testis from the ovary by its "stripy" appearance (see chapter 4). Half a
day later, on day 14.5, strong immunostaining was apparent in the adrenal glands and
moderate staining in some of the Leydig cells within the testis (Fig. 6.1a). On day
15.5, staining in the testis became much stronger (Fig. 6.1b) when compared with day
14.5 and thereafter, this immunostaining remained strong for the rest of the fetal life
(Fig. 6.1c, d). No positive staining was detected in the fetal ovaries at any stage of
development.
6.3.2 Detection of P450cl7 in the fetal gonads
Cytoplasmic staining with antibodies against P450cl7 was first detectable on day
15.5, in a few weakly stained fetal Leydig cells (Fig. 6.2a). On day 16.5, the staining
became stronger with more immunopositive cells within the interstitium (Fig. 6.2b).
As with 3B-HSD, Leydig cells remained strongly immunopositive throughout fetal life
(Fig. 6.2c, d). The staining with antibodies directed against 38-HSD usually resulted
in a stronger colour reaction than staining with antibodies against P450cl7. No
positive staining was detected in fetal ovaries at any stage of gestation.
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Fig. 6.1: 3B-HSD immunostaining was first detectable in fetal testis on day 14.5 (a)
but became much stronger and more widespread one day later, on day 15.5 (b). The
staining remained strong throughout the fetal life (c, day 17.5; d, day 20.5).
Magnification x400.
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Fig. 6.2: Few interstitial cells showed positive immunostaining for P450cl7 in the
fetal testis on day 15.5 (a). The amount of protein increased one day later (b, day
16.5) and thereafter cells remained strongly immunopositive throughout the fetal life
(c, day 17.5; d, day 20.5). Magnification x400.
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6.3.3 Detection of SF-1 in the fetal gonads
SF-1 was immunolocalised to nuclei of cells within the genital ridge from day 13.5
p.c. (not shown). Immunostaining at that age and on day 14.0 was weak and present
in both ovaries and testes. On day 14.5, the intensity of immunostaining increased
and was still present at a similar intensity in cells within both testes and ovaries (Fig.
6.3a, b). In the testis, SF-1 was present in both the interstitial cells and Sertoli cells;
staining of interstitial cells was not uniform and cells with both strong and weak
expression of SF-1 could be clearly distinguished (Fig. 6.3a). During subsequent
days of gestation, the staining in the fetal ovaries (Fig. 6.3d) declined until the only
cells that showed a relatively strong immunostaining were those of the germinal
epithelium (arrows). In the testis, the immunoexpression of SF-1 remained in Sertoli
and interstitial cells throughout fetal development (Fig. 6.3c).
6.3.4 Detection of DAX-I in the fetal gonads
DAX- 1 protein was first detectable in rat gonads within cellular cytoplasm on day
15.5 p.c. Weak immunostaining was detected in the interstitial cells in the testis (Fig
6.4a, arrows) and in the germinal epithelium of the ovary. Immunoexpression within
the testis increased as pregnancy progressed (Fig. 6.4b), however it remained weak
throughout fetal life.
6.3.5 Detection of 3B-HSD and SF-1 in fetal testis
Double immunostaining using antisera raised against 36-HSD and SF-1 resulted in
strong immunostaining in both cases. The results obtained clearly demonstrated that
the interstitial cells with abundant nuclear immunostaining for SF- 1 also expressed
3B-HSD (Fig. 6.5a, arrows) and are therefore steroidogenically active fetal Leydig
cells. In contrast, interstitial cells with "weak" expression of SF-1 were not
immunopositive for 3B-HSD (Fig. 6.5a, arrowheads).
6.3.6 Detection of SF-1 and DAX-1 in fetal gonads
Double immunostaining with antibodies raised against SF-1 and DAX-1 proteins
revealed only partial colocalisation of SF-1 and DAX-1 in the interstitial cells (Fig.
6.5b). Some DAX-1 positive cells did not appear to express SF-1 and while the
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majority of cells with strong SF-1 expression also showed positive immunostaining
for DAX-1, some were also immunonegative for DAX-1.
Fig. 6.3: Weak immunostaining for SF-1 was detectable on day 14.0 but the staining
became much stronger half day later on day 14.5 in the testis (a) and ovary (b). In the
testis, SF-1 was present in interstitial and Sertoli cells (arrowheads) within the
testicular cords (asterisks). Among interstitial cells, two different populations could
be distinguished; cells with strong immunoexpression of SF-1 and cells with weak SF-
1 expression. The staining in the testis remained strong throughout the fetal life (c,
day 17.5) but declined in the ovary so that on day 17.5 (d) only cells of the germinal
epithelium still strongly expressed SF-1 (arrow). Strong immunostaining was also
detected in adrenals (Ad). Magnification x200.
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Fig. 6.4 : DAX-1 immunostaining was detected in the fetal rat testis on day 15.5 (a)
in cytoplasm of some interstitial cells (arrows). During the following days of
gestation, the amount of protein increased (b, day 18.5). Postnatally, immunostaining
was very weak and as in fetal life, was confined to a subpopulation of interstitial,
presumably Leydig cells (not shown). Magnification x400.
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6.4 Discussion
Using immunocytochemistry with specific antibodies, the patterns of expression of
two steroidogenic enzymes and two orphan nuclear receptors with important functions
in sexual differentiation and gonadal development was demonstrated in the fetal rat
testis. Previous data on the ontogeny of steroidogenic enzymes has been principally
based on measurements of different steroids and their precursors (Bloch, 1979;
Feldman and Bloch, 1978; Picon, 1976; Warren et al., 1973) but with the exception of
P450scc (Rouiller et al., 1990), there is no data on cellular localisation of the
individual enzyme proteins in the fetal testis. Studies by Rouiller et al. (1990) have
detected the presence of P450scc in fetal rat testis using immunocytochemistry on day
15.5 of gestation, in agreement with our observation on the onset of synthesis of
another cytochrome P450, P450cl7, suggesting that a similar mechanism for initiating
expression of those two cytochromes may exist. In addition, several studies have
reported that the onset of testosterone production begins on day 15.5 p.c. (Feldman
and Bloch, 1978; Picon, 1976; Warren et al., 1973). Whilst the testosterone content
in the fetal testis is reported to be low on day 15.5, it rises sharply thereafter to reach a
peak on day 18.5 (Feldman and Bloch, 1978; Warren et al., 1973). After that,
testosterone levels in the rat testis remain at a similar level or even slightly decline
during the rest of fetal life. The present findings on the pattern of immunoexpression
of P450cl7 are in accordance with these reports with only weak immunostaining in
some Leydig cells on day 15.5 but an increase in the numbers of immunopositive cells
one day later and abundant immunostaining thereafter. However, while reports on the
onset of synthesis of P450scc and P450cl7 coincide with the reported start of
testosterone production, that of another steroidogenic enzyme, namely 3B-HSD, was
detected in the testis one day earlier, on day 14.5. Studies by Magre and Jost (1980)
have reported that morphological differentiation of steroidogenic cells in the fetal rat
testis occurs on day 15.5, simultaneously with the reported onset of testosterone
production. However, studies by Bloch (1979) have recorded 3B-HSD activity in the
rat testis on day 14.5 of gestation in agreement with the current study. The reported
absence of other steroidogenic enzymes (Feldman and Bloch, 1978; Warren et al.,
1973) in the fetal testis on that day raises the question of what the role of 3B-HSD
might be at this age. There are no reports of production of progesterone by the fetal
testis and this would be unlikely as neither P450scc protein (Rouiller et al., 1990) nor
enzyme activity (Warren et al., 1973) are detectable before day 15.5. P450scc is
involved in the first step of steroidogenesis, converting cholesterol to pregnenolone
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(Miller, 1988) and as it is not present at day 14.5 p.c., no pregnenolone would be
available to act as a substrate for 3B-HSD.
The regulation of the expression of steroidogenic enzymes and the production of
testosterone in fetal testis have not been fully elucidated. Oestrogens (Bartke et al.,
1977; Moger, 1980) and androgens (Darney et al., 1996; Poinds et al., 1984) both
inhibit production of steroid hormones, mainly by reducing the activity of the 17a-
hydroxylase enzyme in fetal (Majdic et al., 1996) and adult testis (Darney et al., 1996;
Kalla et al., 1980). LH, secreted by pituitary gonadotrophs, is believed to be the
primary regulator of testosterone production in the adult testis but its function during
fetal life is not clear (Saez, 1994) although several studies have shown that LH is able
to stimulate testosterone production in the fetal testis (Feldman and Bloch, 1978;
Habert, 1993). LH is probably involved in the rise of testosterone production that
occurs up to day 18.5 p.c. in the rat (Saez, 1994), but it is unlikely that LH is essential
to trigger production of testosterone on days 15.5 to 16.5 since LH is only detectable
in the fetal pituitary (Watanabe and Daikoku, 1979) and circulation (Aubert et al.,
1985) on day 17.5. Some reports suggest that, at least in primates, placental hCG
might play a role in initiating testosterone synthesis (Saez, 1994). Whilst hCG is able
to increase production of testosterone both in fetal and adult rat testis in vitro and it is
possible that hCG is indeed the triggering factor in the primate testis, studies have so
far failed to identify a factor similar to hCG in rat placenta (Habert and Picon, 1990;
Wurzel et al., 1983). Reports that 3B-HSD protein and enzyme activity (Bloch, 1979)
are present one day before the onset of P450scc and P450cl7 expression suggest that
different regulatory mechanisms may exist for determining expression of 3B-HSD and
the cytochrome P450s. Whether regulation occurs at a transcriptional or
posttranscriptional level (or both) currently remains unanswered.
Steroidogenic factor-1 (SF-1) has been recently discovered as a common regulator of
expression of genes encoding several steroidogenic enzymes, including P450scc and
P450cl7 (Ikeda et al., 1993; Lala et al., 1992; Morohashi et al., 1992; Zhang and
Mellon, 1996). Further studies have demonstrated the importance of SF-1 in
development of the gonads and adrenal glands since transgenic mice lacking a
functional SF- 1 gene do not develop either gonads or adrenal glands and die shortly
after birth, probably due to lack of gluco- and mineralocorticoids (Luo et al., 1994).
SF-1 is expressed very early in the mesonephric area, before the gonads differentiate
(Hatano et al., 1994; Ikeda et al., 1994) and hence well before steroidogenesis starts,
consistent with a role of that factor in early gonadal differentiation. The present study
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identified expression of SF-1 in the gonads on day 14.0, however, immunoexpression
was increased half a day later on day 14.5, coinciding with the appearance of 36-HSD
protein in the fetal testis. Whether these two findings are connected is unclear, since
so far there have been no reports of SF-1 regulating 36-HSD expression. In contrast,
the genes encoding for P450scc and P450cl7 have been reported to be regulated by
SF-1. Double immunostaining using anti SF-1 and anti-36-HSD antibodies showed
clear colocalisation of SF-1 and 36-HSD in those interstitial cells with strong SF-1
expression. However, within the interstitium of the fetal testis, other population(s) of
SF-1 positive cells were detected, which had lower SF-1 expression and did not
express 36-HSD and therefore are not steroidogenically active fetal Leydig cells. At
present, it is only possible to speculate on the identity of this non-Leydig cell
population of cells and what the function of SF- 1 in this cell population might be.
One obvious possibility is that these cells are Leydig cell precursors and that SF- 1
plays a role in differentiation of these cells into functional Leydig cells.
DAX-1 is a recently discovered orphan nuclear receptor (Guo et al., 1995; Zanaria et
al., 1994). The gene lies in the region of the X chromosome (Zanaria et al., 1994),
duplications of which are associated with XY female sex reversal (Bardoni et al.,
1994). Similarities between the phenotype of SF-1 knock out mice and patients with
AHC has led to suggestions that there is an interaction between SF-1 and DAX-1. This
hypothesis was further supported by the finding of a putative SF-1 binding element in
the DAX-1 upstream region (Burris et al., 1995) but it is not yet known if SF-1
directly regulates DAX-1 expression. The precise role(s) ofDAX-1 in the gonad have
yet to be elucidated although it has recently been reported that DAX-1 mRNA is
expressed in the gonadal ridge and the interstitium of the testis of adult mouse (Swain
et al., 1996). The presence of a putative SF-1 binding site on DAX-1 led us to
anticipate that SF-1 might co-localise with DAX-1 in the fetal testis and/or be
expressed in a less mature cell type. In contrast to SF-1 which was detected in the
nuclei of both interstitial and Sertoli cells, specific DAX-1 immunostaining was
present only in cells within the interstitium. DAX-1 protein was first detectable on day
15.5 of gestation in the rat testis and was localised to the cytoplasm of interstitial cells
in fixed tissue sections. This finding is somewhat surprising as the presence of
putative DNA and ligand binding domains in DAX-1 suggest this protein, like SF-1,
may function as a transcription factor. In the tissue sections SF-1 was localised
exclusively to cellular nuclei consistent with previous data using frozen tissue
sections. We have as yet no explanation for the cytoplasmic localisation ofDAX-1 but
have seen a similar pattern of staining using antisera directed against peptides of the
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oestrogen receptor (unpublished observations) but not the androgen receptor (Majdic
et ah, 1995) on fixed sections of fetal testis processed in an identical way to those in
the current thesis. Oestrogen receptors have been reported to undergo
nucleocytoplasmic shuttling which is energy dependent (Dauvois et ah, 1993).
Previous investigations using frozen tissue sections have reported that monoclonal
antibodies localise to nuclei of target cells (King and Greene, 1984) and we speculate
that in the case of ER, and possibly DAX-1, the fixation of the tissue may have
influenced the subcellular localisation of the protein in keeping with results reported
for the glucocorticoid receptor (Brink et al., 1992).
A recent study (Swain et al., 1996) detected DAX-1 mRNA in mice using RNase
protection and whole mount in situ hybridization. DAX-1 mRNA was present in the
interstitial cell compartment in adult mice and was presumed to be in the adult Leydig
cells. However in the fetal mouse DAX-1 mRNA was present on day 11.5 p.c.
(approximately equivalent to day 13 in the rat) and declined after day 12.5, a finding
apparently at odds with the present study although no protein data are included in the
study (Swain et al., 1996) and a direct comparison between species is therefore not
possible. In a preliminary experiment we have been able to detect significant amounts
of DAX-1 mRNA in fetal rat testis on day 17.5 by Northern blotting.
SF-1 immunostaining was detected in several cell populations within the testis.
Sertoli, Leydig and other interstitial cells all expressed SF-1 protein while only some
interstitial cells show positive immunostaining with anti-DAX-1 antibodies and double
immunostaining demonstrated that DAX-1 and SF-1 are not exclusively localised in
the same cell types. The importance of this finding is not known, however it would
question the role of SF-1 in regulation of DAX-1 as was suggested earlier (Burris et
al., 1995). While similarities in the phenotypes as a result of mutations in the DAX-1
and SF-1 genes firmly suggest the interaction of those two factors, lack of exclusive
colocalisation may suggest an indirect rather than a direct connection between these
two proteins. However, in the present study, investigations were confined to
immunocytochemistry and it is possible that this method is not sensitive enough to
detect a very low level of protein expression and that expression of DAX-1 protein
occurs in additional cells within the testis at levels undetectable using
immunocytochemistry with the present antiserum. Direct regulation of DAX-1
expression by SF-1 cannot be ruled out at the present time and further studies will be
needed to clarify the function and possible interaction of these proteins.
7. Immunoexpression of inhibin and activin
subunits in the fetal and neonatal rat testis
7.1 Introduction
Inhibins and activins are structurally related dimeric gonadal glycoproteins that were
initially characterised by their ability to alter FSH secretion from the pituitary (Vale et
al., 1986, 1988; Ying, 1988). Inhibin selectively suppresses FSH secretion (Vale et
al., 1988) while activin stimulates pituitary FSH release (Schwall et al., 1989).
Inhibin and activin are members of the TGF-B superfamily (Wallach, 1996; Ying,
1988), a large family of growth factors that regulate cell proliferation, differentiation
and function. The group also includes AMH and the decapentaplegia gene product in
Drosophila (Massague, 1990). Inhibins are composed of an a-subunit and one of two
similar, but distinct, B subunits (BA and BB). Activins are dimers of two B subunits
and the three possible combinations of activin dimers have been designated activin A
(BA/BA), activin B (BA/BB) and activin AB (BA/BB; Vale et al., 1988). The genes for
all three subunits have a similar structure containing one intron; translation of their
mRNAs produces large precursor molecules which are subsequently cleaved to
produce the functional subunits (Ying, 1988). The precursor molecule for the a-
subunit in rat is 366 aminoacids long and the mature subunit which is 133 aminoacids
long is located at the carboxyterminal. BA and BB subunits which are 116 and 115
aminoacids long are produced by proteolytic cleavage of the larger precursor
molecules, 424 and 407 aminoacids long, respectively (Woodruf et al., 1987; Ying,
1988).
It is widely accepted that inhibin is produced in the adult testis, mainly by Sertoli cells
(Ying, 1988). Some reports have also suggested that the production of inhibin and
activin also occurs in Leydig and peritubular cells (Maddocks and Sharpe, 1989;
Roberts et al., 1989; Shaha et al., 1989). Similar patterns of expression have been
described in the fetal and neonatal testis, although, immunostaining of the Leydig cells
did appear to be more prominent than in adult testis (Roberts et al., 1989; Shaha et al.,
1989). A similar pattern of expression has also been reported in the primate (rhesus
monkey and human) fetal and neonatal testis (Rabinovici et al., 1991).
The main biological function of both inhibin and activin is believed to be the control of
FSH secretion from the anterior pituitary (Wallach, 1996; Ying, 1988). Inhibin is a
potent suppressor of FSH release and reduces the cellular content of FSH in cultured
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rat pituitary cells but does not affect the other pituitary hormones including LH and
TSH (Ying, 1988). The time course of action of inhibin differs from that of GnRH.
Suppression of FSH release by inhibin occurs within 4-18 hours whereas the
response to GnRH requires only seconds to a few hours (Ying, 1988). In contrast,
activins have a strong stimulatory effect on release of FSH from the anterior pituitary.
Activin is a more potent stimulator of FSH release than GnRH, however, in the
presence of inhibin, the stimulatory effect of activin is completely abolished (Ying,
1988). Like inhibin, activin does not exhibit any effect on secretion of LH or other
pituitary hormones (Ying, 1988). Apart from their role in modulating FSH secretion,
both inhibin and activin are believed to have important autocrine and paracrine
functions within the gonads (Chen, 1993; Lin et al., 1989) and other tissues (Spencer
et al., 1990). Studies by Boitani and co-workers (1995) and Kaipia and co-workers
(1994) have demonstrated that activin stimulates Sertoli cell proliferation whilst Lin et
al. (1989) have reported that activin can inhibit hCG-stimulated testosterone
production by cultured Leydig cells. In the same study, Lin et al. failed to detect any
influence of inhibin on Leydig cell function, however some earlier studies have
reported that inhibin has a stimulatory effect on testosterone production in isolated
immature and adult Leydig cells (Hsueh et ah, 1987). Transgenic mice lacking a
functional inhibin a subunit develop normally and are born without any obvious
abnormalities. However, postnatally these animals develop testicular tumours with
almost 100% penetrance suggesting that inhibin is not required for normal fetal
development but may act as a tumour supressor in the testis (Matzuk et ah, 1992).
In 1987, another group of proteins with the ability to suppress FSH secretion was
identified (Robertson et al., 1987; Ueno et al., 1987). This were named follistatins.
Several bioactive peptides were detected in bovine and porcine follicular fluid, and the
cloning of the cDNA showed that all derived from a single copy gene (Michel et al.,
1993). The apparent ability of follistatin to suppress FSH secretion was only 10-30%
of that of inhibin, resulting in the suggestion that follistatins were weak, and perhaps
redundant, inhibin agonists with uncertain function (s) (Michel et al., 1993).
However, studies by Kogawa and Nakamura and their colleagues (Kogawa et al.,
1991; Nakamura et al., 1990) have shown that follistatins bind to activins and to a
lesser extent to inhibins (Shimonaka et al., 1991). The role of follistatin is not as yet
completely elucidated, but the available data suggest that it may function primarily as a
regulator of activin bioavailibility rather than as a simple carrier molecule (Michel et
al., 1993; Moore et al., 1994). Follistatin is reported to be expressed both in the
pituitary gland (Kogawa et al., 1991) and in the adult testis (Shimasaki et al., 1989)
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but has not been identified in the fetal testis (Roberts and Barth, 1994).
7.2 Experimental procedures
7.2.1 Collection and processing of tissues
Tissues were collected from time mated animals, fixed and processed into paraffin
wax as described in chapter 3 (section 3.4). Tissue sections were cut and processed
as described in section 3.4.2.
7.2.2 Immunocytochemical staining
Immunocytochemical staining was performed as described in chapter 3 (section 3.5).
Specific monoclonal antibodies raised in mice against all three inhibin/activin human
subunits and against human follistatin were gift from Dr. Nigel Groom (Brooks
University, Oxford, UK). Antibodies directed against the a-subunit were used at a
dilution of 1:500, those against BB subunit at a dilution of 1:5000, those against BA in
dilutions 1:500 - 1:5000 and those against follistatin at a dilution of 1:50. Sections
were subjected to antigen retrieval (section 3.5.1), blocked with normal rabbit serum
and then incubated overnight at 4°C in a humidified chamber. The following day,
sections were washed twice in TBS, incubated with biotinylated rabbit anti-mouse
immunoglobulins (Dako) for 30 min at room temperature, washed twice with TBS
and incubated with ABC-horseradish peroxidase complex (Dako) for 30 min at room
temperature. The colour reaction product was developed by incubation in a mixture of
0.05% (w/v) 3,3'-diaminobenzidine tetra-hydrochloride(DAB, Sigma) in 0.05M Tris-
HC1, pH 7.4 and 0.01% hydrogen peroxide. Development of the colour reaction was
monitored under the microscope and after 5-15 min, slides were placed in distilled
water to stop the reaction. After a wash in distilled water, sections were
counterstained with haematoxylin, dehydrated in alcohols, cleared in xylene and
coverslipped using Pertex mounting medium (Cellpath).
To detect a-subunit and the steroidogenic enzyme 3B-hydroxysteroid dehydrogenase
(3B-HSD) simultaneously in one section, double fluorescent immunostaining was
performed. Tissue sections were blocked with normal goat serum and incubated with
the mixture of both primary antibodies (anti 3B-HSD were used at a dilution 1:1000
and anti a-inhibin at a dilution 1:500) overnight at 4°C. Incubation with primary
antibodies was followed by two washes in TBS and incubation with mixture of
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fluorescent secondary antibodies (goat anti-mouse FITC conjugated and goat anti-
rabbit TRITC conjugated, Sigma) at a dilution of 1:20 for 1 h at room temperature.
Sections were washed again three times in TBS and coverslipped using glycerol
gelatine. Sections were examined under UV light using an Olympus Provis
microscope.
Specificity of antibodies was checked by either replacing primary antibodies with the
normal mouse serum or by preabsorbing the antibodies with the peptide against which




Positive cytoplasmic immunostaining for a subunit was first detectable in fetal testis
on day 14.5 (Fig. 7.1a), the earliest age at which the testis could be morphologically
distinguished from the ovary. At this age the colour reaction product was equally
strong in both Sertoli and interstitial cells but one day later, on day 15.5 (Fig. 7.1b),
the immunostaining appeared much stronger in the interstitial cells. Thereafter,
immunostaining remained very strong in the fetal Leydig cells but was barely
detectable in the fetal Sertoli cells from day 17.5 onwards (Fig. 7.1c, d). Double
immunofluorescent immunostaining with antibodies directed against the a-subunit and
36-HSD clearly showed colocalisation of 36-HSD and a-subunit in the fetal testis
from the 17.5 p.c. days old fetuses (Fig. 7.2).
Fig. 7.1: Inhibin a-subunit was first detected on day 14.5 p.c. (a).
Immunostaining was present in both interstitial (arrow) and Sertoli (arrowhead) cells.
As pregnancy proceeded (b, day 15.5; c, day 17.5; d, day 20.5), the immunostaining
remained strong in the fetal Leydig cells but became almost undetectable in Sertoli
cells. Magnification x300.
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Fig. 7.2: Double fluorescent immunostaining with antibodies directed against 3B-
HSD and inhibin a-subunit demonstrate clear and exclusive colocalisation of 3B-HSD
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Inhibin a subunit continued to be expressed in clusters of fetal Leydig cells for several
days after birth (Fig. 7.3a). As development of the testis continued postnatally with
replacement of fetal Leydig cells with those of the adult type, the amount of a subunit
declined (Fig. 7.3b). In contrast, the amount of a subunit in Sertoli cells increased
immediately after birth with strong immunostaining detectable by day 3 of postnatal
life (Fig. 7.3a). Immunostaining in Sertoli cells remained strong throughout postnatal
development and became stage specific around day 27 (Fig. 7.3c). In the adult testis,
the immunostaining was stronger in Sertoli cells, however, weak immunostaining was
also detectable in interstitial cells (Fig. 7.3c, d).
Fig. 7.3: Postnatally, strong expression of inhibin a-subunit appeared in Sertoli
cells immediately after birth (a, day 3 postnatal). The staining remained strong
throughout postnatal development (b, day 16; c day 27; d, day 90) and became stage
specific at around day 27 (c). Immunostaining remained strong in the fetal type
Leydig cells (a, arrow) but was weaker in adult-type Leydig cells (c, arrow).
Magnification x200.
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7.3.2 BB-subunit
The BB subunit was first detectable by immunocytochemistry with specific antibodies
in fetal Leydig cells on day 16.5 (Fig. 7.4a). Immunostaining in the Leydig cells
remained strong throughout fetal life (Fig. 7.4b, c) and, like the a-subunit, remained
strong in fetal-type Leydig cells present neonatally but was weaker in their adult
counterparts (Fig. 7.5c). Within the tubules inhibin BB subunit was detected in the
Sertoli cells, however, immunostaining was very weak throughout fetal life.
Postnatally, immunostaining in the cytoplasm of Sertoli cells remained weak until day
27 (Fig. 7.5a, b, c). As with inhibin a-subunit, immunostaining for inhibin BB
subunit in the adult testis was strongest in Sertoli cell cytoplasm (Fig. 7.5).
Fig. 7.4: Inhibin BB-subunit was first detectable by immunocytochemistry in the
fetal testis on day 16.5 (a), two days after a-subunit was detected. Like the a-
subunit, the immunostaining was most prominent in fetal Leydig cells. The staining
pattern remained similar throughout the fetal life (b, day 17.5; c, day 20.5).
Magnification x200.
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Fig. 7.5: Like inhibin a-subunit, immunostaining for BB subunit was detected in
Sertoli cells immediately after birth (a, day 3) but was much weaker than
immunostaining for a-subunit. The amount of 6B subunit had increased in Sertoli
cells by day 16 (b) and thereafter remained high throughout postnatal development (c,
day 27) and in the adult testis (d, day 90). Immunostaining in the Leydig cells
remained strong postnatally in the fetal type Leydig cells (a, arrow) but was much
reduced in adult type Leydig cells (c, arrow). Magnification x200
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7.3.3 BA-subunit
Incubation with antisera specific for inhibin BA-subunit did not result in any specific
immunolocalisation in the rat testis during fetal and neonatal life. Similarly, no
specific immunoexpression has been detected in adult rat testis.
7.3.4 Follistatin
No follistatin immunoexpression was detected in the fetal testis at any time prior to
birth. However, immediately after birth, immunostaining was detected in the Leydig
cells (Fig. 7.6a). Both the fetal and adult type Leydig cells remained immunopositive
throughout postnatal development (Fig. 7.6b) and in the adult testis.
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Figure 7.6: Follistatin immunoexpression was detectable immediately after birth in
the fetal type Leydig cells (a, day 7, arrows) and immunostaining in the Leydig cells
remained strong throughout life (b, day 27). Magnification x200.
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7.4 Discussion
Inhibins and activins are dimeric glycoproteins, produced mainly in the gonads (Vale
et al., 1988) which were initially identified as hormonal regulators of FSH secretion
by the pituitary (Vale et al., 1988); Schwall, 1989). Several studies have
subsequently demonstrated that in addition to their action on FSH secretion
inhibins/activins play an important regulatory role at a paracrine level in several
tissues/organs during fetal, neonatal and adult life (Chen, 1993; Wallach, 1996). The
expression of inhibin/activin is not confined to the gonads; during embryonic
development, the 6 subunits are expressed in wide range of tissues including
embryonic heart, salivary glands, neural tissues and the adrenal glands, as well as in
the gonads (Roberts et al., 1991; Roberts and Barth, 1994). The inhibins/activins
were initially isolated as Sertoli and granulosa cell products, modulating FSH
secretion (Schwall et al., 1989; Vale et al., 1988). However, several studies have also
reported the expression of inhibin and activin subunits in testicular interstitial cells pre-
and postnatally in rat (Roberts et al., 1989; Shaha et al., 1989) and primate
(Rabinovici et al., 1991). In addition, studies by de Winter et al. (1994) have shown
expression of activin-A by peritubular cells in immature testis. Studies by Roberts and
co-workers (1989) have detected a-subunit protein using immunocytochemistry in
both Sertoli and interstitial cells in 12 day-old neonatal rats with the stronger
immunostaining being in the Sertoli cells. Immunostaining with antibodies directed
against BB subunit produced a similar intensity of immunostaining in both interstitial
and Sertoli cells but no staining was detected in clusters of Leydig cells. In addition,
Shaha et al. (1989) did not detect any significant expression of a or BB subunit
proteins in interstitial cells of fetal and neonatal testis. In contrast, Roberts and co¬
workers (Roberts et al., 1991; Roberts and Barth, 1994) observed expression of a-
subunit mRNA in interstitial and intratubular cells but detected BB subunit mRNA
expression only in the intratubular compartment and BA mRNA only in the interstitial
compartment later in gestation. However, Rabinovici et al. (1991) reported strong
immunoexpression of a and BB subunit proteins in the interstitial cells of the fetal
testis at midgestation in the human and rhesus monkey with a-subunit also detected in
Sertoli cells while BB subunit appeared to be only in Leydig cells. The results
described in this chapter demonstrate strong immunostaining by specific antisera of
both a- and BB subunits in cytoplasm of some of the interstitial cells within the fetal
rat testis. Double fluorescent immunostaining using antibodies directed against 3B-
HSD clearly showed complete colocalisation of a subunit and 3B-HSD confirming that
steroidogenically active Leydig cells are the cells which also express inhibin a-
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subunits. Preliminary observations suggest that the inhibin BB subunit is also co-
localised in the same fetal Leydig cell population. The first detectable
immunoexpression of a-subunit was evident at a very early stage of testicular
development, immediately following the formation of testicular cords.
Immunoexpression of BB subunit was detectable two days later and BA subunit was
undetectable at the time points studied. These results question the role of a-subunit
expression at this early stage since the lack of expression of either B subunits means
no biologically active inhibin could be formed. It is possible that the early onset of
synthesis of the a-subunit is part of a protective mechanism ensuring the formation of
inhibin rather than activin once B subunit expression commences. Recently it has been
suggested that the N-terminal peptide of the a-subunit could have a regulatory
paracrine function in the adult ovary (Russel and Findlay, 1995) and a similar role
during fetal testicular development cannot be excluded. Alternatively, it is possible
that small amounts of BB subunit are produced at the same time as a-subunit but at
levels that are undetectable by immunocytochemistry.
The detection of BB immunostaining in fetal testis on day 16.5 p.c. would be
consistent with the formation of inhibin B or activin B within the fetal gonad.
However, at this time the expression of both subunits was confined to the fetal Leydig
cells and occurred at a time when FSH expression is not detectable (Aubert et al.,
1985; Watanabe and Daikoku, 1979) so that the role(s) of inhibin/activin in the fetus
appear initially not to be confined to regulation of FSH secretion. Several studies have
demonstrated potential effects of inhibins/activins on Sertoli cell proliferation (Boitani
et al., 1995; Kaipia et al., 1994). A number of different studies agree that neither
inhibin nor activin influence basal testosterone production by Leydig cells but could
regulate hCG stimulated steroidogenesis although the action of inhibin and activin
seems to be dependent on the time of exposure as well as the presence of LH or hCG
(Hsueh et al., 1987; Lin et al., 1989). All these studies suggest possible autocrine
and/or paracrine roles for inhibins/activins within the fetal testis. However, inhibin at
least, does not appear to be essential for testicular development during fetal life as
transgenic mice lacking a functional a subunit do not show any abnormalities at the
time of birth (Matzuk et al., 1992).
The pattern of expression of both a- and BB subunits changed dramatically after birth.
While the level of immunostaining in the fetal type Leydig cells remained unchanged
for several days, the expression of a-subunit in Sertoli cells had increased dramatically
by day 3 of postnatal life. The cause of this increase is unknown but it could well be
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connected with the reported increase in the levels of circulating FSH which occurs just
prior to birth and continues postnatally in the rat (Aubert et al., 1985). FSH is known
to stimulate inhibin/activin production (Ying, 1988); in the fetus, FSH can be detected
around day 19.5 p.c. (Aubert et al., 1985; Watanabe and Daikoku, 1979) but its
concentration is initially very low and only starts to rise just before birth. In light of
the well established interrelationship between levels of inhibins/activins and FSH in
the adult it is likely that the increased levels of FSH results in stimulation of a-subunit
gene expression in Sertoli cells immediately after birth.
Follistatins were originally identified as proteins with the ability to suppress FSH
secretion from the pituitary similarly to inhibins but with much lower potency
(Robertson et al., 1987; Ueno et al., 1987). However, additional studies have shown
their ability to bind activin (Kogawa et al., 1991; Nakamura et al., 1990) and it is
thought that their primary function is the binding of bioactive activins to prevent their
biological effects (Michel et al., 1993; Moore et al., 1994). Follistatins are expressed
in the adult testis (Shimasaki et al., 1989) and pituitary (Kogawa et al., 1991) but
studies by Roberts and Barth (1994) have failed to detect mRNA expression in the
fetal testis. The immunocytochemical study presented in this chapter confirmed their
finding with no immunodetection of follistatin in the fetal testis at any age. This
would suggest that activin is required in the fetal testis for normal development or
alternatively that no bioactive activin is produced in the fetal testis and therefore there
is no need for follistatins to prevent its action. Strong immunoexpression of inhibin a
subunit two days before the appearance of 6B subunit and very strong expression
throughout gestation would support the second hypothesis, suggesting that a subunit
is produced in excess to the BB subunit and thus prevents the formation of activin.
Several studies in vitro have shown the effects of activin in fetal testicular cells
(Boitani et al., 1995; Kaipia et al., 1994), however, it is not known whether these
effects are important for normal testicular development in vivo since bioactive activin
may not be present in the fetal testis. Postnatally, the expression of follistatin was
detectable in the Leydig cells immediately after birth. This is rather surprising since at
that age the Leydig cells are still of the fetal type, found in the fetal testis. What
triggers the expression of follistatin in these cells is not known. It is unlikely to be
LH, which regulates the function of Leydig cells during late fetal life (Saez, 1994)
since LH is already present in the fetus on day 17.5 of gestation (Aubert et al., 1985).
FSH could have a role in stimulating the expression of a subunit in the Sertoli cells
immediately after birth but as no FSH receptors are present on the Leydig cells, the
same is unlikely to be true for follistatin expression. Therefore, the question of the
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regulation of onset of follistatin immunoexpression remains unanswered and will
require further studies. Studies by Boitani and co-workers (1995) have suggested that
Sertoli cell proliferation is stimulated by activin in the presence of FSH. Postnatally,
Sertoli cell proliferation in the rat testis starts to decline and ceases by day 18
postnatally. Therefore, the expression of follistatin in the testis postnatally could be
involved in the regulation of the effects of activin on Sertoli cells by binding activin
and therefore preventing its mitogenic action on Sertoli cells.
Fetal type Leydig cells differ from their adult counterparts in several respects (Saez,
1994). It is believed that postnatally, the fetal Leydig cells do not transform into their
adult type counterparts but degenerate and are replaced by a new population of adult
type Leydig cells which differentiate from interstitial cells and repopulate the
developing testis (Saez, 1994). The data reported in this chapter suggest yet another
difference between fetal type and adult type Leydig cells, the expression of inhibin
subunits. Both the a and BB subunits show a similar pattern of expression in the
Leydig cells during neonatal life with immunostaining for both subunits remaining
strong immediately after birth in clusters of Leydig cells. By around day 10-15 of life,
very few Leydig cells are present within the testis and thereafter when the new Leydig
cells repopulate the testis they are scattered between the tubules and not in clusters as
seen during fetal life. The immunoexpression of a and B subunits in this newly
differentiated population of Leydig cells is much weaker than that seen in the clustered
fetal-type cells during early life. The significance of this finding is unknown, but as
discussed earlier, may be consistent with a role for inhibin/activin in the fetal Leydig
cells as a paracrine or autocrine factor acting locally within the testis.
8. Effect of oestrogenic chemicals on the function
of fetal Leydig cells
8.1 Introduction
Testosterone synthesis is a multistep process that requires the action of several
enzymes to transform cholesterol into testosterone (Miller, 1988). The first step in
the process is the transport of cholesterol into the inner mitochondrial membrane; a
protein called StAR (Steroidogenic acute regulatory protein) has been recently
identified as a factor involved in this step. StAR is thought to function as a carrier of
cholesterol to facilitate its transport from the outer to the inner mitochondrial
membrane and this appears to be the limiting step in acute regulation of
steroidogenesis (Lin et al., 1995). The first enzymatic step in steroidogenesis is the
conversion of cholesterol to pregnenolone, a reaction catalysed by the enzyme
cytochrome P450 side chain cleavage (P450scc). Pregnenolone then diffuses across
the mitochondrial membranes and in the smooth endoplasmic reticulum is converted
to progesterone by the action of 3B-hydroxysteroid dehydrogenase (3B-HSD). The
next step in the enzymatic cascade is catalysed by another cytochrome P450 enzyme,
17a-hydroxylase/Ci7.20 lyase (P450cl7), a single protein that catalyses two distinct
reactions, the hydroxylation of progesterone at C17 followed by the cleavage of the
two-carbon side-chain to yield the C19 steroid, androstenedione, the immediate
precursor of testosterone. The final enzymatic reaction is the reduction of
androstenedione by 17B-hydroxysteroid dehydrogenase (Miller, 1988). The
expression of the enzymes involved in testosterone synthesis appears to be regulated
by different mechanisms; testosterone production seems to be regulated principally
by regulation of the expression and activity of P450scc and P450cl7 while the
enzymes 3B-HSD and 17B-hydroxysteroid dehydrogenase appear to be constitutively
expressed (Keeney et al., 1988; Payne and Youngblood, 1995). Expression of
P450cl7 in adult Leydig cells is a tightly regulated process, dependent upon the
stimulation of the cells by LH via its specific receptor and mediated by cAMP
(Payne and Youngblood, 1995). In the absence of LH the expression of P450cl7
ceases, in contrast to that of P450scc which is constitutively expressed at a low level
even in the absence of LH (Payne and Youngblood, 1995). Testosterone (Darney et
al., 1996; Hales et al., 1987; Pointis et al., 1984) and oestrogens (Bartke et al., 1977;
Moger, 1980) both exert inhibitory effects on steroidogenesis in adult rat Leydig
cells but oestrogens appear to have no such effect on mouse testis (Hales et al.,
1987). Several studies have shown that in adult animals the inhibitory effects of
testosterone (Darney et al., 1996; Hales et al., 1987) and oestrogens (Kalla et al.,
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1980; Nozu et al., 1981a) on testosterone biosynthesis are largely explained by
reduced expression of cytochrome P450cl7 enzyme.
In the fetal testis, expression of P450cl7 appears to be locally regulated. While LH
modulates testosterone production in the fetal testis (Feldman and Bloch, 1978;
Habert, 1993) at the later developmental stages, it is not expressed when the onset of
testosterone production and P450cl7 expression occurs (Aubert et al., 1985;
Watanabe and Daikoku, 1979). The factor(s) that trigger testosterone production
and/or expression of P450cl7 are not known. Studies on isolated gonads have
shown that testosterone production starts autonomously; when the indifferent genital
ridges were dissected and cultured in vitro, testosterone production occurred in the
absence of any external factors (Agelopoulou et al., 1984; Gangnerau and Picon,
1987). One candidate as a local regulator of cytochrome P450s enzymes is
steroidogenic factor-1 (SF-1) (Lala et al., 1992; Morohashi et al., 1992). Sequences
which bind SF-1 have been found on several cytochrome P450 genes: P450scc,
P450cl7, P450c21 and P450aromatase (Clemens et al., 1994; Lynch et al., 1993;
Morohashi et al., 1992; Zhang and Mellon, 1996). The SF-1 gene is expressed in
fetal and adult steroidogenic tissues (Hatano et al., 1994; Ikeda et al., 1994;
Morohashi et al., 1994) and studies in vitro have demonstrated its importance in
regulation of expression of the cytochrome P450s (Clemens et al., 1994; Lynch et
al., 1993; Zhang and Mellon, 1996). SF-1 mRNA and protein are present in the fetal
gonads, adrenal glands, hypothalamus and pituitary gland (Hatano et al., 1994; Ikeda
et al., 1994; Ingraham et al., 1994). SF-1 is expressed in the genital ridges of both
sexes but following gonadal differentiation expression in the ovary almost
disappears. Expression of SF-1 in the testis remains strong throughout the fetal life
(Hatano et al., 1994; Ikeda et al., 1994) in Leydig cells, other interstitial cells and
Sertoli cells (Hatano et al., 1994). The exact functions of SF-1 as well as the
regulation of its expression and action are not known, however its ability to
influence the expression of steroidogenic enzymes in vitro makes it a likely
candidate for a tissue specific regulator of steroidogenesis and as a possible mediator
of the action of extracellular factors. Consistent with its pattern of expression and an
important role in development mice lacking a functional SF-1 gene fail to develop
gonads or adrenals and have a disorganised hypothalamus and nonfunctional
pituitary gonadotrophs (Ingraham et al., 1994; Luo et al., 1994)
A possible link between the reported increase of reproductive abnormalities in
Western men and oestrogens has been outlined in chapter 2. Some of the
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abnormalities which have been recorded, including hypospadias and cryptorchidism,
might be the result of reduced or inappropriate exposure to testosterone during
periods of fetal life critical for normal masculinisation of the male fetus. It is
therefore possible that an increased exposure to oestrogens or chemicals that mimic
oestrogen action during fetal life could interfere with regulation of steroidogenesis in
the fetal Leydig cells and consequently result in impaired production of testosterone.
Octylphenol polyethoxylate is one example of a group of chemicals known as
alkylphenol polyethoxylates that were introduced in the 1940s and which are the
second largest group of nonionic surfactants in commercial production. These
chemicals are widely used in detergents, paints, herbicides and pesticides. Large
amounts of octylphenol polyethoxylate are produced worldwide and a significant
amount of this substance ends up in the aquatic environment, where APEOs usually
form relatively stable metabolites like nonylphenol and octylphenol (OP) which tend
to accumulate in sewage sludge and river sediment (Naylor et al., 1992). Several
studies have shown that both nonylphenol and OP have a weak oestrogenic activity.
They can stimulate growth of breast cancer cells in vitro, bind to the oestrogen
receptor, and stimulate transcriptional activity of reporter genes containing an
oestrogen response element (White et al., 1994). Furthermore, when tested in vivo
on fish, OP has been shown to inhibit testicular growth in male trout and to stimulate
the production of vitellogenin, an oestrogen inducible protein normally produced
only by female fish and incorporated in egg yolk (Jobling et al., 1996). Sharpe et al.
(1995) have used rats to study the effect on male offspring of OP-treated mothers.
Female rats were treated with OP via drinking water for 8-9 weeks in the period
before mating, throughout gestation and postnatally until weaning. In these
experiments, treatment with low doses of either DES or OP resulted in a small but
significant effect on testicular size and daily sperm production in adult offspring,
however, none of the treatments had any adverse effect on testicular morphology.
The aim of the studies described in this chapter was therefore to assess the effects of
oestrogen exposure at the level of gene expression in the developing fetal testis as a
first step towards understanding the mechanism(s) underlying the observed effects of
oestrogenic chemicals.
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8.2 Experimental procedures
8.2.1 Animals, treatments and tissue recovery
Female rats were time mated as described in chapter 3. Pregnant females were
injected subcutaneously on day 11.5 and 15.5 p.c. with diethylstilbestrol (DES; 100
or 500jlg/kg) or 4-octylphenol (OP; 100 or 600 mg/kg) in corn oil (lml/kg) or with
the vehicle alone (controls). Pregnant females were killed on day 17.5 p.c. by
inhalation of carbon dioxide and subsequent cervical dislocation. Fetuses were
examined under a dissecting microscope and the testes recovered. Testes were either
immersion fixed in Bouin's solution for 5-6 h prior to processing for
immunocytochemistry and in situ hybridisation or used for extraction of RNA
(sections 3.3.2 and 3.4) or determination of enzyme activity (section 8.2.6).
8.2.2 Immunocytochemistry
Immunocytochemical staining was performed as described in chapters 3 and 6.
8.2.3 Reverse transcription plus polymerase chain reaction
Primers based on the sequence of rat 17a-hydroxylase [upstream 5'-CTTGTCGGA
CCAAGGAAAAGGCGT (bases 344-367, sense strand) and downstream 5'-AGCC
AGCTGATCGTGCAGC (bases 669-692, antisense strand)] and primers based on
the bovine SF-1 sequence [upstream 5'-GACCAGATGACACTGCTGC (bases 996-
1014, sense strand) and downstream 5'-AACTCCTGGCGGTCCAGTT (bases 1204-
1222, antisense strand)] were synthesised on an Applied Biosystems PCR mate
(ABI). Reverse transcription was undertaken as described in chapter 3 (section
3.6.2) using the RNA samples from 17.5 days old fetal testes. The conditions used
with both sets of primers were 65°C 5 min, 53°C 5 min, 70°C 15 min and samples
were then placed on ice. The reaction volume was increased to 100pl and PCR
undertaken as described in chapter 3. PCR conditions for both sets of primers were
denaturation at 95°C for 3 min, followed by 30 cycles of amplification 94°C 0.5 min,
55°C 1 min, 70°C 2 min with a final elongation at 70°C for 10 min. The expected
size of the amplified products was 348 bp for 17a-hydroxylase and 226 bp for SF-1.
Amplified product(s) were analysed by electrophoresis on a 2% agarose gel run in
TBE using standard methods.
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The resultant cDNAs were subcloned into the pCRII vector according to the
manufacturer's instructions (InVitrogen) as described in chapter 3 (section 3.6.3).
The identity of cloned cDNAs was confirmed by sequencing using an ABI
automated sequencer and fluorescent primers as described in chapter 3 (section
3.10).
8.2.4 Riboprobe synthesis
To synthesise sense and antisense riboprobes 17a-pCRII or SF-l-pCRII were
linearised with Xho I and Bam HI restriction enzymes and cRNAs transcribed with
SP6 or T7 RNA polymerase (Boehringer) respectively. Single stranded RNA
synthesised from 17a-pCRII was labelled with 35S-UTP (400 Ci/mmol; Amersham)
and purified as described in chapter 3 (section 3.8) using RNA spin columns (IBI)
and the efficiency of the labelling determined using a beta counter (LKB). Antisense
RNA synthesised form SF-l-pCRII was labelled with 32P-UTP (NEN-Dupont) and
purified on a polyacrylamide gel (section 3.11.1)
8.2.5 In situ hybridisation
Paraffin sections (5pm) were mounted on slides coated with TESPA (Sigma), dried
overnight at 50°C, dewaxed in xylene and rehydrated in graded ethanols. In situ
hybridisation was performed essentially as described in chapter 3 (section 3.9).
Sections were hybridised with 106 cpm 35S-cRNAs in 40 pi hybridisation buffer at
50°C overnight. Next day, sections were washed in 4X SSC for 10 min at room
temperature, incubated in RNase A (Sigma) solution (2mg/ml in 0.01M Tris-HCl,
0.05M NaCl, 5mM EDTA pH 8.0) for 30 min at 37°C, washed 2 times for 5 min
each in 2X SSC at room temperature and finally washed in 0.1X SSC/30%
formamide for 30 min at 40°C. Sections were dehydrated in graded ethanols, air
dried, dipped in undiluted photographic emulsion (NTB-2, Kodak) and exposed at
4°C in a light tight box for 2 weeks and processed as described in chapter 3. To
ensure that all the sections were hybridised and washed under the same conditions,
sections from control and treated animals were mounted on the same slide.
Tissue sections were observed under bright field illumination using an Olympus
BH2 microscope and a x40 objective. Images were captured into computer using a
datatranslation quick capture card and a Macintosh Ilex computer and quantified
using NIH image 1.57 computer software. To determine the abundance of P450cl7
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mRNA, the number of silver grains in 10 fields in the interstitial region of the testis
was counted. Background counts were determined by counting 10 random fields in
regions of the same sections that were outside the interstitium, e.g. mesonephros, and
the average of the grain counts in these regions was deducted from the grain
densities determined for the interstitial regions. The silver grains were counted in 2-
3 testes from 3 different litters for each treatment group, and the group mean + SEM
were calculated. Sections from the same testes were also probed with sense strand
probes and no differences between grain densities in the different regions of the
sections were observed.
8.2.6 RNase protection assay
The RNase protection assay was performed as described in chapter 3 (section 3.11);
2.5|ig of total RNA was mixed with 5 x 105 cpm of purified probe and hybridised
overnight at 50°C. Any single stranded RNA was digested, remaining double
stranded RNA precipitated and run on a 6% polyacrylamide gel as described in
chapter 3. The gel was dried and exposed to autoradiographic film or a
phosphorescent screen; results were quantified and analysed using a Phosphorimager
(Molecular Dynamics). The quantified data from four experiments (RNAs from four
different litters for each treatment group) were pooled together and analysed.
8.2.7 Measurement of 17a-hydroxyIase enzyme activity
The activity of the 17a-hydroxylase enzyme was measured as described previously
(O'Shaughnessy and Murphy, 1991). Fetal testes from two animals (4 testes) were
pooled and homogenised in 0.4ml phosphate buffer saline (0.05M PBS, pH 7.6). As
a substrate for the enzyme, 10^ cpm [3H] progesterone (88Ci/mmol, Amersham)
were dissolved in 35 jil DMSO and mixed with 0.87ml phosphate buffer (0.05M, pH
7.2) containing NADPH (lmmol/L, Sigma). Homogenised sample (100(il) was
mixed with tritiated progesterone in phosphate buffer and incubated at 37°C for 20
min. Nonradioactive progesterone (Sigma) was added to the incubation mixture to
give a final substrate concentration of 2(iM, which previous studies have shown to
be saturating (O'Shaughnessy and Murphy, 1991). Reactions were stopped by
adding lOOql of 1M NaOH into each tube on ice. To allow determination of steroid
recovery, 14C-label led testosterone (50Ci/mmol) and androstendione (50Ci/mmol,
Amersham) were added (2000 cpm of each to each reaction) and the steroids
extracted from the solution using 5ml volume of toluene (AnalaR, BDH). The
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organic phase was recovered, dried by heating to 45°C under a stream of nitrogen,
dissolved in few drops of methanol and applied to plastic backed silica gel plates
(Whatman, Maidstone, Kent). Steroids were separated by TLC in chloroform-ether
(7:1, vol/vol). Fluorescent bands (detecting under UV light) corresponding to 17-
hydroxy-progesterone, androstendione and testosterone were cut from the plates,
placed in pony vials (Packard Instrument Company, Caversham) and mixed with
6mls of scintillation fluid (Ecoscint A, National Diagnostic). Samples were left for
30 min at room temperature to allow steroids to elute into the scintillation fluid. The
amount of each radiolabeled steroid was determined on a beta counter using a
program to detect both 3H (counting range 5-304KeV) and 14C (counting range 325-
765KeV) simultaneously. The activity of 17a-hydroxylase was expressed as pmol
of radiolabeled progesterone converted by one testis in 1 min. Controls were run in
each experiment using PBS without added tissue. The 17a-hydroxylase activity was
measured in eight separate pools of four testes from five different litters for the
control group and in six separate pools of four testes from three different litters for
each of the treatment groups.
8.2.8 Statistical analyses
Data from each experiment were subjected to ANOVA to determine whether there
were significant effects of treatment. Where this was indicated, subgroup
comparisons between means for control and individual treatment groups were then
made using the variance from the experiment as a whole as the measure of error.
8.3 Results
8.3.1 Expression ofmRNAs for P450cl7 and SF-1
In situ hybridisation using a specific radiolabeled cRNA directed against rat
P450cl7 resulted in detection of abundant silver grains, as expected, in the
interstitial region of the day 17.5 fetal testis after exposure to photographic emulsion
for 2 weeks (Fig. 8.1). Less silver grains were detected in fetal testis from the
animals treated with DES (Fig 8.1c) when compared with controls (Fig. 8.1a) or with
low dose OP (Fig. 8.1b). Sense controls did not show any signal above background
(Fig. 8.Id). The results were confirmed and extended by image analysis
quantification and were subjected to statistical analysis (Fig. 8.2). Quantification of
results showed a statistically significant (p<0.001) reduction of expression in
Chapter 8 Effect ofoestrogens 134
animals treated with 500|lg/Kg of DES but no significant difference between control
animals and animals treated with low dose of OP.
Fig. 8.1: In situ hybridisation using 35S-labelled cRNA to rat P450cl7 mRNA on
sections of fetal rat testis. Panel a, control, panel b, OP treatment (100 mg/Kg) of
mother, panel c, DES treatment (500 Jig/Kg) of mother. A strong concentration of
grains was present in the control rat testis and brightfield illumination revealed that
they were concentrated mainly within the interstitial region of the testis. The
specific hybridisation signal appeared reduced in the testes of males deriving from
mothers treated with 500 (Ig/Kg DES (c). The sections probed with the sense probe
did not show any signal above background (d). Magnification x200.
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1—1 OP (lOOmg/Kg) + SEM
n=3 litters
rn DES (500|ig/Kg) ± SEM
^ n=3 litters
Fig. 8.2: Quantification of the results obtained by in situ hybridisation for P450cl7
in fetal rat testis. The number of silver grains detected was reduced significantly in
animals from mothers exposed to 500 |ig DES (column 3, p<0.001) compared with
controls (column 1). Maternal treatment with lOOmg/Kg OP resulted in a slight
reduction in grain counts but this did not reach significance (column 2). Testes from
three animals from each litter were analysed and the mean for number of grains in
each field of view calculated.
RNase protection assay using a specific radiolabeled cRNA directed against rat SF-
1 resulted in bands of double stranded RNA after electrophoresis and exposure to
autoradiographic film (Fig. 8.3). The amount of SF-1 mRNA appeared to be
reduced in the testes from both OP and DES treated animals compared with controls.
In contrast, the amount of mRNA in the ovary appeared to be increased following
the exposure to OP but remain unchanged in the ovary from animals treated with
DES (Fig. 8.3, upper panel). As a control, 18S mRNA was simultaneously detected
in RNase protection reactions and was used to adjust the results of quantification
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(Fig. 8.3, lower panel). Quantification of the results showed a significant reduction
(p<0.05) in the amount of SF-1 mRNA in testes from both treated groups when
compared to controls (Fig. 8.4). The increase in the expression of SF-1 mRNA in
the ovary, however, did not reach statistical significance (Fig. 8.5).
a
1 2 3 4 5 6 7
b
Fig. 8.3: Results obtained by RNase protection assay using SF-1 cRNA (a) and 18S
cRNA (b) revealed that whilst a similar amount of total RNA was present in all
samples (b) the amount of SF-1 mRNA varied with treatment (a). SF-1 mRNA was
higher in fetal testes from controls (lane 1) than in those from DES- or OP-treated
mothers (lanes 2 and 3 respectively). In contrast, whilst the amount of SF-1 mRNA
in fetal ovaries from control (lane 5) or DES-treated (lane 6) mothers was lower than
that in the testis (lane 1), ovaries in fetuses in OP-treated mothers showed increased
SF-1 mRNA expression (lane 7) compared with control ovaries (lane 5). A sample
of adult rat adrenal (lane 4) was included as a positive control. Pregnant rats were
treated with either 500(J.g/Kg of DES or lOOmg/Kg of OP.





























□ OP (600mg/Kg) + SEM
n=4 litters
DES (500pg/Kg) + SEM
n=4 litters
Fig. 8.4: SF-1 mRNA in testes from the fetuses of OP and DES-treated mothers
were reduced significantly (p<0.05; *) compared with controls. The amount of
specific signal for SF-1 mRNA was quantified using a phosphorimager (Molecular
Dynamics) and corrected for total RNA by comparison to the signal obtained for 18S
ribosomal RNA.






[""] OP (600mg/Kg) ± SEM
n=4 litters
Y/\ DES (500gg/Kg) ±SEM
n=4 litters
Fig. 8.5: SF-1 mRNA in ovaries from the fetuses of control and DES-treated
mothers were comparable, however that in the ovaries from the fetuses of OP-treated
mothers appeared to be increased, though this just failed to reach statistical
significance.
8.3.2 Detection of P450cl7 and 36-HSD proteins in the fetal testis
The gross histology of the testes recovered on day 17.5 of gestation from treated and
control animals appeared similar. Testes from fetal males recovered from untreated
mothers contained numerous Leydig cells which were stained strongly following
immunohistochemistry with primary antibodies directed against the steroidogenic
enzymes P450cl7 (Fig. 8.6) and 3B-HSD (Fig. 8.7). Specific immunostaining of
P450cl7 within fetal Leydig cells appeared to be the same in fetal testes of untreated
control mothers (Fig. 8.6a) and those from mothers treated with lOOmg/Kg OP (Fig.
8.6b) or 100|ig/Kg DES (Fig. 8.6d). However there was a marked reduction in
immunostaining when testes were recovered from fetuses of mothers given
600mg/Kg OP (Fig. 8.6c) or 500|ig/Kg DES (Fig. 8.6e). In contrast, when fetal
testes were immunostained for 3B-HSD there was no apparent reduction in positive
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immunostaining in testes of fetuses from treated mothers (Fig. 8.7b and c) compared
with controls (Fig. 8.7a).
Fig. 8.6: Immunocytochemical staining of Leydig cells in fetal rat testis using
antibodies directed against P450cl7. Panel a, testis from control group, panels b and
c, testes from fetuses of mothers treated with lOOmg/kg and 600 mg/Kg OP
respectively, panels d and e, testes from fetuses of mothers treated with 100|ig/kg
and 500 Jig/Kg DES respectively. Specific immunostaining of P450cl7 was reduced
in fetuses from the higher dose treatment groups (c, e) compared with controls (a).
Magnification x200 (a), xl20 (b-e).
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Fig. 8.7: Immunocytochemical staining of Leydig cells in fetal rat testis using
antibodies directed against 36-HSD. Panel a, testis from control, panel b, from OP
600mg/Kg treatment group, panel c, testis from DES 500 jig/Kg treatment group.
Note that numbers of Leydig cells and the abundance of 3S-HSD appears the same in
all groups. Magnification x200.
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8.3.3 Enzymatic activity of 17a-hydroxyIase in fetal testes from control and
treated mothers
17a-hydroxylase activity was measured in 4 testes pooled from two fetuses. Eight
such pools from five litters were analysed for the control group and 6 pools from 3











OP (lOOmg/Kg) ± SEM
n=3 litters (24 testes)
[X] OP (600mg/Kg) ± SEM
n=3 litters (24 testes)
III DES (100pg/Kg) ± SEM
n=3 litters (24 testes)
DES (500gg/Kg) + SEM
n=3 litters (24 testes)
Fig. 8.8: Level of 17a-hydroxylase enzyme activity in fetal testes isolated on day
17.5 of gestation from mothers treated with vehicle (^control, column 1), OP (600
mg/Kg or 100 mg/Kg; columns 2, 3 ) or DES (500 (Ig/Kg or 100 fig/Kg; columns 4,
5) show significantly reduced activity in the animals treated with DES or high dose
of OP. Each bar is the mean + SEM for 8 (control group) or 6 (all treated groups)
determinations using tissue pooled from 2 male fetuses per determination.
* p<0.05, *** p<0.001, in comparison with control group.
* **
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Enzyme activity in animals treated with the high (500|ig/Kg) or low (100|ig/Kg)
doses of DES was reduced by 78% (p<0.001) or 30% (p<0.05) respectively, when
compared to enzyme activity in control animals. In animals treated with the high
(600mg/Kg) dose of OP, enzyme activity was reduced by 30% (p<0.05) while the
lower dose (lOOmg/Kg) of OP resulted in an 18% reduction (p<0.07>0.05) in
enzyme activity compared to control animals (Fig. 8.8).
8.3.4 Detection of SF-1 protein in the fetal testis
Staining with antibodies directed against SF-1 detected a positive signal in the nuclei
of most cells within the testis including fetal Leydig and Sertoli cells (Fig. 8.9; see
also chapter 6). There was an obvious reduction in intensity of immunostaining in
animals treated with 600mg/Kg of OP (Fig. 8.9b) or 500fig/Kg of DES (Fig. 8.9c)
when compared to controls (Fig. 8.9a). The reduction in immunostaining was most
obvious in the Sertoli cells which appeared to be immunonegative in the testes from
animals treated with DES.
Fig. 8.9: Immunolocalisation of SF-1 in the gonads removed from the fetuses of
control and oestrogen-treated mothers on day 17.5 of gestation. In testes of fetuses
from control mothers immunostaining was present in Sertoli cell nuclei (arrows)
within the cords and in the majority of interstitial cells some of which were very
heavily stained (arrowheads). When the amount of SF-1 was determined in sections
from the testes of fetuses from DES- (c) or OP-treated (b) mothers processed at the
same time on the same slides a marked decrease in the level of immunostaining was
noted in the treated animals (compare b and c with a). The effect was most marked
when the Sertoli cells were examined (arrows) as these appeared immunonegative in
DES-treated animals (c). Within the interstitium immunostaining was reduced but
not absent from all cells. Magnification x400.
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8.4 Discussion
Testosterone is essential for maintenance of fertility in adult life (Sharpe, 1994) and
for the development of the male reproductive tract during fetal life (George and
Wilson, 1994). In the rat, synthesis of testosterone in the Leydig cells of the fetal
testis starts on day 15.5 p.c. and then increases rapidly over the next few days to
reach a peak on day 18.5 (Feldman and Bloch, 1978; Warren et al., 1973). The
results obtained in the present study in which oestrogenic chemicals were
administered to mothers at around this time demonstrate that oestrogens could
interfere with steroid production in the testis during fetal life by inhibiting
expression and activity of P450cl7 and expression of SF-1. The long term
consequences of these reductions are not known but deficits in various aspects of
masculinisation are an obvious possibility.
The reduction in 17a-hydroxylase enzyme activity in fetal testes resulting from
oestrogen administration to the mothers, was accompanied by reduced expression of
P450cl7 mRNA as determined by RT PCR (not shown) and in situ hybridisation,
consistent with the effect of the oestrogenic chemicals being mediated at the level of
transcription of the CYP17 gene. In the same tissue sections in which reduced
immunostaining for 17a-hydroxylase was observed, the number of Leydig cells
expressing 3B-HSD did not appear to have changed. Studies on steroidogenesis by
adult Leydig cells have demonstrated that expression of P450cl7 is acutely regulated
by LH stimulation and that levels of enzyme fall rapidly in the absence of cAMP
whilst expression of 3B-HSD remains unchanged under the same circumstances
(Keeney et al., 1988; Payne and Youngblood, 1995). In rats, plasma LH levels
remain low until fetal day 19.5 (Aubert et al., 1985) and it has been concluded that
although LH receptors are present in the fetal rat testis on or about day 15.5 (Warren
et al., 1984), activation of expression of steroidogenic enzymes and fetal testicular
testosterone production involves factors other than LH, presumably originating
within the testes (Pakarinen et al., 1994). Recently a factor termed SF-1, present in
fetal gonads and adrenals during and after sexual differentiation, has been shown to
regulate expression of steroidogenic enzymes and this may therefore be the missing
regulator of fetal Leydig cell steroidogenesis (Hatano et al., 1994; Lala et al., 1992;
Morohashi et al., 1992). As SF-1 has been reported to regulate the expression of
P450cl7, we looked at the expression of this transcription factor. Like that of
P450cl7, the expression of SF-1 appeared to be reduced in the fetal testes from
animals whose mothers were treated with either DES or OP. Reduced expression of
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SF-1 may provide an explanation for the reduced expression of P450cl7 as SF-1
binding sites are present on the CYP17 gene and SF-1 was shown to regulate
P450cl7 expression in vitro (Zhang and Mellon, 1996). However SF-1 is expressed
not only in Leydig cells but also in other interstitial cells and Sertoli cells (Hatano et
al., 1994; Ikeda et al., 1994) and studies on SF-1 "knock out" mice have shown that
SF-1 is essential for normal development of the reproductive system (Luo et al.,
1994). The data obtained by immunostaining suggest that a reduction in SF-1
expression occurs in all the cell types in the fetal testis. The most striking reduction
appeared to be in the Sertoli cells of animals from mothers treated with DES,
however it is possible that these cells still express SF-1 but at a level undetectable by
immunocytochemistry. The way in which SF-1 acts as a transcriptional regulator on
its target genes is not yet fully elucidated. Some studies suggest that it requires a
ligand, which has not yet been identified, to be fully functional (Shen et al., 1994).
It is possible that different mechanisms may operate in different cells and that in
some situations SF-1 may be active in the absence of ligand (Zhang and Mellon,
1996) or modulate cell function by dimerisation with other members of the
steroid/thyroid hormone superfamily (Beato et al., 1995).
Oestrogen receptors (ER) have been detected in genital tracts of male mice using
binding assays (Cooke et al., 1991b) and immunocytochemistry (Greco et al., 1992).
Within the mouse testis, ER immunostaining has been detected in interstitial cells
including Leydig cells on fetal days 15 to 19 (Greco et al., 1993). Tsai-Morris and
co workers (1986) reported that exposure of fetal rat Leydig cells (day 21) in vitro to
oestradiol resulted not only in a decrease in the synthesis of testosterone but also in
an increase in ER detected by binding assays. They concluded that the action of
oestrogens was mediated at the level of the nucleus, consistent with the action of
oestrogen being mediated via its receptor, because incubation of isolated
microsomes with oestrogen failed to affect enzyme activities (Nozu et al., 1981b).
In the mouse, P450 aromatase mRNA was detected in testes on and after day 17.5
p.c. (Greco and Payne, 1994) suggesting that fetal and neonatal testes have the
capacity to produce oestrogens locally. Recent studies of mice in which expression
of the ER gene was disrupted selectively found that the mature adult males were
infertile because of impaired spermatogenesis but otherwise appeared to have
anatomically normal accessory organs (Korach, 1994).
DES is a potent oestrogen, and previous observations in man (Gill et al., 1979) and
animals (McLachlan and Newbold, 1975) have indicated that it is likely to exert
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adverse effects during the time of masculinisation and reproductive tract
development. In contrast, there are no published studies of the effects of OP on
mammalian development, although it has been shown to be weakly oestrogenic in
vitro (White et al., 1994). OP is an alkylphenolic compound formed as a metabolite
of some non-ionic surfactants and which are used widely in industrial and some
household detergents, as plastic and petrol additives, spermicides and as dispensers
for insecticides (Naylor et al., 1992). However, the level of human exposure is
largely unknown. The present data are the first to show that maternal exposure to
high levels of such compounds can suppress 17a-hydroxylase activity. OP has been
shown previously to bind to the ER and to stimulate oestrogen-dependent growth of
breast cancer cells and gene expression in vitro to a similar extent to 176-estradiol,
albeit with approximately 1000-fold less potency (White et al., 1994). Male trout
exposed to low levels of OP (38.5 (J.g/1) in the surrounding water synthesise
vitellogenin, an oestrogen inducible protein normally only expressed in the female,
and as a result had reduced testis size (Jobling et al., 1996). Studies in our group
have shown that exposure of male rats to OP during gestation and neonatal life,
whether administered by injection or via the drinking water, results in small but
significant reductions in testicular size and sperm production in adulthood (Sharpe et
al., 1995). In these experiments the doses added to the drinking water were very
low, comparable to those to which humans may be exposed. Similarities between
the effects of treatment with DES and OP suggest that the potentially deleterious
action of OP on developing mammalian testis may be due to its oestrogenic activity,
however, the mechanism underlying these observations remains to be elucidated.
Reduced sperm output has been interpreted as being a consequence of reduction in
Sertoli cell number rather than alteration of Leydig cell function but it is possible
that the suppression of 17a-hydroxylase activity and/or reduced expression of SF-1
could have contributed to changes in Sertoli cell function.
It is presumed that the present effects of DES and OP on P450cl7 and SF-1 are
mediated via the oestrogen receptor, although it has been reported recently that the
major and persistent metabolite of DDT, p,p'-DDE, which had previously been
implicated in induction of abnormalities in male sex development in wildlife, bound
more efficiently to the androgen receptor than it did to the oestrogen receptor (Kelce
et al., 1995) and that DES could also bind to the androgen receptor. In the present
study we do not believe that the effects on Leydig cell 17a-hydroxylase activity
observed following treatment with DES or OP reflect interaction at the level of the
AR as the few AR which are present within the testis at this time are not present in
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Leydig cells (Majdic et al., 1995) and chapter 5. The pattern of expression of ER in
the fetal testis has also been examined during the present studies. On day 17.5 p.c.,
ER were present only in interstitial cells and double immunostaining with antibodies
against 3B-HSD demonstrate that these are mostly Leydig cells (Majdic and
Saunders, in preparation), but no difference was observed between control and
treated animals either in intensity or distribution of staining. These results are in
accordance with previously published observations (Greco et al., 1992) where
authors noted expression of ER in the interstitial cells. Whilst it seems logical to
conclude that the reduced expression of P450cl7 and SF-1 in Leydig cells may
reflect direct action of oestrogenic chemicals via the ER, this could not account for
the parallel decrease in expression of SF-1 in Sertoli cells in which no ER were
detected. It is therefore presumed that the effect of oestrogens on these cells is
indirect or mediated via a different receptor system. However, very recently, a
second type of ER (beta) has been cloned from the prostate and shown to be
expressed in granulosa cells of the ovary (Kuiper et al., 1996). Sequence analysis
revealed that ERB had significant sequence differences to the ER (alpha) to which
the used antiserum was raised. The possibility therefore exists that the effects
observed on SF-1 expression might also be mediated via a different ER subtype but
this will require additional investigations. To date, the information on the control of
expression of the SF-1 gene is restricted to the identification of a putative binding
site with homology to the consensus E-box element which binds proteins with a
helix-loop-helix motif. Mobility shift analysis has suggested that a protein(s)
capable of binding to this element is present in the fetal testis (Nomura et al., 1995),
however, the protein has not yet been identified. No data on the presence of a
putative binding site for ER on the SF-1 gene has been presented.
While it is feasible to assume a direct action of oestrogens via ER on fetal Leydig
cells, the possible role of LH in regulation of P450cl7 expression cannot be ignored.
In adult animals, oestrogens and androgens both exert negative feedback effect(s) on
production and release of pituitary gonadotrophins (Griffin and Wilson, 1992). In
the fetal rat, LH is first detectable on day 17.5 (Aubert et al., 1985; Watanabe and
Daikoku, 1979) and while it is unlikely that LH is important at the initiation of
steroidogenesis in Leydig cells it is probably involved in stimulating the rise in
testosterone production between days 17.5 and 18.5 p.c. (Saez, 1994). Preliminary
studies using immunocytochemistry to detect LHB protein in fetal pituitary cells
from the control and treated animals described above did not show any major
changes in the intensity of immunostaining or in the number of LHB positive cells
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between groups. However, differences in the rate of LH release and/or production
cannot be excluded without further analyses wtiich should include an examination of
the level of LH6 mRNA and measurement of levels of LH in fetal circulation.
The importance and effect(s) of reduced 17a-hydroxylase enzyme activity induced
by exogenous oestrogens during fetal life and the consequent reduction in productionof testosterone are not clear. Long term effects on male reproductive function have
been reported following maternal treatment with DES in both humans (Gill et al.,1979) and rodents (McLachlan and Newbold, 1975), although a recent survey did
not find any evidence that long term male fertility had been affected (Wilcox et al.,1995). However, the question remains as to whether extended exposure to low doses
of oestrogens throughout life could have a long term and deleterious effect on
Leydig cell steroidogenesis. Evidence that the effects of intra-uterine exposure tolow doses of oestrogen might be reflected in altered Leydig cell function in
adulthood is provided by an intriguing report from Nonneman and co-workers
(1992) in which they found that mice differed in their adult reproductive
characteristics according to whether they developed in utero between two male
fetuses, which have higher testosterone levels, or between two female fetuses whichhave higher estradiol levels. They recorded lower levels of 17a-hydroxylase activityin adult male mice which had been adjacent to the female fetuses than those next to
the males and higher androgen receptor in the prostates of these same mice leadingto the conclusion that low level oestrogen exposure exerts a significant influence on
androgen metabolism and responsiveness.
Similarly, the importance of reduced expression of SF-1 is not known. In the present
study we treated animals only after gonadal differentiation starts, however, in some
parallel studies, pregnant females received their first injection of OP on day 9.5 p.c.,prior to gonadal differentiation. The gonads of these animals did not show any grossabnormalities at the time of birth. It is possible that the fetus develops a "defensive"
mechanism by overexpressing certain important proteins/hormones and thereby
ensures that normal development occurs despite some deleterious external
influences. Lower levels of SF-1 expression may still be sufficient to initiate the
normal development of the gonads. However, any long term effects of inappropriate
gene expression during fetal life that might become evident only during adult life
cannot be excluded.
In conclusion, these data show that maternal exposure to oestrogens such as OP and
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DES inhibits expression of SF-1 and the activity of 17a-hydroxylase in the fetal
testis. The mechanisms which bring about this reduction and its consequences
remain to be elucidated. We cannot yet conclude that the reduction in SF-1
expression and P450cl7 enzymatic activity necessarily explain the incidence of
reproductive problems in male offspring from DES-treated mothers or the rise in the
reported incidence of similar problems in the general population. However, the
present observations suggest that the effect of long term exposure to oestrogenic
chemicals, especially environmental oestrogens, on Leydig cell function needs to be
more fully explored.
9. General discussion
Sexual differentiation is one of the most intriguing and interesting processes of
developmental biology. Discoveries in recent years have broadened our understanding
of the events underlying development of the gonads and sexual phenotype but many
questions still remain unanswered. Notably, there have been increasing numbers of
reports suggesting that a decline in male reproductive health is occurring which has
been highlighted by an increase in the incidence of abnormalities of development of the
male reproductive tract. For example, the reported incidence of testicular cancer,
hypospadias and cryptorchidism (Giwercman, 1995; Toppari et al., 1996) has
increased drastically and statistical analysis of sperm concentration data for normal
men from over 60 publications during the period 1938-1990 found that mean sperm
concentrations had declined from an average of 113xl06/ml to 66xl06/ml over this
time period (Carlsen et al., 1992). These data have been supported by the results of
other studies (Auger et al., 1995; Irvine, 1994; van Waeleghem et al., 1994),
however, a decline in sperm counts does not appear to have occurred in all developed
countries (Suominen and Vierula, 1993). It has been suggested (Giwercman, 1995;
Sharpe and Skakkebaek, 1993) that the development of testicular cancer, hypospadias,
cryptorchidism and eventual sperm output are all predetermined during development of
the male reproductive system during fetal and neonatal life. Understanding how and
why development of the male urogenital system may be adversely affected is therefore
dependent on elucidating the molecular, biochemical and endocrine mechanisms that
operate during this critical period.
9.1 Physiological development of the fetal gonads
Development of the testis is a precisely regulated process that requires accurate
temporal and spatial expression ofmany different genes/proteins. Several genes, the
products of which appear important during gonadal development, have recently been
identified and it is likely that many more are still undiscovered (Bogan and Page,
1994; Capel, 1995; Ryner and Swain, 1995). To aid in understanding the
mechanisms underlying normal testicular development it is important to know the
temporal and spatial localisation of expression of the genes involved.
Expression of a normal, functional androgen receptor (AR) is necessary to enable
testosterone, the main male sexual hormone, to act on its target cells. Lack of a
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functional androgen receptor in humans is associated with androgen insensitivity
syndrome, a pathological condition where XY individuals develop testes which remain
undescended and so have a female or intersex phenotype (Griffin and Wilson, 1989;
Quigley et al., 1995). Several studies have shown the presence of androgen receptors
in the developing genital tract in humans (Kalloo et al., 1993) and rodents (Bentvelsen
et al., 1995; Cooke et al., 1991a) using either ligand binding or immunocytochemistry
but there have been no previous reports on the presence and cellular localisation of AR
within the fetal testis. In this study, the AR were clearly shown to be present in nuclei
of interstitial cells from day 17.5 onwards, however, rather surprisingly, during fetal
life the AR were not localised to the Leydig cells, as in the adult testis, but in other
types of interstitial cells and in peritubular cells. In addition in contrast to the situation
in the adult testis, the AR was not present in nuclei of fetal Sertoli cells. The
implications of this finding are not known, however, a clear conclusion could be
drawn that testosterone cannot influence steroidogenesis in the fetal Leydig cells. In
contrast feedback inhibition of testosterone production by testosterone acting via AR
has been shown in adult testis (Darney and Ewing, 1981; Hales et al., 1987; Pointis et
al., 1984). The absence of AR from fetal Leydig cells may be associated with the high
steroidogenic capacity of these cells (Huhtaniemi, 1994; Saez, 1994), which is
necessary to maintain the high testosterone levels required for virilisation of the male
genitalia (George and Wilson, 1994). The lack of AR in fetal Leydig cells could
therefore prevent the negative feedback effect of testosterone and consequently prevent
inhibition of testosterone production. The lack of another feedback inhibition loop,
namely desensitisation of fetal Leydig cells following stimulation with LH, has been
reported (Payne and Youngblood, 1995; Warren et al., 1987) and it is feasible that
fetal Leydig cells have developed mechanisms to prevent negative effects on
testosterone production ensuring maintenance of testosterone production at levels
sufficient for normal masculinisation of the fetus. In our studies, the first AR
immunopositive cells within the testis were detected on day 17.5 in an area of the
gonad close to the mesonephros. During the next few days of gestation, the AR
immunopositive cells became dispersed throughout the interstitial and peritubular
compartment of the testis. Studies by Buehr et al. (1993) have demonstrated that
migration of cells from the mesonephros into the fetal testis occurs and have
highlighted the importance of this migration for normal testicular development. The
presence of the first AR immunopositive cells in the area adjacent to the mesonephros
and strong expression of AR in the cells within the mesonephros one day before the
appearance of the AR positive cells in the testis make it tempting to conclude that AR
positive cells migrate from the mesonephros and gradually populate the testis.
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However, at present this idea is purely speculative and further studies will be needed
to establish if it is true.
Fetal rat Leydig cells start to produce testosterone on day 15.5 p.c. (Feldman and
Bloch, 1978; Habert and Picon, 1982; Picon, 1976), simultaneously with their
morphological differentiation (Magre and Jost, 1980). However, studies by Bloch
(1979) and the results presented in this thesis suggest that the functional differentiation
of these cells starts earlier since 36-HSD, one of the steroidogenic enzymes essential
to testosterone synthesis, was detectable on day 14.5 p.c. The importance, or
implications, of this finding are not known and clearly different mechanisms are
involved in the regulation of expression of the different steroidogenic enzymes
because two other enzymes, P450scc (Rouiller et al., 1990) and P450cl7, are not
detectable in the fetal testis before day 15.5 p.c. The factor triggering testosterone
production has not yet been identified. In the primate fetus, such a factor could be
hCG (Saez, 1994) but studies in the rat have so far failed to identify a similar factor
(Habert and Picon, 1990; Wurzel et al., 1983) leading to speculation that either non-
gonadotrophic factors may be involved or that autonomous regulation of testosterone
production occurs in the fetal rat testis. The orphan nuclear receptor SF-1 has been
implicated as an important transacting transcription factor essential to gonadal
development (Ingraham et al., 1994; Luo et al., 1994). SF-1 regulates the expression
of several cytochrome P450s enzymes (Clemens et al., 1994; Lynch et al., 1993;
Morohashi et al., 1992; Zhang and Mellon, 1996) and AMH (Shen et al., 1994). The
presence of SF-1 in the fetal testis from the earliest stages of gonadal development
(Hatano et al., 1994; Ikeda et al., 1994) and its ability to regulate the transcription of
both P450scc and P450cl7 would suggest that SF-1 could be the factor that triggers
and regulates early expression of some or all of the steroidogenic enzymes and thus
controls early testosterone production. However, as the expression of 36-HSD in the
fetal rat testis occurs one day before that of P450scc and P450cl7, additional factors
that either act independently of SF-1 or that interact with SF-1 to allow it to function
differently on different genes must be involved.
Another orphan nuclear receptor, DAX-1, also appears to play important role(s) in
gonadal development (Guo et al., 1995; Zanaria et al., 1994). The DAX-1 gene is
located in the DSS region of the X chromosome (Zanaria et al., 1994) and if DAX-1 is
indeed the gene which when duplicated is associated with sex reversal, it might be the
first ovary determining gene identified. However, DAX-1 is not the only gene in the
DSS region and further studies will be needed to confirm whether DAX-1 is
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important in DSS (Bardoni et al., 1994). The phenotype of patients with mutations in
DAX-1 is similar to that observed in mice lacking a functional SF-1 gene and some
studies have suggested that a direct interaction occurs between SF-1 and DAX-1, a
hypothesis supported by the discovery of an SF-1 binding site upstream of the DAX-1
gene (Burris et al., 1995). However, the pattern of cellular localisation described in
this study does not support this theory. While these factors coimmunolocalise in
many interstitial cells within the testis, some DAX-1 immunopositive cells did not
show immunoexpression of SF-1. It is possible that these cells do contain SF-1
protein but at low levels, undetectable using immunocytochemistry. However, the
interstitial cells that express both proteins are those that have the strongest
immunoexpression of SF-1 while the cells with lower expression of SF-1 do not
express DAX-1, so it seems likely that cells containing DAX-1 alone are truly SF-1
negative. In accordance with this data, an SF-1 binding element is not absolutely
necessary for transcription of this gene (K.L. Parker, personal communication), and
expression of DAX-1 occurs in fetuses lacking functional SF-1 (Parker, 1996) further
suggesting that the interaction of these two genes/proteins is indirect rather than direct.
The function of DAX-1 is not known but the timing of expression of the protein and
pattern of cellular localisation described in this study as well as the phenotype of the
patients with mutations in the DAX-1 gene who have a disorganised adrenal cortex
(Muscatelli et al., 1994) could suggest involvement in regulation of steroidogenesis in
the testis and adrenal glands. However, its role in the fetal ovary is not likely to be the
same as unlike the testis the fetal ovary is steroidogenically quiescent. It is possible
that DAX-1, like SF-1, acts as a transcription factor for modulation of multiple genes
and therefore has additional function(s) in the development of the ovary.
Alternatively, since DAX-i is not the only gene located in the DSS region of the X
chromosome it is possible that DAX-1 is responsible for adrenal hypoplasia congenita
but not for dosage sensitive XY female sex reversal and is thus not an ovary
determining gene.
Another difference between adult and fetal Leydig cells, namely in their abilities to
synthesise inhibin/activin subunits, has been established during this study. Inhibins
and activins are well known modulators of FSH release from the pituitary (Wallach,
1996; Ying, 1988) and it is well established that the principle site of synthesis of
inhibins and activins in the adult testis are the Sertoli cells (Ying, 1988). Several
studies have suggested some inhibin/activin production also occurs in Leydig cells,
especially in immature animals and fetuses (Maddocks and Sharpe, 1989; Roberts et
al., 1989; Shaha et al., 1989). The studies described in this thesis have made use of
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new, highly specific, monoclonal antibodies and have demonstrated that the major site
of synthesis of inhibin a and BB subunits in the testis during fetal life are the Leydig
cells. The immunoexpression of a-subunit starts very early with positive
immunostaining detectable on day 14.5 p.c. Two days later, immunoexpression of
the BB subunit was detectable, suggesting that the fetal testis has the potential to
produce bioactive inhibin. The role of inhibin during fetal life is not known, however
it is likely to be different from its role in the adult organism where its main role is the
modulation of FSH release since FSH is not detectable in the rat fetus until day 17.5
(Aubert et al., 1985). This finding also raises the question of the regulation of inhibin
expression since it has been shown that this can in turn be regulated by FSH (Ying,
1988). Several studies have demonstrated that inhibin and activin can act as local
paracrine or autocrine regulators of testicular cells in immature and adult animals and it
is possible that they perform a similar role(s) in the fetal testis (Boitani et al., 1995;
Chen, 1993; Hsueh et al., 1987; Lin et al., 1989). In the absence of FSH stimulation
regulation of expression of inhibin subunits within the fetal testis may be influenced
by other local factors which are as yet unidentified. One candidate could be SF-1 as it
is present in the testis at the appropriate time and as discussed has been implicated in
the regulation of many genes involved in reproduction and steroidogenesis. This
hypothesis is supported by the lack of inhibin expression in the fetal ovaries where
SF-1 expression declines, however, no reports have been published identifying an
SF-1 binding element in any of the genes encoding the inhibin subunits.
Immunoexpression of proteins examined during this study and their localisation to the
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9.2 Influence of oestrogenic chemicals on testis
development
In the 1950s and 60s, several million women received treatment with DES during their
pregnancy as a preventive to miscarriage (Stillman, 1982). Follow-up studies have
shown that DES was not effective (Dieckmann et al., 1953) and furthermore had
harmful effects on the male and female offspring from treated mothers (Bibbo et al.,
1977; Gill et al., 1979; Stillman, 1982). In males, an increased incidence of
cryptorchidism, hypospadias and smaller testis with lower sperm output and lower
sperm quality was noted (Bibbo et al., 1977; Gill et al., 1979; Stillman, 1982). Some
studies in experimental animals have also demonstrated similar deleterious effects of
exposure to DES and other oestrogens on the development of the male reproductive
tract in rats and mice (Boylan, 1978; McLachlan and Newbold, 1975; Nomura and
Kanzaki, 1977; Vannier and Raynaud, 1980).
In recent years, several studies have reported an increasing incidence of testicular
cancer, cryptorchidism and hypospadias in the normal male population in the western
world (Giwercman, 1995; Giwercman and Skakkebaek, 1992; Toppari et al., 1996).
In addition a number of intriguing reports recording falling sperm counts in several
developed countries in the last few decades have been published (Auger et al., 1995;
Carlsen et al., 1992; Irvine, 1994; van Waeleghem et al., 1994). Similarities between
the problems recorded in offspring from DES treated mothers and those occurring in
the normal population have lead to the suggestion of a possible connection to
oestrogen exposure. Sharpe and Skakkebaek (1993) have reviewed the possible
sources of exposure to oestrogenic compounds in the modem world and came to the
conclusion that we are exposed to much higher amounts of oestrogens today compared
to 50 years ago. One important source of oestrogenic substances are the chemicals in
our environment. It has been known for several years that some PCBs and p,p-DDE
(a DDT metabolite) have weak oestrogenic activity (Bittman and Cecil, 1970). In
addition, for several other chemicals currently widespread in our environment
oestrogenic activity has been recently established using in vitro tests (Jobling et al.,
1995; White et al., 1994). Studies by Sharpe and co-workers (1995) have shown that
exposure to some of these chemicals, including octylphenol (OP), also used in the
studies described in this thesis, could cause the development of smaller testes and a
lower sperm output in adult rats, if they were exposed whilst in utero and during
lactation via their mothers. The mechanism of action of these chemicals is not yet
known but the effects were noted even when the levels of treatment were low and
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comparable to those to which humans may be exposed. In adult life, oestrogens
influence the function of the pituitary and the testis directly via oestrogen receptors
(ER) which are present in both organs (Griffin and Wilson, 1992). Similarly, ER are
present in the fetal testis and pituitary (Greco et al., 1993, Majdic and Saunders,
unpublished observations), suggesting that these chemicals may also act via the ER at
this stage of life. Immunocytochemically, the ER were detected in the fetal Leydig
cells (Majdic and Saunders, unpublished observation), suggesting possible action of
oestrogenic chemicals directly on these cells. However, we were unable to detect ER
in Sertoli cells, suggesting that reduced expression of SF-1 protein in these cells may
be due to indirect regulation. Very recently, a second type of ER has been cloned
(ER-B; Kuiper et al., 1996), and although not much is known about its expression, it
is possible that oestrogenic chemicals may act via ER-B, expressed in Sertoli cells. In
the present study, reduced expression of both the steroidogenic enzyme cytochrome
P450cl7 and SF-1 have been detected following exposure to DES or OP in utero.
The consequences of these findings are not known but one obvious possibility is a
reduction in testosterone production. Knowing the importance of testosterone for
normal masculinisation (George and Wilson, 1994) one could easily imagine the
deleterious effects impaired testosterone production could have. However, in this
study the actual testosterone levels have not been measured and it is possible that
reduced activity of P450cl7 has only a limited influence on total testosterone
synthesis. Similarly, it is possible that testosterone production in the fetal testis is
higher than required thus enabling the fetus to compensate for any negative influences
on testosterone biosynthesis during this critical period. This might explain the lack of
any gross morphological changes in treated animals, however, none of the animals
treated with a high dose of DES in utero, where the reduction in P450cl7 activity was
most prominent, were examined postnatally due to the problems with delivery in these
animals. The reduced level of P450cl7 mRNA in the fetal Leydig cells could either be
derived from a direct influence of oestrogenic chemicals acting via the ER, or
alternatively via changes in the levels of LH resulting in reduced stimulation of Leydig
cells. Preliminary studies using immunocytochemistry have not demonstrated any
significant reduction in the number of LHB positive cells in the pituitary from fetuses
treated with either DES or OP via their mother, however, examination of mRNA
expression and the measurement of LH in fetal circulation are necessary to determine
whether there are changes in the concentration of this gonadotrophin. The changes in
P450cl7 activity in fetal Leydig cells could result from alterations in SF-1 levels as it
has been shown to regulate the transcription of CYP17 gene in vitro (Zhang and
Mellon, 1996). Whether this effect of oestrogens is directly mediated via ER is not
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known. There have as yet been no reports about the presence of an oestrogen
response element in the SF-1 gene. The only regulatory element in the SF-1 gene so
far identified is an E-box element (Nomura et al., 1995) and there are no reports about
regulation of expression of SF-1 in vivo. SF-1 is expressed in several cell types in the
testis and has a wide range of effects on the development of the reproductive axis.
Therefore any change in SF-1 expression could have serious consequences.
However, as mentioned earlier, the animals from treated mothers did not show any
gross morphological abnormalities, again suggesting that compensatory mechanism(s)
are in place with the expression of SF-1 being high enough to maintain normal
gonadal development even after treatment. Further studies are needed to elucidate how
oestrogen exposure results in reduced SF-1 expression.
In conclusion, these data have demonstrated one possible mechanism by which
deleterious effects of oestrogenic chemicals could occur, but further studies will be
necessary to elucidate the importance of the present findings and to further explain the
mechanisms of oestrogen action on development of the reproductive tract. At present
it is not yet possible to be sure that the effects attributed to oestrogenic chemicals are
involved in the reported increase in incidence of male reproductive abnormalities.
However, hypospadias and cryptorchidism can result from impaired testosterone
action and could result from lowered testosterone production due to impaired
steroidogenesis.
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Expression of Cytochrome P450 17o-Hydroxylase/C17-20
Lyase in the Fetal Rat Testis Is Reduced by Maternal
Exposure to Exogenous Estrogens
G. MAJDIC*, R. M. SHARPE, P. J. O'SHAUGHNESSY, and P. T. K. SAUNDERS
Medical Research Council Reproductive Biology Unit, Edinburgh, EH3 9EW; and the Department of
Veterinary Physiology, University of Glasgow (P.J.O.), Glasgow, United Kingdom G61 1QH
ABSTRACT
Testosterone is required for normal development of the male re¬
productive tract. Synthesis of testosterone occurs in the Leydig cells
and is dependent upon the expression of several enzymes, including
cytochrome P450 17a-hydroxylase/C17-20-lyase (P450cl7), which is
highly regulated within the testis. The aim of the present study was
to investigatewhethermaternal exposure to estrogenic chemicals was
able to affect Leydig cell function in the developing male fetus at the
time of masculinization. Pregnant rats were injected sc with dieth-
ylstilbestrol (DES; 100 or 500 pg/kg), 4-octylphenol (OP; 100 or 600
mg/kg), or vehicle (oil, control) on days 11.5 and 15.5 postcoitum.
Doses were chosen to reflect the reported estrogenic potency of the
chemicals in vitro. On day 17.5, fetal testes were fixed before per¬
forming in situ hybridization and immunocytochemistry, used for
extraction of RNA, or homogenized in phosphate buffer for determi¬
nation of 17c*-hydroxylase enzyme activity.
There was no difference between fetuses from control and treated
mothers in either the overall histology of the testes or the apparent
number ofLeydig cells, as determined by immunocytochemistry with
an antibody directed against 3/3-hydroxysteroid dehydrogenase. How¬
ever, there was a consistent and striking reduction in the amount of
P450cl7 detected by immunocytochemistry in testes from the groups
given the higher dose of DES or OP. These observations were sup¬
ported by measurement of 17a-hydroxylase activity, which was sig¬
nificantly reduced compared with that in controls (6.25 ± 0.65 pmol/
testis-min) in fetuses from animals treated with 100 jug/kg DES (4.27
± 0.39; P < 0.05), 500 pg/kg DES (1.4 ± 0.47;P < 0.001), or 600 mg/kg
OP (4.25 ± 0.33; P < 0.05). RT-PCR and in situ hybridization revealed
that these changes were mirrored by reductions in P450cl7 messen¬
ger RNA in testes from fetuses from treated mothers compared with
control levels.
In conclusion, maternal treatment with either a potent synthetic
estrogen (DES) or a putative environmental estrogen (OP) results in
reduced expression of the messenger RNA and protein for P450cl7 in
fetal Leydig cells. These results, therefore, provide a mechanism by
which inappropriate exposure of the fetus to estrogenic chemicals
might have an adverse affect on fetal steroid synthesis and mascu¬
linization. (Endocrinology 137: 1063-1070, 1996)
NORMAL DEVELOPMENT of the testis and male re¬productive tract is a tightly regulated process. The
earliest step in formation of the testis from the indifferent
gonad is the differentiation ofSertoli cells, which occurs after
expression of Sry (the testis-determining factor) (1) on day
10.5 in the mouse. The Sertoli cells then orchestrate the for¬
mation of the testis cords and synthesize and secrete anti-
Mullerian hormone (2). In the rat on or about day 15 of
gestation, Leydig cells differentiate from mesenchymal cells
in the interstitial region of the testis between the seminiferous
cords (3). Fetal Leydig cells are the site of synthesis of tes¬
tosterone, which is essential for masculinization of the re¬
productive tract and external genitalia and the development
of a normal male phenotype (4).
During the 1950s to 1970s, some women were given di-
ethylstilbestrol (DES), a potent estrogen, as a preventative for
miscarriage. Studies have shown that the offspring of these
women had an increased incidence of abnormalities of their
reproductive tracts. In the adult males, an increased inci-
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dence of hypospadias, cryptorchidism, as well as smaller
testes and semen abnormalities have been reported (5). How¬
ever, a recent follow-up survey of the same patients did not
find their fertility to have been reduced (6). Prenatal exposure
of male mice to DES has been associated with epididymal
cysts, cryptorchidism, and, in some cases, sterility (7). In the
past 50 yr, the incidence of testicular cancer has increased
progressively in many developed countries, whereas aver¬
age sperm counts have fallen by 40-50% during the same
time period, and other developmental male reproductive
disorders also have increased in incidence (8, 9). Similarities
between the reproductive problems of males born to DES-
treated mothers and those occurring in the rest of the pop¬
ulation has led to the hypothesis that one potential cause of
male reproductive abnormalities may be inappropriate ex¬
posure to estrogens during fetal life (8, 9).
Synthesis of testosterone is dependent upon the expres¬
sion of four steroidogenic enzymes (10), including P450 17a-
hydroxylase/C17-20-lyase (P450cl7), which is highly
regulated in the Leydig cells, and 3/3-hydroxysteroid dehy¬
drogenase (3/3HSD), which appears to be largely constitutive
(11,12). The messenger RNAs (mRNAs) encoding these en¬
zymes are present in fetal mouse testis on day 13.5 postco¬
itum (pc) (approximately equivalent to day 15.5 in the rat)
(13). In the fetal rat testis, testosterone synthesis is detectable
on day 15.5 of pregnancy (14), with testosterone production
reaching its peak around day 18.5 pc and then declining (15).
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In the adult testis, testosterone production by Leydig cells
can be inhibited by exposure to estrogens (16,17), and it has
been shown that this inhibition is associated with lower
activity of the 17a-hydroxylase enzyme (18, 19). Estrogen
receptors (ER) have been detected using immunocytochem-
istry in fetal mouse testes (including the interstitial cells) and
associated ducts on days 13, 15, and 17 of gestation (20).
Incubation of fetal rat Leydig cells recovered on day 21 of
pregnancy with estradiol is reported to result in decreased
androgen production and an increase in ER detectable by
binding assay (21).
In the present study we examined the effects of maternal
treatment with DES or a putative environmental estrogen,
4-octylphenol (OP), at two different times during pregnancy,
corresponding to the development of the fetal testis (day
11.5) and the onset of Leydig cell steroidogenesis (day 15.5).
Our results show that administration of these estrogenic
chemicals to the mother results in a specific reduction in
steroidogenic enzyme activity within the fetal testis associ¬
ated with reduced levels of P450cl7 mRNA and protein.
Materials and Methods
Animals, treatments, and tissue recovery
Adult female rats were placed in individual cages with male rats and
checked for the presence of copulatory plugs each morning. The day
when the plug was found was taken as day 0.5 pc. Pregnant females were
injected sc on days 11.5 and 15.5 pc with DES (Sigma Chemical Co., St.
Louis, MO; 100 or 500 p,g/kg) or OP (Aldrich Chemical Co., Rouses
Point, IL; 100 or 600 mg/kg) in corn oil (1 ml/kg) Or with the vehicle
alone (controls). Pregnant females were killed on day 17.5 pc by inha¬
lation of carbon dioxide followed by cervical dislocation. Fetuses were
examined under a dissecting microscope, and the testes were recovered.
Testes were either immersion fixed in Bouin's solution for 5-6 h before
processing for immunocytochemistry and in situ hybridization (22) or
used for extraction of RNA or determination of enzyme activity (see
below). Fetal age was confirmed by morphological examination of the
fetuses (23).
RNA extraction
Dissected testes from two to five fetuses from the same litter were
pooled in 1 ml TRI reagent (Sigma) and homogenized by passing
through a 27-gauge needle. Homogenate was mixed thoroughly with
chloroform (0.2 ml; IBI, Cambridge, UK) and kept at room temperature
for 15 min. Samples were then centrifuged at 12,000 X g for 15 min before
the upper aqueous phase was transferred to fresh tubes. RNA was
precipitated in the presence of 3 /ag polyinosine (Pharmacia, Piscataway,
NJ) (24) using 0.5 ml isopropanol (Sigma) for 15 min at -20 C. Samples
were centrifuged at 12,000 X g for 15 min to pellet the RNA, which was
washed with 75% ethanol, air-dried, and dissolved in 20 or 50 /al distilled
water. The concentration of RNA was determined by measuring OD at
260 nm, and its quality was checked by electrophoresis of 5 jug/lane in
a denaturing agarose gel (25).
RT-PCR
Primers based on the sequence of the rat CYP17 gene (26) upstream
5' -CTTGTCGGACCAAGGAAAAGGCGT (bases 344-367, sense
strand) and downstream 5'-AGCCAGCTGATCGTGCAGC (bases 669-
692, antisense strand) were synthesized on an Applied Biosystems PCR
mate (ABI, Warrington, Cheshire, UK). Reverse transcription was un¬
dertaken using 250-500 ng total RNA in a 20-/U.1 volume containing 10
mM Tris-HCl (pH 8.3), 90 mM KC1,1 mM MnCl2, 200 /tm of each deoxy-
NTP, 5 U Tth polymerase (ABI) (27), and 0.75 jim antisense primer. The
conditions used were 65 C for 5 min, 53 C for 5 min, and 70 C for 15 min,
and the samples were then placed on ice. The reaction volume was
increased to 100 p.1, and PCR was undertaken in buffer containing 1.5
mM MgCl2, 40% glycerol, 10 mM Tris-HCl (pH 8.3), 890 mM KC1, 6 mM
EGTA, 0.4% Tween 20 (MnCl2 in the first reaction solution was chelated
by the EGTA), and 0.15 p,M of the upstream primer. PCR conditions were
denaturation at 95 C for 3 min, followed by 30 cycles of amplification at
94 C for 0.5min, 55 C for 1 min, and 70 C for 2min,with a final elongation
at 70 C for 10 min. The expected size of the amplified product was 348
bp. To provide an internal control, cyclophilin complementary DNA
(cDNA) was amplified simultaneously in every reaction, using upstream
primer 5'-GTGGCAAGTCCATCTACG (bases 263-280 sense strand)
and downstream primer 5'-CAGTGAGAGCAGAGATTACAG (bases
626-646 antisense strand) based on the sequence of rat cyclophilin (28).
The expected size of the amplified product was 380 bp. Amplified
product(s) were analyzed by electrophoresis on a 2% agarose gel run in
Tris-borate-EDTA buffer using standard methods. The cDNAs were
subcloned into pCRII vector according to the manufacturer's instruc¬
tions (Invitrogen Corp., San Diego, CA). The specificity of amplification
was confirmed by sequencing the cloned fragments of P450cl7 and
cyclophilin cDNAs using an ABI automated sequencer and fluorescent
primers, as previously described (29).
In situ hybridization
To synthesize sense and antisense riboprobes, p450cl7-pCRIl was
linearized with Xhol (antisense) and BamHl (sense), and complementary
RNA (cRNA) was synthesized with SP6 or T7 RNA polymerase, re¬
spectively (Boehringer Mannheim). Probes were labeled with [35S]UTP
(400 Ci/mmol; Amersham, Aylesbury, UK), as described previously
(22), and purified using RNA spin columns (IBI). Paraffin sections (5 p,m)
were mounted on slides coated with 3-aminopropyl triethoxy-silane
(Sigma), dried overnight at 50 C, dewaxed in xylene, and rehydrated in
graded ethanols. Sections were hybridized with 106 cpm [35S]cRNA in
40 p.1 hybridization buffer at 50 C overnight. Next day, sections were
washed in 4 X SSC (1 X SSC contains 0.15 M NaCl and 15 mM sodium
citrate, pH 7) for 10 min, incubated in ribonuclease A (Sigma) solution
(2 mg/ml in 0.01 M Tris-HCl, 0.05 M NaCl, and 5 mM EDTA, pH 8.0) for
30 min at 37 C, washed twice for 5 min each time in 2 X SSC, and finally
washed in 0.1 X SSC-30% formamide for 10 min at 40 C. Sections were
dehydrated in graded ethanols, air-dried, dipped in undiluted photo¬
graphic emulsion (NTB-2, Eastman Kodak, Rochester, NY), exposed at
4 C in a light-tight box for 2 weeks, and processed as previously de¬
scribed (22). To ensure that all of the tissue sections were hybridized and
washed under the same conditions, sections from control and treated
animals were mounted on the same slide. Sections were observed under
brightfield illumination using an Olympus BH2 microscope (Olympus
Corp., New Hyde Park, NY) and a X40 objective. Images were captured
using a data translation quick capture card and a Macintosh Ilex com¬
puter, and quantified using NIH image 1.57 program. To determine the
abundance of P450cl7 mRNA, the number of silver grains in 10 random
fields in the interstitial region of the testes was counted. Background
counts were determined by counting 10 random fields in regions of the
same sections that were outside the interstitium, e.g. mesonephros, and
the average of the grain counts in these regions was deducted from the
grain densities determined for the interstitial regions. The silver grains
were counted in 2-3 testes from 3 different litters for each treatment
group, and the group mean ± sem were calculated. Sections from the
same testes were also probed with sense strand riboprobes, and no
differences between grain densities in the different regions of the section
were observed.
Immunocytochemistry
Rabbit IgGs directed against recombinant human P450cl7 (30) were
a gift from Prof. Michael Waterman (Vanderbilt University, Nashville,
TN), and rabbit antihuman 3J3HSD (31) was a gift from Prof. Ian Mason
(Department of Clinical Biochemistry, University of Edinburgh, Edin¬
burgh, UK). The staining procedure employed was similar for both
antibodies. Sections (5 jum) were mounted on slides coated with 3-amin¬
opropyl triethoxy-silane (Sigma) and dried overnight at 50 C. Before
incubationwith primary antibodies, sections were dewaxed, rehydrated
in graded ethanols, and washed in water and TBS (0.05 M Tris-HCl, pH
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7.4, and 0.85% NaCl). Sections to be incubated with antiserum to P450cl7
were subjected to antigen retrieval (32) by microwaving in 0.01 m citrate
buffer (pH 6.0) on full power for 20 min and thereafter standing for 20
minwithout disturbance. All sections were blocked using normal swine
serum (Dako, High Wycombe, UK) diluted 1:5 in TBS. Both antibodies
were diluted 1:1000 in normal swine serum in TBS before incubation on
sections under plastic coverslips overnight at 4 C. On the following day,
coverslips were removed, and sections were washed twice in TBS (5 min
each wash), incubated for 30 min with biotinylated swine antirabbit Ig
(Dako) diluted 1:500 in TBS, then washed again in TBS (twice for 5 min
each time). For detection of bound antibodies, sections were first incu¬
bated with avidin-biotin complex conjugated with horseradish perox¬
idase for 30 min and washed twice in TBS (5 min each time). Color
reaction product was developed by incubating sections in a mixture of
0.05% (wt/vol) 3,3'-diaminobenzidine tetrahydrochloride (Sigma) in
0.05 m Tris-HCl, pH 7.4, and 0.01% hydrogen peroxide. After 5-15 min,
sections were washed in water, counterstained with hematoxylin, de¬
hydrated in graded ethanols, cleared in xylene, and coverslipped using
Pertexmounting medium (Cell Path, Hemel Hempstead, UK). The spec¬
ificity of the antibodies was confirmed using normal rabbit serum in¬
stead of the primary antibodies; no staining was observed in these
controls.
Measurement of 17a-hydroxylase activity
The activity of 17a-hydroxylase was measured as described previ¬
ously (33). In the current experiments, fetal testes from two animals (four
testes) were pooled and homogenized in 0.4ml PBS (0.05 m PBS, pH 7.6).
As substrate for the enzyme, 106 cpm [3H]progesterone (88 Ci/mmol;
Amersham) were dissolved in 35 pi dimethylsulfoxide and mixed with
0.87 ml phosphate buffer (0.05 m; pH 7.2) containing NADPH (final
concentration, 1 mmol/liter; Sigma). Homogenized testes (100 /xl) were
mixed with [3H]progesterone in phosphate buffer and incubated at
37 C for 20 min. Nonradioactive progesterone (Sigma) was added to the
incubationmixture to give a final substrate concentration of 2 pM, which
previous studies have shown to be saturating (33). Reactions were
stopped by adding 100 pi 1 m NaOH to each tube in ice. To allow
determination of steroid recovery, 14C-labeled testosterone (50 Ci/
mmol) and androstenedione (50 Ci/mmol; Amersham) were added
(2000 cpm of each to each reaction), and the steroids were extracted from
the solution using 5 ml toluene (AnalaR, BDH, Poole, UK). The organic
phase was recovered, dried by heating to 45 C under a stream of ni¬
trogen, dissolved in a few drops of methanol, and applied to a plastic-
backed silica gel plate (Whatman, Clifton, NJ). Steroids were separated
by TLC in chloroform-ether (7:1, vol/vol). Fluorescent bands (detected
under UV light) corresponding to 17-hydroxyprogesterone, andro¬
stenedione, and testosterone were cut from the plates, placed in vials
(Packard Instrument Co., Caversham, Berkshire, UK) and mixed with 6
ml scintillation fluid (Ecoscint A, National Diagnostic, Atlanta, GA). The
amount of each radiolabeled steroid was determined in a 0-counter
using a program to detect both 3H (counting range, 5-304 kiloelectron
volts) and l4C (counting range, 325-765 kiloelectron volts) simulta¬
neously. The activity of 17a-hydroxylase was expressed as picomoles of
radiolabeled progesterone converted by one testis in 1 min. Controls
were run in each experiment using PBS without added tissue. The
17a-hydroxylase activity was measured in eight separate pools of four
testes from five different litters for the control group and in six separate
pools of four testes from three different litters for each of the treatment
groups.
Statistical analysis
Data from each experiment were subjected to ANOVA to determine
whether there were significant effects of treatment. Where these were
indicated, subgroup comparisons between means for the control and
individual treatment groups were then made using the variance from the
experiment as a whole as the measure of error.
Results
Expression ofP450cl 7 mRNA
Multiple reactions were performed to determine the ex¬
pression of P450cl7 mRNA in individual samples of testes
from control and treated animals; primers directed against
cyclophilin (28) were added at the same time as those for the
enzyme to allow an internal check on the efficiency of the
amplification reaction. The comparisons shown in Fig. 1 re¬
vealed an apparent reduction in the amount of P450cl7
cDNA amplified from the testes of fetuses exposed to high
dose DES (lanes 3 and 5). The method was not considered
sufficiently quantitative to determine whether changes had
occurred after OP treatment (lane 2). The amounts of cyclo¬
philin cDNA amplified from all samples were approximately
similar.
In situ hybridization using a specific radiolabeled cRNA
directed against rat P450cl7 resulted in the detection of abun¬
dant silver grains, as expected, in the interstitial region of the
day 17.5 fetal testis after exposure to photographic emulsion
for 2 weeks (Fig. 2). Fewer silver grains were detected in fetal
testes from the animals treated with DES (Fig. 2c) than in
those from controls (Fig. 2a). Sense controls did not show any
signal above background (not shown). The results were con¬
firmed and extended by image analysis (Fig. 3), which re¬
vealed a slight reduction in grain counts in the interstitial
region after low dose OP treatment (Fig. 2b).
Detection ofP450cl7 and 3fHSD protein in fetal Leydig
cells
The gross histologies of the testes recovered on day 17.5 of
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Fig. 1. Coamplification ofmRNAs for P450c17 and cyclophilin using
RT-PCR. The amplified products were 348 bp for P450cl7 (lower
band) and 380 bp for cyclophilin (upper band)-, all samples contained
500 ng total RNA isolated from fetal rat testes isolated on day 17.5
of gestation from mothers treated as follows: lane 1, control; lane 2,
OP (100 mg/kg); lane 3, DES (500 pg/kg); lane 4, control; lane 5, DES
(500 pg/kg). Note that although all fetal samples contain roughly the
same amount of cyclophilin mRNA, maternal treatment with DES
resulted in an apparent reduction in P450cl7 mRNA.
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Fig. 2. In situ hybridization using 35S-labeled cRNA to rat P450cl7
mRNA on sections of fetal rat testis, a, Control; b, OP treatment (100
mg/kg) ofmother; c, DES treatment (500 pg/kg) ofmother. Exposure
to emulsion was for 2 weeks; all sections were exposed on the same
slide. Note that a strong concentration of grains is present in the
control rat testis, and brightfield illumination revealed that they were
concentrated mainly within the interstitial region of the testis. The
specific hybridization signal appeared reduced in the testes of males
deriving from mothers treated with 500 pg/kg DES. Magnification,
X100; bar = 100 pm.
Testes from fetal males recovered from untreated mothers
contained numerous Leydig cells that were stained strongly
after immunohistochemistry with primary antibodies di¬
rected against the steroidogenic enzymes P450cl7 and
3/3HSD (Figs. 4 and 5). Specific immunostaining of P450cl7
within fetal Leydig cells appeared the same in testes of un¬
treated control mothers (Fig. 4a) and those from mothers
treated with 100 mg/kg OP (Fig. 4b) or 100 Mg/kg DES (Fig.
4d). However, there was a marked reduction in immunos¬
taining when testes were recovered from fetuses of mothers
given 600 mg/kg OP (Fig. 4c) or 500 ju,g/kg DES (Fig. 4e). In
contrast, when fetal testes were immunostained for 3/3HSD,
there was no apparent reduction in the number of interstitial
cells with positive immunostaining in testes from treated
mothers (Fig. 5, b and c) compared with the control value
(Fig. 5a).
Enzymatic activity of 17a-hydroxylase in fetal testes from
control and treated mothers
17a-Hydroxylase activity was measured in four testes
pooled from two fetuses. Eight such pools from five litters
were analyzed for the control group, and six pools from three
litters were analyzed for each treatment group. Enzyme ac¬
tivity in animals treated with the high (500 pg/kg) or low
(100 pg/kg) dose of DES was reduced by 78% (P < 0.001) or
30% (P < 0.05), respectively, compared to enzyme activity in
control animals. In animals treated with the high (600 mg/
kg) dose of OP, enzyme activity was reduced by 30% (P <
0.05), whereas the lower dose (100 mg/kg) of OP resulted in
an 18% reduction (0.07 > P < 0.05) in enzyme activity com¬
pared to that in control animals (Fig. 6).
Discussion
Testosterone is essential for the maintenance of fertility in
adult life (34) and development of the male reproductive
tract during fetal life (4). In the rat, synthesis of testosterone
in the Leydig cells of the fetal testis starts on day 15 pc and
then increases rapidly over the next few days to reach a peak
on day 18.5 (14). The results obtained in the present study in
which estrogenic chemicals were administered to mothers
around this time demonstrate that estrogens could interfere
with steroid production in the testis during fetal life by
inhibiting the expression and activity of P450cl7. The long
term consequences of this reduction in enzyme activity are
not known, but deficits in various aspects of masculinization
are an obvious possibility.
The reduction in 17a-hydroxylase enzyme activity in fetal
testes resulting from estrogen administration to the mothers
was accompanied by reduced expression of P450cl7mRNA,
as suggested by RT-PCR analysis and confirmed by in situ
hybridization, consistent with the effect of the estrogenic
chemicals being mediated at the level of transcription of the
CPY17 gene. In the same tissue sections in which reduced
immunostaining for 17a-hydroxylase was observed, the
number of Leydig cells expressing 3/3HSD did not change.
Studies on steroidogenesis by adult Leydig cells have dem¬
onstrated that expression of P450cl7 is acutely regulated by
LH stimulation and that levels of enzyme fall rapidly in the
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Fig. 3. Quantification of the results ob¬
tained by in situ hybridization for
P450cl7 in fetal rat testis. The number
of silver grains detected in the intersti¬
tial region of the testis was reduced sig¬
nificantly in animals from mothers ex¬
posed to 500 jag DES (column 3; P <
0.001) compared with controls (lane 1).
Maternal treatmentwith 100 mg/kg OP
resulted in a slight reduction in grain
counts in the interstitium when cor¬
















absence of cAMP, whereas expression of 3/3HSD remains
unchanged under the same circumstances (11, 35). In rats,
plasma LH levels remain low until fetal day 19.5, and it has
been concluded that although LH receptors are present in the
fetal rat testis on or about day 15.5 (36), activation of ex¬
pression of steroidogenic enzymes and fetal testicular tes¬
tosterone production involves factors other than LH, pre¬
sumably originating within the testes (37). Recently, a factor
termed SF-l/Ad4BP present in fetal gonads and adrenals
during and after sexual differentiation has been shown to
regulate the expression of steroidogenic enzymes, and this
may, therefore, be the missing regulator of fetal Leydig cell
steroidogenesis (38, 39).
Classical estrogen action is mediated via an intracellular
receptor that, after steroid binding, interacts with specific
regions of DNA and acts as a transcriptional regulator for
selected genes (40). ER have been detected in the genital tract
of the male mouse using binding assays (41) and immuno-
cytochemistry (20). Within the testis, ER immunostaining
was present in interstitial cells, including Leydig cells, on
fetal days 15-19 (42). Tsai-Morris and co-workers (21) re¬
ported that exposure of fetal rat Leydig cells (day 21) in vitro
to estradiol resulted not only in a decrease in the synthesis
of testosterone, but also in an increase in ER detected by
binding assays. They concluded that the action of estrogens
was mediated at the level of the nucleus, consistent with the
action of estrogen being mediated via its receptor, because
incubation of isolated microsomes with estrogen failed to
affect enzyme activities (43). In the mouse, P450 aromatase
mRNA was detected in testes on and after day 17 (13), sug¬
gesting that fetal and neonatal testis have the capacity to
produce estrogens locally. Recent studies of mice in which
expression of the ER gene was disrupted selectively found
that the mature adult males were infertile because of im¬
paired spermatogenesis, but appeared to have anatomically
normal accessory organs (44).
DES is a known potent estrogen, and previous observa¬
tions in man (5) and animals (7) have indicated that it is likely
to exert adverse effects during the time of masculinization
and reproductive tract development. In contrast, there are no
published studies of the effects of OP at this time, although
it has been shown to be weekly estrogenic in vitro (45). OP
is an alkylphenolic compound formed as a metabolite of
some nonionic surfactants that are used widely in industrial
and some household detergents as plastic and petrol addi¬
tives, spermicides, dispensers for insecticides, etc. (46). How¬
ever, the level of human exposure is largely unknown. The
present data are the first to show that maternal exposure to
high levels of such compounds can suppress 17a-hydroxy-
lase activity. OP has been shown previously to bind to the ER
and stimulate estrogen-dependent growth of breast cancer
cells and gene expression in vitro to a similar extent as 17/3-
estradiol, albeit with approximately 1000-fold less potency
(45). Male trout exposed to low levels of OP (38.5 /ag/liter)
in the surrounding water synthesize vitellogenin, an estro-
gen-inducible protein normally only expressed in the female,
and as a result have reduced testis size (47). Our own studies
have shown that exposure of male rats to OP during gesta¬
tion and neonatal life, whether administered by injection or
via the drinking water (48), results in small, but significant,
reductions in testicular size and sperm production in adult¬
hood. These changes are thought to reflect alterations in
Sertoli cell number rather than altered Leydig cell function,
but it is possible that suppression of 17a-hydroxylase activity
could have contributed to these observations.
It is presumed that the present effects of DES and OP on
P450cl7 are the result of effects mediated via the ER, al¬
though it has been reported recently that the major and
persistent metabolite of DDT (l,l,l-trichloro2,2(p-chloro-
phenyl)ethane, p,p'-DDE (l,l-dichloro-2,2-bis(p-chlorophe-
nyl)ethylene), which had previously been implicated in the
induction of abnormalities in male sex development in wild-
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Fig. 4. Immunocytochemical staining of Leydig cells in fetal rat tes¬
tis using antibodies directed against P450cl7. a, Testis from control
group; b and c, testes from fetuses of mothers treated with 100 and
600 mg/kg OP, respectively; d and e, testes from fetuses of mothers
treated with 100 and 500 pg/kg DES, respectively. Note that specific
immunostaining ofP450cl7 is reduced in fetuses from the higher dose
treatment groups (c and e) compared with controls (a). Magnification,
X100; bar = 100 pm.
life, bound more efficiently to the androgen receptor than it
did to the ER (49) and that DES could also bind to the
androgen receptor. In the present study we do not believe
that the effects on Leydig cell 17a-hydroxylase activity ob¬
served after treatment with DES or OP reflect interaction at
the level of the AR, as our earlier studies have shown that the
' I r *
Fig. 5. Immunocytochemical staining of Leydig cells in fetal rat tes¬
tis using antibodies directed against 3/3HSD. a, Testis from control;
b, testis from 600 mg/kg OP treatment group; c, testis from 500 pg/kg
DES treatment group. Note that the number of Leydig cells appears
the same in all groups. Magnification, X100; bar = 100 fim.
few AR present within the testis at this time are not present
in Leydig cells (50).
The importance and effect(s) of reduced 17a-hydroxylase
enzyme activity induced by exogenous estrogens during fe¬
tal life and the consequent reduction in testosterone produc¬
tion are not clear. The formation of a testis with normal
appearance despite estrogen administration on day 11.5 (a
time before gonadal differentiation) suggests that expression
of the genes involved in gonadal differentiation, including
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Fig. 6. Level of 17a-hydroxylase en¬
zyme activity in fetal testes isolated on
day 17.5 of gestation from mothers
treated with vehicle (control; lane 1),
OP (600 or 100 mg/kg; lanes 2 and 3), or
DES (500 or 100 /xg/kg; lanes 4 and 5).
Each bar is the mean ± sem for eight
(control group) or six (all treated
groups) determinations using tissue
pooled from two male fetuses per deter¬
mination. *, P < 0.05; ***, P < 0.001
(compared with control group).
SRY and SOX-9 (51), was unaffected, although we have not
as yet addressed this question directly. Long term effects on
male reproductive function have been reported after mater¬
nal treatment with DES in both humans and rodents (5, 42),
although a recent survey did not find any evidence that long
term male fertility had been affected (6). However, the ques¬
tion remains as to whether extended exposure to low doses
of estrogens throughout life could have a long term and
deleterious effect on Leydig cell steroidogenesis. Evidence
that the effects of intrauterine exposure to low doses of es¬
trogen might be reflected in altered Leydig cell function in
adulthood is provided by an intriguing report from Nonne-
man and co-workers (52), in which they found that mice
differed in their adult reproductive characteristics according
to whether they developed in utero between two male fetuses,
which have higher testosterone levels, or between two female
fetuses, which have higher estradiol levels. They recorded
lower levels of 17a-hydroxylase activity in adult male mice
that had been adjacent to female fetuses than those next to
males, and higher androgen receptor in the prostates of these
same mice, leading to the conclusion that low level estrogen
exposure exerts a significant influence on androgen metab¬
olism and responsiveness.
In conclusion, our data show that maternal exposure to
estrogens such as OP and DES inhibits 17a-hydroxylase ac¬
tivity in the fetal rat testis. The mechanism(s) that bring about
this reduction and its consequences remain to be elucidated.
We cannot yet conclude that the reduction in enzymatic
activity and consequent reduction in androgen synthesis nec¬
essarily explain the incidence of reproductive problems in
male offspring from DES-treated mothers or the rise in the
reported incidence of similar problems in the general pop¬
ulation. However, the present observations suggest that the
effect of long term exposure to estrogenic chemicals, espe-
nn, Control_±SEM
^ n=5 litters (32 testes)
□ OP (100mg/Kg) ±SEMn=3 litters (24 testes)
k™ OP (600mg/Kg) ± SEM
^ n=3 litters (24 testes)
^ DES (100jig/Kg)±SEM
n=3 litters (24 testes)
DES (500gg/Kg)±SEM
^ n=3 litters (24 testes)
dally environmental estrogens, on Leydig cell function needs
to be more fully explored.
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Differential patterns of expression of DAX-1 and steroidogenic factor-1 (SF-1)
in the fetal rat testis.
GREGOR MAJDIC and PHILIPPA T.K. SAUNDERS*
MRC Reproductive Biology Unit, 37 Chalmers Street, Edinburgh EH3 9EW, UK.
ABSTRACT Gonadal differentiation is dependent upon a cascade of molecular and morphological events.
Steroidogenic factor 1 (SF-1) and DAX-1 have been implicated in this process. A SF-1 binding site has been
reported to be present on the DAX-1 gene. We therefore used immunocytochemistry to determine whether these
two transcription factors are co-expressed in tire fetal testis. DAX-1 was immunolocalised to the cytoplasm of
interstitial cells from fetal testis of rat and human from day 15.5 and 16 weeks of gestation respectively. SF-1
was detected in nuclei of fetal Sertoli and interstitial cells. In the fetal rat expression of SF-1 in interstitial
cells was not uniform; cells with abundant SF-1 all contained 3-fSHSD and were classified as Leydig cells.
DAX-1 expression was not exclusive to cells which contained SF-1 and SF-1/DAX-1 co-expressing cells were not
exclusively fetal Leydig cells. We conclude that in the fetal testis expression of the DAX-1 protein is not
dependent upon the presence of SF-1 although SF-1 is present at an earlier stage of gestation in the gonad.
DAX-1 may therefore play a separate or complementary role to that of SF-1 in the modulation of testicular
gene expression and differentiation.
In the past few years a number of new genes
expressed during the period of fetal gonadal
development have been identified (1, 2) although
the role(s) of most have yet to be elucidated. One
gene product shown to play an essential role in
gonadal development and steroidogenesis is the
transcription factor steroidogenic factor-1 (SF-1) (3,
4). Another gene, DAX-1, has been localised to the
interval on the X-chromosome associated with
dosage-dependent sex reversal (5). The DAX-1
protein has been shown to bind to DNA (6) and in
common with SF-1, DAX-1 appears to be a member
of the nuclear receptor hormone superfamily (7, 8)
the ligand(s) of which are as yet unidentified.
Notably a putative SF-1 binding element has been
identified in the 5' flanking region of human DAX-
1 and binding has been demonstrated in vitro (9).
However, the question of whether SF-1 may
determine DAX-1 expression has not been explored
in vivo.
We have investigated the patterns of
expression of SF-1 and DAX-1 in the fetal testis and
present the first photographic evidence of the
pattern of immunoexpression of DAX-1 in the fetal
testis of human and rat. Notably, SF-1 is
synthesised within fetal testicular cells at an
earlier stage of development and in a wider range
of cells than the DAX-1 protein. Within the
testicular interstitium expression of DAX-1 protein,
as determined by immunocytochemistry, occurs in
SF-1 positive as well as SF-1 negative cells.
*to whom correspondence should be addressed
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Materials and methods
Animals and Tissues Fetal tissues were obtained
from timed mated rats on days 13.5 to 20.5 of
gestation and fixed in Bouin's as described
previously (10). Human fetal testis fixed in Bouin's
were from a collection at the MRC Human Genetics
Unit, Edinburgh accumulated from routine autopsy
examinations between 1991 and 1993.
Immunohistochemistry Immunolocalisation was
carried out on 5g sections mounted on coated slides
using our standard methods (10) except that human
tissues were not microwaved Rabbit anti-human
DAX-1 was purchased from Santa Cruz
Biotechnologies (Santa Cruz, CA) and used at 1:100.
The antibody was reported to bind to DAX-1 of
human, mouse and rat origin on Western blots.
Rabbit anti-bovine AdBP4 (SF-1) was a kind gift
from Dr Ken-ichirou Morohashi (Kyushu
University, Japan) and was used at 1:200. Rabbit
anti-human 3-beta hydroxysteroid dehydrogenase
(3-flHSD) was a kind gift from Professor Ian Mason
(University of Edinburgh, UK) and was used at
1:1000. Sections were counter stained with
hematoxylin. Specificity of the antibodies was
checked by either replacing the primary, antigen-
specific antiserum with normal rabbit serum or by
preabsorption with peptide.
Results
DAX-1 immunostaining in fetal testis
In the fetal testis of the rat (Fig la) and human
(Fig lb) DAX-1 was immunolocalised to the
cytoplasm of interstitial cells. In the rat weak
immunostaining was first detectable on day 15.5 p.c.
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Fig. 1 Immunolocalisation of DAX-1 protein to interstitial
cells of the fetal testis. Panel a, fetal rat testis day 18.5 of
gestation; panel b, fetal human testis 24 weeks gestation.
Note the absence of expression of DAX-1 in Sertoli cells
within the seminiferous cords and the cytoplasmic
localization of the protein in these fixed tissue sections
(arrows). Bar = lOOgM
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(not shown). The intensity of immunostaining
remained low on day 16.5 but increased thereafter
(Fig la, day 18.5 p.c.) and remained strong
throughout fetal life. Staining was also observed
in a perinuclear region of some fetal gonocytes but
this was non-specific. In the human weak
immunostaining for DAX-1 was present at 16 weeks
gestation (earliest age examined) and was
increased in intensity at 18 (not shown) and 24
weeks (Fig lb) of pregnancy. No immunostaining of
interstitial cells was observed when the antiserum
was preabsorbed with the cognate peptide or when
the primary specific antiserum was replaced by
non-immune serum (not shown). In the rat DAX-1
was also detected in the cytoplasm of interstitial
cells in adult testis as well as in the fetal ovary
and in the cortex of the fetal adrenal gland (not
shown).
Relationship between DAX-1 positive cells and
those expressing SF-1 and 3-/5HSD in fetal rat
testis
Consistent with previous reports (3, 4) SF-1 was
immunolocalised to interstitial and Sertoli cell
nuclei on day 14.5 p.c. The intensity of
immunostaining remained higher in interstitial
than Sertoli cell nuclei throughout gestation in the
rat. On day 17.5 (Fig 2) intensity of immunostaining
within nuclei of interstitial cells was variable
however those containing abundant nuclear SF-1
appeared to be steroidogenically active Leydig
cells as they also contained cytoplasmic 3p-HSD
(Fig. 2a intense blue). In contrast to SF-1 the
population of interstitial cells containing DAX-1
was more restricted (Fig 2b blue color) Not all
DAX-1 positive cells contained SF-1 in their nuclei
(Fig 2b arrows) and many interstital cells
containing SF-1 were DAX-1 negative (Fig 2b,
arrowheads). Co-localization of SF-1 and DAX-1
did not appear to be confined to presumptive fetal
Leydig cells.
Discussion
DAX-1 and SF-1 are both believed to act as
transcriptional regulators and have been proposed
as modulators of gene expression during gonadal and
adrenal development. The demonstration that
gonadal development fails to occur normally in SF-
1 knockout mice has convincingly shown that
expression of this protein is essential during fetal
life (3). The precise role(s) of DAX-1 in the gonad
have yet to be elucidated although it has recently
been reported that DAX-1 mRNA is expressed in
the gonadal ridge and in the adult testis of the
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mouse (6, 11). The presence of an SF-1 binding site
on DAX-1 (9) led us to anticipate that SF-1 might
co-localise with DAX-1 in the fetal testis and/or be
expressed in a less mature cell type. These results
demonstrate for the first time immunolocalization
of DAX-1 to fetal testis of rat and human. In
contrast to SF-1 which was detected in the nuclei of
both interstitial and Sertoli cells, specific DAX-1
immunostaining was present only in cells within
the interstitium. DAX-1 protein was first
detectable by immunocytochemistry on day 15.5 of
gestation in the rat and at 16 weeks of gestation in
the human. Studies using a homologous cDNA
probe to determine the pattern of expression of
DAX-1 mRNA by in situ hybridisation are planned
to address the issue of whether a wider population
of cells within the fetal testis express DAX-1
mRNA than has been detected by
immunocytochemistry in the present study.
DAX-1 was localised to the cytoplasm of
interstitial cells in fixed tissue sections from both
rat and human during fetal life. This finding is
somewhat surprising as the presence of putative
DNA and ligand binding domains in DAX-1 suggest
this protein, like SF-1, may function as a
transcription factor (6). In the same sections SF-1
was found exclusively in cellular nuclei consistent
with previous data using frozen tissue sections (4).
We have as yet no explanation for the localization
of DAX-1 but have seen a similar pattern of
staining using antisera directed against peptides of
the estrogen receptor (unpublished observations)
but not the androgen receptor (10) on fixed sections
of fetal testis processed in an identical way to those
in the current paper. Estrogen receptors have been
reported to undergo nucleocytoplasmic shuttling
which is energy dependent (12). Previous
investigations using frozen tissue sections have
reported that monoclonal antibodies localize to
nuclei of target cells (13) and we speculate that in
the case of ER, and possibly DAX-1, the fixation of
the tissue may have influenced the subcellular
localization of the protein in keeping with results
reported for the glucocorticoid receptor (14).
Fig. 2 Co-localisation of SF-1, 3(5-HSD and/or DAX-1 to
interstital cell populations in the fetal rat testis on day
17.5 of gestation, Panel a, double immunolocalisation of
SF-1 and 3(1-HSD. SF-l(brown color) is present in the
nuclei of all cells expressing 3(5-HSD (intense blue color) in
their cytoplasm (steroidogenic Leydig cells). SF-1 is also
present in the nuclei of other interstitial cells and Sertoli
cells within the seminiferous cords; panel b, double
immunolocalisation of SF-1 (brown color) and DAX-l(blue
color). Some interstital cells contain SF-1 but no DAX-1
(arrowheads), others contain DAX-1 but no SF-1 (arrows)
whilst co-localisation is also observed. Bar = lOOpM
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A recent study (11) detected DAX-1 mRNA in
mice using RNase protection and whole mount in
situ hybridization. DAX-1 mRNA was present in
the interstitial cell compartment in adult mice and
was presumed to be in the adult Leydig cells.
However in the fetal mouse DAX-1 mRNA was
present on day 11.5 p.c. (approximately equivalent
to day 13 in the rat) and declined after day 12.5 a
finding apparently at odds with the present study
although no protein data are included in that study
(11) and a direct comparison between species is
therefore not possible. In a preliminary experiment
we have been able to detect significant amounts of
DAX-1 mRNA in fetal rat testis on day 17.5 by
Northern blotting (unpublished observations).
Immunolocalization of SF-1 in interstitial cells
in the fetal rat testis was not uniform and double
immunostaining revealed that those cells
containing abundant nuclear SF-1 also contained the
steroidogenic enzyme 3P-HSD expressed in fetal
Leydig cells (15). It has been reported that fetal
Leydig cells have no mitotic activity and therefore
the increase in their numbers occurring between
days 16.5 and 18.5 of gestation in the rat, at a time
when DAX-1 is expressed, may be due to
recruitment and differentiation of mesenchymal-
type interstitial cells (15). In a previous study, we
identified a population of fetal interstitial cells
that were immunopositive for androgen receptor
(AR) but not for 3p-HSD (10), and which we
proposed could be progenitors of Leydig cells. The
DAX-1 positive cell population identified in the
current study may overlap partially with those
containing AR but it has not yet been possible to
evaluate this. Interestingly, no DAX-1
immunostaining was detected in Sertoli cells
although these contained SF-1. We conclude that
whereas SF-1 may regulate DAX-1 expression in
other tissues such as the adrenal, in the testis the
situation is complex and SF-1 and/or DAX-1 acting
individually or together may modulate gene
transcription and functional differentiation of fetal
interstitial and Leydig cells.
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Abstract
Androgens are required for the development of male
internal and external genitalia. Androgen action is medi¬
ated by an intracellular receptor which acts as a transcrip¬
tion factor following activation by ligand binding. The aim
of the present study was to define the time of appearance
of androgen receptor (AR) in the male fetal rat gonad
using immunohistochemistry. Intact fetuses (days 13-5—
16-5) or testicular tissue (days 16-5—20-5 and days 3—7
postnatal) were fixed in Bouins' solution and processed
into paraffin wax. On day 16-5 nuclear AR were present
in mesenchymal cells surrounding the Wolffian duct but
those around the Mullerian duct were receptor negative.
During the following day (17-18) the abundance of
nuclear staining increased, becoming detectable in the
epithelial cells of the Wolffian ducts. Within the testis
some nuclear staining was apparent at day 17 but was
confined to interstitial cells surrounding the seminiferous
cords. As development of the testis proceeded the abun¬
dance of nuclear AR in peritubular and elongated
mesenchymal cells increased. AR were not detected in
fetal Leydig cells expressing 3(3-hydroxysteroid dehydro¬
genase nor in the ovaries or associated ducts of female
fetuses at the same ages.
In conclusion, in the rat we have found AR expression
detectable by immunohistochemistry in mesonephric mes¬
enchyme to be confined to that underlying the Wolffian
ducts and to be absent from the area around the degen¬
erating Mullerian duct. On and after day 17 of gestation
AR is present in Wolffian duct epithelial cell nuclei and
within the testis it is confined to peritubular and interstitial
cells which may have migrated from the mesonephros.
Fetal Leydig cells were receptor negative. Within the
seminiferous cords AR in Sertoli cells remained low until
after birth and some perinuclear staining was detected in
cells thought to be gonocytes. We believe this to be the
first report of immunolocalisation ofAR to fetal testicular
interstitial cells.
Journal of Endocrinology (1995) 147, 285-293
Introduction
Androgens are essential for masculinisation of the repro¬
ductive tract and the external genitalia during develop¬
ment in utero (see George & Wilson 1994). Androgen
action is mediated by a specific intracellular receptor
expressed in target tissues which binds to testosterone and
dihydrotestosterone with high affinity (Carson-Jurnica
et al. 1990). Ligand binding is essential for activation of the
receptor which then binds to specific targets on DNA
resulting in modulation of the level of gene expression
(Rundlett et al. 1990). In the absence of a functional
i androgen receptor protein genetic males (XY karyotype)
develop a female phenotype (androgen insensitivity
syndrome, Griffin & Wilson 1989).
In the fetus the gonads develop along the inner surface
of the mesonephros. On day 13 post coitum (p.c.) in the
rat, germ cells can be recognised among the differentiating
Sertoli cells and on day 14 cells within the testis can be
seen to be organised into distinct cords with germ cells
surrounded by Sertoli cells (Pelliniemi et al. 1993). Syn¬
thesis of anti-Mullerian hormone mRNA by the Sertoli
cells can be detected on day 13 in the rat (Lee & Donahoe
1993) and production of testosterone by fetal Leydig cells
is reported to start on day 15-5 p.c. and to be maximal on
days 18-5-19-5 (Warren et al. 1972).
Cooke et al. (1991) examined expression of androgen
receptor protein (AR) in male reproductive organs (ex¬
cluding the testis) of the mouse from day 13 onwards using
a ligand binding method. They reported the presence of
binding in mesenchymal cells at all times examined but
found epithelial expression ofAR to be delayed, with only
the epithelium of the efferent ductules positive on day 16
(approx. rat day 18). Androgen receptors have been
detected, using immunocytochemistry, in external geni¬
talia of both male and female human fetuses at 18—22
weeks of gestation after the time of androgen-dependent
differentiation of the external genitalia (Kalloo et al. 1993).
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Recently we have successfully used an antigen retrieval
method (Shi ct a I. 1993) in combination with a specific
anti-androgen receptor antibody to visualise stage-
dependent expression ofAR in nuclei of Sertoli cells of the
rat during the spermatogenic cycle (Bremner ct al. 1994).
In view of the important role of androgen in the devel¬
opment of normal male phenotype (Griffin & Wilson
1989) and testicular function in the adult (Sharpe 1994)
we decided to use immunohistochemistry to determine
the ontogeny of AR expression in the rat testis and
associated ducts. We have found that the first expression ot
AR within the fetal rat testis occurs in interstitial cells on
or about the end of day 17 of gestation. Significant nuclear
staining is not seen in Leydig cells or in Sertoli cells during
fetal life. Mesenchymal cells surrounding ducts destined to
form the epididymis and seminal vesicles contain abundant
nuclear AR on day 16-5 whilst the cells surrounding the
degenerating Mullerian duct are AR negative.
Materials and Methods
Animals and tissues
Adult female Wistar rats (aged 90-100 days) obtained from
our colony were maintained under standard animal house
conditions. Timed matings were carried out by the intro¬
duction ofan adult male and the presence of a vaginal plug
in the morning was taken as evidence ofmating during the
previous 12 h (day 0 5). Animals were killed by inhalation
of carbon dioxide and subsequent cervical dislocation.
Whole fetuses (days 11-5—17-5) and testes and kidneys
dissected from fetuses on days 16'5—20'5 (delivery on day
21—23 in our colony) and from neonates (days 3, 5, 7) were
immersion-fixed in Bouins' solution for 6—7 h prior
to processing into paraffin wax (see Millar et al. 1993).
The age of the fetuses was confirmed by morphological
examination (see Kaufman 1992).
Histology and immunohistochemistry
For examination of testicular histology during fetal life,
serial sections (5 microns) were cut through fetuses which
had been oriented in paraffin blocks using heated forceps
(see Kaufman 1992), mounted on slides and stained
with haematoxylin and eosin. To perform lmmunocyto-
chemistry, sections (5 microns) were cut and mounted on
slides coated with 3-aminopropyl triethoxy-silane (Sigma
Chemical Co., Poole, Dorset, UK), dried overnight
(50 °C), dewaxed, rehydrated in graded ethanols, washed
in water, submerged in 0-01 M citrate buffer (pH 6) and
microwaved on full power (650 W, 4 times 5 min). After
standing for 20 min without disturbance in the microwave
oven, sections were washed once (5 min) in TBS (0-05 M
Tris—HC1 pH 7 4, 0 85% NaCl) and blocked using normal
swine serum diluted in TBS (1:5, NSS-TBS). Anti-human
androgen receptor antibody raised in rabbits against the
first 17 amino acids of the AR which are conserved
between rat and human, was purchased from Novocastra
(Newcastle, UK). This polyclonal antibody was diluted
1:20 in NSS-TBS (see above) and incubated on the
sections overnight at 4 °C under plastic coverslips. Control
sections were incubated either with non-immune rabbit
serum (diluted 1:20) or antiserum which had been
incubated with a 20-fold excess of free peptide (hAR
1-17). After removal of coverslips, sections were washed
twice in TBS (5 min), incubated for 30 min with bio-
tinylated swine anti-rabbit immunoglobulin (Dako, High
Wycombe, Bucks, UK) diluted 1:500 in NSS-TBS, then
washed again in TBS (2 times 5 min). For detection of
bound antibodies, sections were first incubated with alka¬
line phosphatase conjugated to avidin-biotin complex
(Dako) for 30 min, washed in TBS (2 times 5 min),
followed by a final wash in Tris—Mg buffer (100 niM
Tris-HCl pH 9 5, 100 mit NaCl, 50 mm MgCl2). Colour
reaction product was developed by incubation in a solution
containing 337-5 pg/ml nitro-blue tetrazolium, 175 pg/ml
5-bromo-4-chloro-3-indolyphosphate and 1 mm levami-
sol in Tris-Mg buffer for 30-120 min (de Jong et al. 1985).
Sections were counterstained with haematoxylin, dehy¬
drated in absolute alcohol, cleared in xylene and cover-
slipped using Pertex mounting medium (Cell Path pic,
Hemel Hempstead, Herts, UK).
To determine which cells within the interstitial region
of the fetal testis belonged to the Leydig cell population,
immunostaining using antibodies against androgen recep¬
tor (as described above) was followed by that using rabbit
anti-human 3(3-hydroxysteroid dehydrogenase (3p-HSD;
Lorence et al. 1990) kindly donated by Professor Ian
Mason, Department of Clinical Biochemistry, University
ot Edinburgh. Immunostaining with anti-AR was fol¬
lowed by a quick wash in double distilled water and 2
washes in TBS (5 min each). Sections were blocked with
normal swine serum (diluted 1:5 in TBS) for 30 min,
followed by incubation with antibodies against 3P-HSD
(1:500 dilution) overnight at 4 °C. Sections were washed
twice in TBS (5 min each wash), incubated with swine
anti-rabbit immunoglobulins (Dako) for 30 min at room
temperature, washed again 2 times 5 min in TBS and
incubated with rabbit peroxidase-antiperoxidase complex
(Dako) for 30 min at room temperature. After two washes
in TBS, sections were equilibrated for 5 min in 0-02 m
sodium acetate buffer (pH 5-2). Colour reaction was
developed by incubation in a mixture of 0-02% 3-amino-
9-ethylcarbazole (Sigma) in 10 ml 0-02 m sodium acetate
buffer (pH 5-2) containing 1-2 ml dimethylsulphoxide
(DMSO; BDH, Merck Ltd, Lutterworth, Leics, UK) and
0 01% hydrogen peroxide. After 5-10 min, sections were
washed in double distilled water and coverslipped using
aquamount (BDH) mounting medium. Specificity of the
3P-HSD antibody was checked by using normal rabbit
serum; no colour reaction was obtained.
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fiCL'Rl- 1. Development of the rat fetal testis: sections are from fetuses of timed mated females. Fetuses were fixed in Bourns'
solution and stained with haematoxylin and eosin. (a) Testis and associated structures 011 day 14-3 of gestation; testis containing
identifiable seminiferous cords (sc), tn =Mullerian duct, w=Wolfhati duct, mt—inesonephric tubules, *—niesorchium. (b) Dav 17-5
of gestation. Labelling as in (a). Note increased testis size, distinct solid seminiferous cords, and absence of a Mullerian duct.
Bar= 100 (am.
Results
Fctiil development of the testis
In the fetuses recovered from timed mated females in our
colony male and female gonads were first easily distin¬
guishable from each other tin dav I 4 5 at which time the
testis appeared larger than the corresponding ovarv and
there was some organisation into seminiferous cords giving
it a characteristic 'striped appearance (Fig. In). The
appearance of the rat testis on dav 15-5 appeared compar¬
able to that of a day 1.V5 mouse embrvo illustrated in
Kaufman's Atlas of Mouse Development : Kaufman 1002).
On day 17 a. w ithin the testis distinct seminiferous cords
containing germ cells could be distinguished ensile dag.
1 />. labelled SO 1 surrounded lw the cells ot the iiitersiitmin.
Outside the testis the Mullen::' dec: was no longer
distinct on dav 17 w hilst, in contrast, the Wolffian unci
and incsonephric tubules were enlarged lag. IN.
Detection ot iintlwoen receptor by iiiiiiuiiioltistoclicinistry
In the testis and associated structures there was no clear
immunolocalisation of nuclear AR protein on or before
day 15-5. On dav 16-5 (Fig. 2<i) nuclear AR was clearly
present in the nuclei of mesenchymal cells surrounding the
Wolffian duct and within the epithelium of the meso-
nephric tubules and their undcrlving mesenchyme, but
was absent from the cells around the Mullerian duct. The
central region of the degenerating mesonephros was onlv
weaklv positive. Ai this time the adrenal gland, tinnitus
and mamiiiars gland rudiment were all stained positively
'not shown'r As dav K> progressed and on day 1/ (Fig.
2/1.ct nuclear staining of mesenchvmal cells surrounding
tile ducts increased and staining of nuclear AR in the cells
ol the 'niiiieimu. o| the W'ollli.in duct became more
nr..:,..;;:. . a , '• : . lew AR positive cells were
pr seni .-. ■;:11;i n ;-.s;s . a: md these were confined to
tie- mi, ia: a ur.ed arrow. In female letuses
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figurl-: 2. Immunocytochemical localisation of cells containing AK protein in testes and associated ducts and their underlying
mesenchyme on days 16-5—18*3 ot gestation, (a) On dav 16-5 AK protein is clearly present in the nuclei of cells within the
mesenchymal cells surrounding the Wolffian duct (arrow ed, w) and within the epithelium of the mesonephric tubules (arrowed,
mt) and its underlying mesenchyme, but is absent from the cells around the degenerating Mullerian duct (arrowed, 111). The
central region of the degenerating mesonephros is onlv weakly positive. A few cells of the interstitial population between the
seminiferous cords within the testis are positive (curved arrow ). I hiring day 17 ((b) 17 0. (c) 17-5) nuclear staining of mesenchymal
cells surrounding the developing ducts is strongly positive and nuclear AK in the epithelium of the Wolffian duct is very
prominent (arrow). Even late on day 17 few AK positive cells .ire present within the testis (curved arrowk (d) Isolated testis and
mesonephric tubules from dav ISA. The testis has been cut so that the seminiferous cords are seen in longitudinal section. Positive
AK staining within the testis is confined to interstitial celK (curved arrows). Sections were counterstained with haematoxylin.
mn =mesonephros. Bar= mx) um.
lournal of l:ndociinoloi>\
Fetal androgen receptors ■ c, maidic and others 289
examined at the same ages no specific AR nuclear staining
was ever observed in the ovary or Mullerian ducts (not
shown).
In testes isolated from rat fetuses towards the end of
pregnancy (days 18 5—20 5) nuclear All was immuno-
localised to the cells forming a narrow layer around the
individual tubules (Fig. 2d curved arrows, Fig. 3a,b). The
location of these cells would be consistent with identifi¬
cation as peritubular myoid cells which form a distinct
unicellular layer around the seminiferous tubules in the
adult rat testis (Skinner 1991). Other cells within the
interstitial area including the central mesenchyme of
the testis (Fig. 3b) were also AR positive. Outside the testis
mesenchymal cells underlying the Wolffian duct and
mesonephric tubules and the respective epithelial cells
contained abundant nuclear AR (Fig. 3a,b). Although
Sertoli cell AR nuclear immunostaining was clearly dis¬
tinguishable on postnatal days 3, 5 (Fig. 3c) and 7 it
remained significantly lower than that detected in the
adjacent peritubular cells and other interstitial cells. Pre-
absorption of antiserum with AR peptide abolished
specific immunostaining (Fig. 3d).
In order to address whether cells within the interstitial
population were members of the Leydig cell population,
double immunostaining with antibodies directed against
AR and 3J3-HSD, a constitutively expressed, steroidogenic
enzyme essential to production of testosterone by Leydig
cells (Payne & Youngblood 1995), was undertaken. The
results obtained (Fig. 4) clearly demonstrated that nuclear
AR immunostaining was confined to cells which did not
express 3(3-HSD and that on the days examined (days
17-5-19-5 p.c.) the fetal Leydig cell population did not
appear to be responsive to androgens via the AR.
Discussion
In the fetal rat testis synthesis and secretion of testosterone
is detectable on day 15 5 following almost immediately
after differentiation of the fetal Leydig cells from mesen¬
chymal cells surrounding the primitive sex cords. Maximal
output of testosterone by the fetal Leydig cells occurs on
days 18 5—19-5 at the time when numbers of cells are at
their highest (reviewed by Huhtaniemi 1994). Androgens
act via a specific intracellular receptor that interacts with
nuclear DNA to bring about changes in the expression of
androgen responsive genes (reviewed in Parker 1991).
Androgens, and a functional androgen receptor, are essen¬
tial for normal development of male genitalia and a
number of studies have addressed the timing and distri¬
bution of androgen receptors in the developing urogenital
system using binding assays (Takeda ct al. 1985, Cooke
ct al. 1987, 1991). These studies and those using in vitro
approaches have implicated the cells of the mesenchyme as
the primary targets for androgen action during fetal life.
This concept is supported bv the results obtained when
mesenchymal or epithelial samples from Tfm mice (which
have a defect in their AR) were used in combination with
those from normal animals; the presence of a normal AR in
the mesenchymal cells was found to be essential for
development (Lasnitzi & Mizuno 1980). In the current
study we have identified clear and abundant nuclear AR
m mesenchymal cells surrounding the Wolffian duct on
day 16 of pregnancy. However, AR were not distributed
uniformly throughout the mesenchymal cells within the
mesonephric area being absent from the cells surrounding
the Mullerian duct, which is destined to regress under the
influence of anti-Mullerian hormone (AMH/M1S; Lee &
Donahoe 1993), and sparse in the central region directly
adjoining the testis. Some cells within the epithelial layer
of the Wolffian duct, especially in the area which will
develop into the epididymis, contained nuclear AR on day
165 and the nuclei of nearly all the epithelial cells of the
ducts were positively stained for AR on and after day 17.
The present results are consistent with the location ofAR
described in earlier reports using ligand binding but seem
to place expression ofAR in the epithelial cells of the ducts
one to two days earlier than might have been expected
front reports in the mouse (Cooke et al. 1991) reflecting
the greater sensitivity of the immunohistochemical tech¬
nique. The results also show that expression ofAR within
the mesenchymal cells of the mesonephric region is not
uniform.
In the adult testis the primary target for androgen action
is believed to be the Sertoli cells within the seminiferous
epithelium (reviewed by Sharpe 1994) although both
peritubular myoid cells and Leydig cells also express AR.
In the rat only the Sertoli cells were found to exhibit
stage-dependent expression of nuclear AR (Bremner et al.
1994) which correlates with the reported stage-dependent
effects of testosterone (Sharpe et al. 1992). In the fetal rat
we failed to find convincing immunolocalisation ofnuclear
AR in the testis before day 17 p.c., at which time a few
cells of the interstitial cell population did appear positive.
As testicular development progressed the number of cells
m the interstitial cell population with AR nuclear
immunostaining increased. Based on their locations within
the testis and lack of staining with antibody against
3P-HSD we would identify these AR positive cells as
being peritubular and interstitial mesenchymal cells, both
of which have a fibroblastic appearance. In the adult testis
peritubular myoid cells around the tubules have been
shown to contain AR (Verhoeven 1980, Bremner ct al.
1994). In an interesting series of experiments in vitro,
Buehr ct al. (1993) found that cells from the mesonephric
region migrated into the testis on or after day 11-5 p.c. in
the mouse and contributed to the interstitial cell popu¬
lation including those in the peritubular layer. In the
absence of an influx of cells from the mesonephros normal
differentiation of testis cords did not occur, consistent with
the synthesis of components of the extracellular matrix by
peritubular cells contributing to organisation of the testis.
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ricuin 3. Immunocytochemical detection of nuclear androgen receptor in presumptive peritubular cells surrounding seminiferous
tubules from day 19-5 of gestation and in Sertoli cells after birth. As pregnancy progresses and the testis continues to enlarge the
amount of nuclear All distinguishable within the testis increases but remains confined to the interstitial cell population especially
the presumptive peritubular cells surrounding the solid seminiferous cords (arrows), (a) Day 19 5. (b) day 20*5. Staining of Sertoli
cells (arrowheads) was not convincing until after birth (see (c)) although on day 20\5 sometimes cells within the seminiferous cords
did appear to have faint perinuclear staining (arrowheads) and these were provisionally identified as gonocytes. After birth (c) (day
5) All immunostaining in peritubular cells was strong and some All could be detected within the seminiferous cords. The
specificitv of staining w as checked by preabsorption of the antibody w ith excess peptide fd). All sections were counterstained with
haeinatoxviin. Bar— l'1'' um.
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ncum. 4. Inimuiiostaiiiing of 19-5-day-old fetal rat testis with antibodies directed against AK and
5(3-HSI), a steroidogenic enzyme expressed only in Leydig cells. Cytoplasm of the Levdig cells stained
strongly positive w ith antibodies against the steroidogenic enzyme ifr-HSI) (light brown staining, asterisks).
However, the Leydig cells nuclei do not show any staining with antibodies against AR (thin arrows). In
contrast, peritubular cells and interstitial mesenchymal cells have nuclei immunostained usine anti-AR
(curved arrows). Bar= U.K.) jam.
In the context of the current findings it is interesting to
speculate that the cells in the fetal testis containing AR
have developed from the same cell population which
expresses AR in the mesonephros and which we were able
to imniunostain on day 16'5 p.c. Previous studies have
suggested that a peritubular sheath of cells is present at
birth but these do not become 'myoid' cells until pubertv
and they do so under the influence of testosterone (Bressler
A Ross 1972, Skinner 1991). Our results demonstrating
abundant immunostainmg of AR would indicate that the
peritubular cells have the potential to be responsive to
androgens during fetal lite and this mav have implications
ror the development of the fetal testis. Peritubular cells
rrom immature rats (postnatal davs 15—25) have recently
been shown to secrete activin-A (de Winter ct al. 1994)
and to respond to androgens with increased expression of
.m androgen response element reporter (Ku ct <//. 19941.
Previous studies have shown that, at this time, thev can
-ccrete a range of growth factors and regulatory agents
reviewed by Skinner 19911 the production of some of
hicb may be testosterone dependent and influence
function of the fetal testis.
In the results of double immunostaining experiments
we found evidence of three clear populations of interstitial
cells; the peritubular cells discussed above. AR positive
cells with elongated nuclei and clumps of fetal Leydig cells
which contained no AR. We speculate that the AR
positive mesenchymal-like interstitial cells might be pro¬
genitors of the fetal Levdig cells and that androgen action
could play a role in their differentiation. In immature rats,
differentiation of adult type Leydig cells from mesenchy¬
mal progenitor cells has been reported to be advanced by
androgen and luteinizing hormone (LH) (Hardv ct ai
199(1. Shan ct <;/. 19951 and it is notable that expression of
LH receptors is reported to occur in the fetal rat testis on
and after dav 15-5 (Warren ct ,tl. 1984). We found positive
staining of AR protein within Sertoli cells of the semin¬
iferous cords was generally unconvincing prior to birth
although m some sections we did observe perinuclear
staining in large round cells which we believe to be
gonoevtes (Clermont A Perev 1957). Previous reports
have demonstrated an increase in the expression of AR in
immature Sertoli cells of the rat over the period when
spermatogenesis is becoming established between davs
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14 and 28 of postnatal life and establishment of stage-
dependent immunostaining of Sertoli cells in the rat
(Bremner ct al. 1994, Kit ct al. 1994).
To detect the AR protein in our sections of fixed tissue
it was necessary to undertake antigen retrieval of the
samples by microwaving in citrate buffer (Shi et al. 1993).
In the absence of this pretreatment, which was rec¬
ommended by the supplier of the antiserum, no im¬
munostaining was detected (M R Millar, unpublished
observations). In a separate study using adult rat testes AR
immunostaining of Sertoli cell nuclei at stages IV-VII has
been reported both following antigen retrieval (Bremner
ct al. 1994) and in samples embedded in polyester wax and
not subjected to antigen retrieval (Vornberger et al. 1994).
The immunogen used to raise the antiserum used in this
study is located at the extreme N terminal end of the
receptor protein in the region associated with ligand
independent-transcriptional activation (Jenster et al. 1991).
Antigen retrieval, due to the high temperatures used, is
believed to cause 'unmasking' of antigenic sites and has
been particularly applicable to proteins with a nuclear
location, and can sometimes be mimicked by treatment of
sections with proteolytic enzymes (Shi et al. 1993). AR are
known to associate with other proteins both before and
after ligand binding (Carson-Jurnica et al. 1990) and a
recent study has shown retention of receptor-bound an¬
drogen is enhanced by an interaction between the AR N
terminal and steroid binding domains (Zhou et al. 1995).
We have not determined whether the detection ofAR by
the antibody directed against the N terminal epitope is
dependent upon the conformation of the AR protein but
in previous investigations have assumed that imnruno-
histochemical localisation of AR reflects the presence
of an active ligand receptor because of the correlation
with known sites of androgen action (Bremner et al.
1994).
In conclusion, we have shown that some cells within the
mesonephric mesenchyme contain AR as early as day 16
of gestation, consistent with these cells being a primary
target of androgen action, but that cells around the
Mullerian duct remain receptor negative. In the fetal rat
testis AR detected by immunohistochemistry are confined
to cells of the interstitial population which may have
migrated from the mesonephros, but are absent from
Leydig cells. In the rat, androgen action within the testis
during fetal life seems likely to be confined to the
peritubular and interstitial mesenchymal cell population.
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